id	sid	tid	token	lemma	pos
dpc-3378	1	1	dermatology	dermatology	NOUN
dpc-3378	1	2	:	:	PUNCT
dpc-3378	1	3	practical	practical	ADJ
dpc-3378	1	4	and	and	CCONJ
dpc-3378	1	5	conceptual	conceptual	ADJ
dpc-3378	1	6	review	review	NOUN
dpc-3378	1	7	|	|	ADV
dpc-3378	1	8	dermatol	dermatol	ADJ
dpc-3378	1	9	pract	pract	NOUN
dpc-3378	1	10	concept	concept	NOUN
dpc-3378	1	11	.	.	PUNCT
dpc-3378	2	1	2024;14(1):e2024038	2024;14(1):e2024038	NUM
dpc-3378	2	2	1	1	NUM
dpc-3378	2	3	the	the	DET
dpc-3378	2	4	role	role	NOUN
dpc-3378	2	5	of	of	ADP
dpc-3378	2	6	sentinel	sentinel	ADJ
dpc-3378	2	7	node	node	ADJ
dpc-3378	2	8	biopsy	biopsy	NOUN
dpc-3378	2	9	in	in	ADP
dpc-3378	2	10	the	the	DET
dpc-3378	2	11	era	era	NOUN
dpc-3378	2	12	of	of	ADP
dpc-3378	2	13	 	 	SPACE
dpc-3378	2	14	adjuvant	adjuvant	ADJ
dpc-3378	2	15	therapy	therapy	NOUN
dpc-3378	2	16	for	for	ADP
dpc-3378	2	17	melanoma	melanoma	PROPN
dpc-3378	2	18	gabriella	gabriella	PROPN
dpc-3378	2	19	brancaccio1	brancaccio1	PROPN
dpc-3378	2	20	,	,	PUNCT
dpc-3378	2	21	giulia	giulia	PROPN
dpc-3378	2	22	briatico1	briatico1	VERB
dpc-3378	2	23	,	,	PUNCT
dpc-3378	2	24	camila	camila	PROPN
dpc-3378	2	25	scharf1	scharf1	PROPN
dpc-3378	2	26	,	,	PUNCT
dpc-3378	2	27	giuseppe	giuseppe	PROPN
dpc-3378	2	28	colella2	colella2	PROPN
dpc-3378	2	29	,	,	PUNCT
dpc-3378	2	30	giovanni	giovanni	PROPN
dpc-3378	2	31	docimo3	docimo3	PROPN
dpc-3378	2	32	,	,	PUNCT
dpc-3378	2	33	ludovico	ludovico	PROPN
dpc-3378	2	34	docimo3	docimo3	PROPN
dpc-3378	2	35	,	,	PUNCT
dpc-3378	2	36	mario	mario	PROPN
dpc-3378	2	37	faenza4	faenza4	PROPN
dpc-3378	2	38	,	,	PUNCT
dpc-3378	2	39	francesco	francesco	PROPN
dpc-3378	2	40	iovino3	iovino3	PROPN
dpc-3378	2	41	,	,	PUNCT
dpc-3378	2	42	salvatore	salvatore	PROPN
dpc-3378	2	43	tolone3	tolone3	PROPN
dpc-3378	2	44	,	,	PUNCT
dpc-3378	2	45	pasquale	pasquale	PROPN
dpc-3378	2	46	verolino2	verolino2	PROPN
dpc-3378	2	47	,	,	PUNCT
dpc-3378	2	48	stefania	stefania	PROPN
dpc-3378	2	49	napolitano5	napolitano5	PROPN
dpc-3378	2	50	,	,	PUNCT
dpc-3378	2	51	teresa	teresa	PROPN
dpc-3378	2	52	troiani5	troiani5	PROPN
dpc-3378	2	53	,	,	PUNCT
dpc-3378	2	54	andrea	andrea	PROPN
dpc-3378	2	55	ronchi6	ronchi6	PROPN
dpc-3378	2	56	,	,	PUNCT
dpc-3378	2	57	renato	renato	PROPN
dpc-3378	2	58	franco6	franco6	PROPN
dpc-3378	2	59	,	,	PUNCT
dpc-3378	2	60	giuseppe	giuseppe	PROPN
dpc-3378	2	61	argenziano1	argenziano1	NOUN
dpc-3378	2	62	1	1	NUM
dpc-3378	2	63	dermatology	dermatology	NOUN
dpc-3378	2	64	unit	unit	NOUN
dpc-3378	2	65	,	,	PUNCT
dpc-3378	2	66	university	university	PROPN
dpc-3378	2	67	of	of	ADP
dpc-3378	2	68	campania	campania	PROPN
dpc-3378	2	69	“	"	PUNCT
dpc-3378	2	70	luigi	luigi	PROPN
dpc-3378	2	71	vanvitelli	vanvitelli	PROPN
dpc-3378	2	72	”	"	PUNCT
dpc-3378	2	73	,	,	PUNCT
dpc-3378	2	74	naples	naples	PROPN
dpc-3378	2	75	,	,	PUNCT
dpc-3378	2	76	italy	italy	PROPN
dpc-3378	2	77	2	2	NUM
dpc-3378	2	78	multidisciplinary	multidisciplinary	ADJ
dpc-3378	2	79	department	department	NOUN
dpc-3378	2	80	of	of	ADP
dpc-3378	2	81	medical	medical	ADJ
dpc-3378	2	82	,	,	PUNCT
dpc-3378	2	83	surgical	surgical	ADJ
dpc-3378	2	84	and	and	CCONJ
dpc-3378	2	85	dental	dental	ADJ
dpc-3378	2	86	specialties	specialty	NOUN
dpc-3378	2	87	,	,	PUNCT
dpc-3378	2	88	oral	oral	ADJ
dpc-3378	2	89	and	and	CCONJ
dpc-3378	2	90	maxillofacial	maxillofacial	ADJ
dpc-3378	2	91	surgery	surgery	NOUN
dpc-3378	2	92	unit	unit	NOUN
dpc-3378	2	93	,	,	PUNCT
dpc-3378	2	94	university	university	PROPN
dpc-3378	2	95	of	of	ADP
dpc-3378	2	96	campania	campania	PROPN
dpc-3378	2	97	“	"	PUNCT
dpc-3378	2	98	luigi	luigi	PROPN
dpc-3378	2	99	vanvitelli	vanvitelli	PROPN
dpc-3378	2	100	”	"	PUNCT
dpc-3378	2	101	,	,	PUNCT
dpc-3378	2	102	naples	naples	PROPN
dpc-3378	2	103	,	,	PUNCT
dpc-3378	2	104	italy	italy	PROPN
dpc-3378	2	105	3	3	NUM
dpc-3378	2	106	department	department	NOUN
dpc-3378	2	107	of	of	ADP
dpc-3378	2	108	advanced	advanced	ADJ
dpc-3378	2	109	medical	medical	ADJ
dpc-3378	2	110	and	and	CCONJ
dpc-3378	2	111	surgical	surgical	ADJ
dpc-3378	2	112	sciences	science	NOUN
dpc-3378	2	113	,	,	PUNCT
dpc-3378	2	114	university	university	PROPN
dpc-3378	2	115	of	of	ADP
dpc-3378	2	116	campania	campania	PROPN
dpc-3378	2	117	“	"	PUNCT
dpc-3378	2	118	luigi	luigi	PROPN
dpc-3378	2	119	vanvitelli	vanvitelli	PROPN
dpc-3378	2	120	”	"	PUNCT
dpc-3378	2	121	,	,	PUNCT
dpc-3378	2	122	naples	naples	PROPN
dpc-3378	2	123	,	,	PUNCT
dpc-3378	2	124	italy	italy	PROPN
dpc-3378	2	125	4	4	NUM
dpc-3378	2	126	multidisciplinary	multidisciplinary	ADJ
dpc-3378	2	127	department	department	NOUN
dpc-3378	2	128	of	of	ADP
dpc-3378	2	129	medical	medical	ADJ
dpc-3378	2	130	,	,	PUNCT
dpc-3378	2	131	surgical	surgical	ADJ
dpc-3378	2	132	and	and	CCONJ
dpc-3378	2	133	dental	dental	ADJ
dpc-3378	2	134	sciences	science	NOUN
dpc-3378	2	135	,	,	PUNCT
dpc-3378	2	136	plastic	plastic	ADJ
dpc-3378	2	137	surgery	surgery	NOUN
dpc-3378	2	138	unit	unit	NOUN
dpc-3378	2	139	,	,	PUNCT
dpc-3378	2	140	university	university	PROPN
dpc-3378	2	141	of	of	ADP
dpc-3378	2	142	campania	campania	PROPN
dpc-3378	2	143	“	"	PUNCT
dpc-3378	2	144	luigi	luigi	PROPN
dpc-3378	2	145	vanvitelli	vanvitelli	PROPN
dpc-3378	2	146	”	"	PUNCT
dpc-3378	2	147	,	,	PUNCT
dpc-3378	2	148	naples	naples	PROPN
dpc-3378	2	149	,	,	PUNCT
dpc-3378	2	150	italy	italy	PROPN
dpc-3378	2	151	5	5	NUM
dpc-3378	2	152	department	department	PROPN
dpc-3378	2	153	of	of	ADP
dpc-3378	2	154	precision	precision	NOUN
dpc-3378	2	155	medicine	medicine	NOUN
dpc-3378	2	156	,	,	PUNCT
dpc-3378	2	157	medical	medical	ADJ
dpc-3378	2	158	oncology	oncology	NOUN
dpc-3378	2	159	unit	unit	NOUN
dpc-3378	2	160	,	,	PUNCT
dpc-3378	2	161	university	university	PROPN
dpc-3378	2	162	of	of	ADP
dpc-3378	2	163	campania	campania	PROPN
dpc-3378	2	164	“	"	PUNCT
dpc-3378	2	165	luigi	luigi	PROPN
dpc-3378	2	166	vanvitelli	vanvitelli	PROPN
dpc-3378	2	167	”	"	PUNCT
dpc-3378	2	168	,	,	PUNCT
dpc-3378	2	169	naples	naples	PROPN
dpc-3378	2	170	,	,	PUNCT
dpc-3378	2	171	italy	italy	PROPN
dpc-3378	2	172	6	6	NUM
dpc-3378	2	173	division	division	NOUN
dpc-3378	2	174	of	of	ADP
dpc-3378	2	175	pathology	pathology	NOUN
dpc-3378	2	176	,	,	PUNCT
dpc-3378	2	177	department	department	NOUN
dpc-3378	2	178	of	of	ADP
dpc-3378	2	179	mental	mental	ADJ
dpc-3378	2	180	health	health	NOUN
dpc-3378	2	181	and	and	CCONJ
dpc-3378	2	182	preventive	preventive	ADJ
dpc-3378	2	183	medicine	medicine	NOUN
dpc-3378	2	184	,	,	PUNCT
dpc-3378	2	185	“	"	PUNCT
dpc-3378	2	186	luigi	luigi	PROPN
dpc-3378	2	187	vanvitelli	vanvitelli	PROPN
dpc-3378	2	188	”	"	PUNCT
dpc-3378	2	189	university	university	PROPN
dpc-3378	2	190	of	of	ADP
dpc-3378	2	191	campania	campania	PROPN
dpc-3378	2	192	,	,	PUNCT
dpc-3378	2	193	naples	naples	PROPN
dpc-3378	2	194	,	,	PUNCT
dpc-3378	2	195	italy	italy	PROPN
dpc-3378	2	196	key	key	ADJ
dpc-3378	2	197	words	word	NOUN
dpc-3378	2	198	:	:	PUNCT
dpc-3378	2	199	melanoma	melanoma	NOUN
dpc-3378	2	200	,	,	PUNCT
dpc-3378	2	201	adjuvant	adjuvant	ADJ
dpc-3378	2	202	therapy	therapy	NOUN
dpc-3378	2	203	,	,	PUNCT
dpc-3378	2	204	sentinel	sentinel	PROPN
dpc-3378	2	205	node	node	ADJ
dpc-3378	2	206	biopsy	biopsy	NOUN
dpc-3378	2	207	citation	citation	NOUN
dpc-3378	2	208	:	:	PUNCT
dpc-3378	2	209	brancaccio	brancaccio	NOUN
dpc-3378	2	210	g	g	PROPN
dpc-3378	2	211	,	,	PUNCT
dpc-3378	2	212	briatico	briatico	NOUN
dpc-3378	2	213	g	g	NOUN
dpc-3378	2	214	,	,	PUNCT
dpc-3378	2	215	scharf	scharf	PROPN
dpc-3378	2	216	c	c	NOUN
dpc-3378	2	217	,	,	PUNCT
dpc-3378	2	218	et	et	PROPN
dpc-3378	2	219	al	al	PROPN
dpc-3378	2	220	.	.	PUNCT
dpc-3378	3	1	the	the	DET
dpc-3378	3	2	role	role	NOUN
dpc-3378	3	3	of	of	ADP
dpc-3378	3	4	sentinel	sentinel	ADJ
dpc-3378	3	5	node	node	ADJ
dpc-3378	3	6	biopsy	biopsy	NOUN
dpc-3378	3	7	in	in	ADP
dpc-3378	3	8	the	the	DET
dpc-3378	3	9	era	era	NOUN
dpc-3378	3	10	of	of	ADP
dpc-3378	3	11	adjuvant	adjuvant	ADJ
dpc-3378	3	12	therapy	therapy	NOUN
dpc-3378	3	13	for	for	ADP
dpc-3378	3	14	melanoma	melanoma	NOUN
dpc-3378	3	15	.	.	PUNCT
dpc-3378	4	1	dermatol	dermatol	NOUN
dpc-3378	4	2	pract	pract	PROPN
dpc-3378	4	3	concept	concept	NOUN
dpc-3378	4	4	.	.	PUNCT
dpc-3378	5	1	2024;14(1):e2024038	2024;14(1):e2024038	X
dpc-3378	5	2	.	.	PUNCT
dpc-3378	5	3	doi	doi	NOUN
dpc-3378	5	4	:	:	PUNCT
dpc-3378	5	5	https://doi.org/10.5826/dpc.1401a38	https://doi.org/10.5826/dpc.1401a38	PROPN
dpc-3378	5	6	accepted	accept	VERB
dpc-3378	5	7	:	:	PUNCT
dpc-3378	5	8	october	october	PROPN
dpc-3378	5	9	9	9	NUM
dpc-3378	5	10	,	,	PUNCT
dpc-3378	5	11	2023	2023	NUM
dpc-3378	5	12	;	;	PUNCT
dpc-3378	5	13	published	publish	VERB
dpc-3378	5	14	:	:	PUNCT
dpc-3378	5	15	january	january	PROPN
dpc-3378	5	16	2024	2024	NUM
dpc-3378	5	17	copyright	copyright	NOUN
dpc-3378	5	18	:	:	PUNCT
dpc-3378	5	19	©	©	PROPN
dpc-3378	5	20	2024	2024	NUM
dpc-3378	5	21	brancaccio	brancaccio	NOUN
dpc-3378	5	22	et	et	PROPN
dpc-3378	5	23	al	al	PROPN
dpc-3378	5	24	.	.	PUNCT
dpc-3378	6	1	this	this	PRON
dpc-3378	6	2	is	be	AUX
dpc-3378	6	3	an	an	DET
dpc-3378	6	4	open	open	ADJ
dpc-3378	6	5	-	-	PUNCT
dpc-3378	6	6	access	access	NOUN
dpc-3378	6	7	article	article	NOUN
dpc-3378	6	8	distributed	distribute	VERB
dpc-3378	6	9	under	under	ADP
dpc-3378	6	10	the	the	DET
dpc-3378	6	11	terms	term	NOUN
dpc-3378	6	12	of	of	ADP
dpc-3378	6	13	the	the	DET
dpc-3378	6	14	creative	creative	ADJ
dpc-3378	6	15	commons	common	NOUN
dpc-3378	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3378	6	17	license	license	NOUN
dpc-3378	6	18	(	(	PUNCT
dpc-3378	6	19	by	by	ADP
dpc-3378	6	20	-	-	PUNCT
dpc-3378	6	21	nc-4.0	nc-4.0	NOUN
dpc-3378	6	22	)	)	PUNCT
dpc-3378	6	23	,	,	PUNCT
dpc-3378	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3378	6	25	,	,	PUNCT
dpc-3378	6	26	which	which	PRON
dpc-3378	6	27	permits	permit	VERB
dpc-3378	6	28	unrestricted	unrestricted	ADJ
dpc-3378	6	29	noncommercial	noncommercial	ADJ
dpc-3378	6	30	use	use	NOUN
dpc-3378	6	31	,	,	PUNCT
dpc-3378	6	32	distribution	distribution	NOUN
dpc-3378	6	33	,	,	PUNCT
dpc-3378	6	34	and	and	CCONJ
dpc-3378	6	35	reproduction	reproduction	NOUN
dpc-3378	6	36	in	in	ADP
dpc-3378	6	37	any	any	DET
dpc-3378	6	38	medium	medium	NOUN
dpc-3378	6	39	,	,	PUNCT
dpc-3378	6	40	provided	provide	VERB
dpc-3378	6	41	the	the	DET
dpc-3378	6	42	original	original	ADJ
dpc-3378	6	43	authors	author	NOUN
dpc-3378	6	44	and	and	CCONJ
dpc-3378	6	45	source	source	NOUN
dpc-3378	6	46	are	be	AUX
dpc-3378	6	47	credited	credit	VERB
dpc-3378	6	48	.	.	PUNCT
dpc-3378	7	1	funding	funding	NOUN
dpc-3378	7	2	:	:	PUNCT
dpc-3378	7	3	none	none	NOUN
dpc-3378	7	4	.	.	PUNCT
dpc-3378	8	1	competing	compete	VERB
dpc-3378	8	2	interests	interest	NOUN
dpc-3378	8	3	:	:	PUNCT
dpc-3378	8	4	none	none	NOUN
dpc-3378	8	5	.	.	PUNCT
dpc-3378	9	1	authorship	authorship	NOUN
dpc-3378	9	2	:	:	PUNCT
dpc-3378	9	3	all	all	DET
dpc-3378	9	4	authors	author	NOUN
dpc-3378	9	5	have	have	AUX
dpc-3378	9	6	contributed	contribute	VERB
dpc-3378	9	7	significantly	significantly	ADV
dpc-3378	9	8	to	to	ADP
dpc-3378	9	9	this	this	DET
dpc-3378	9	10	publication	publication	NOUN
dpc-3378	9	11	.	.	PUNCT
dpc-3378	10	1	sentinel	sentinel	PROPN
dpc-3378	10	2	lymph	lymph	PROPN
dpc-3378	10	3	node	node	PROPN
dpc-3378	10	4	biopsy	biopsy	NOUN
dpc-3378	10	5	(	(	PUNCT
dpc-3378	10	6	slnb	slnb	NOUN
dpc-3378	10	7	)	)	PUNCT
dpc-3378	10	8	is	be	AUX
dpc-3378	10	9	a	a	DET
dpc-3378	10	10	surgical	surgical	ADJ
dpc-3378	10	11	procedure	procedure	NOUN
dpc-3378	10	12	aimed	aim	VERB
dpc-3378	10	13	to	to	PART
dpc-3378	10	14	detect	detect	VERB
dpc-3378	10	15	nodal	nodal	NOUN
dpc-3378	10	16	metastases	metastasis	NOUN
dpc-3378	10	17	in	in	ADP
dpc-3378	10	18	patients	patient	NOUN
dpc-3378	10	19	with	with	ADP
dpc-3378	10	20	clinically	clinically	ADV
dpc-3378	10	21	occult	occult	NOUN
dpc-3378	10	22	disease	disease	NOUN
dpc-3378	10	23	.	.	PUNCT
dpc-3378	11	1	since	since	SCONJ
dpc-3378	11	2	the	the	DET
dpc-3378	11	3	advent	advent	NOUN
dpc-3378	11	4	of	of	ADP
dpc-3378	11	5	new	new	ADJ
dpc-3378	11	6	systemic	systemic	ADJ
dpc-3378	11	7	therapies	therapy	NOUN
dpc-3378	11	8	,	,	PUNCT
dpc-3378	11	9	its	its	PRON
dpc-3378	11	10	role	role	NOUN
dpc-3378	11	11	in	in	ADP
dpc-3378	11	12	melanoma	melanoma	NOUN
dpc-3378	11	13	has	have	AUX
dpc-3378	11	14	been	be	AUX
dpc-3378	11	15	extensively	extensively	ADV
dpc-3378	11	16	debated	debate	VERB
dpc-3378	11	17	over	over	ADP
dpc-3378	11	18	the	the	DET
dpc-3378	11	19	last	last	ADJ
dpc-3378	11	20	years	year	NOUN
dpc-3378	11	21	.	.	PUNCT
dpc-3378	12	1	in	in	ADP
dpc-3378	12	2	this	this	DET
dpc-3378	12	3	article	article	NOUN
dpc-3378	12	4	,	,	PUNCT
dpc-3378	12	5	three	three	NUM
dpc-3378	12	6	possible	possible	ADJ
dpc-3378	12	7	scenarios	scenario	NOUN
dpc-3378	12	8	are	be	AUX
dpc-3378	12	9	discussed	discuss	VERB
dpc-3378	12	10	,	,	PUNCT
dpc-3378	12	11	considering	consider	VERB
dpc-3378	12	12	the	the	DET
dpc-3378	12	13	slnb	slnb	ADJ
dpc-3378	12	14	impact	impact	NOUN
dpc-3378	12	15	on	on	ADP
dpc-3378	12	16	the	the	DET
dpc-3378	12	17	management	management	NOUN
dpc-3378	12	18	of	of	ADP
dpc-3378	12	19	melanoma	melanoma	NOUN
dpc-3378	12	20	patients	patient	NOUN
dpc-3378	12	21	.	.	PUNCT
dpc-3378	13	1	first	first	ADV
dpc-3378	13	2	,	,	PUNCT
dpc-3378	13	3	pt1b	pt1b	ADJ
dpc-3378	13	4	and	and	CCONJ
dpc-3378	13	5	pt2a	pt2a	ADJ
dpc-3378	13	6	patients	patient	NOUN
dpc-3378	13	7	with	with	ADP
dpc-3378	13	8	negative	negative	ADJ
dpc-3378	13	9	slnb	slnb	NOUN
dpc-3378	13	10	(	(	PUNCT
dpc-3378	13	11	stages	stage	NOUN
dpc-3378	13	12	ia	ia	PROPN
dpc-3378	13	13	and	and	CCONJ
dpc-3378	13	14	ib	ib	VERB
dpc-3378	13	15	)	)	PUNCT
dpc-3378	13	16	and	and	CCONJ
dpc-3378	13	17	those	those	PRON
dpc-3378	13	18	with	with	ADP
dpc-3378	13	19	positive	positive	ADJ
dpc-3378	13	20	slnb	slnb	NOUN
dpc-3378	13	21	(	(	PUNCT
dpc-3378	13	22	stage	stage	NOUN
dpc-3378	13	23	iiia	iiia	NOUN
dpc-3378	13	24	)	)	PUNCT
dpc-3378	13	25	would	would	AUX
dpc-3378	13	26	all	all	PRON
dpc-3378	13	27	not	not	PART
dpc-3378	13	28	benefit	benefit	VERB
dpc-3378	13	29	from	from	ADP
dpc-3378	13	30	adjuvant	adjuvant	ADJ
dpc-3378	13	31	treatment	treatment	NOUN
dpc-3378	13	32	.	.	PUNCT
dpc-3378	14	1	therefore	therefore	ADV
dpc-3378	14	2	,	,	PUNCT
dpc-3378	14	3	slnb	slnb	NOUN
dpc-3378	14	4	might	might	AUX
dpc-3378	14	5	be	be	AUX
dpc-3378	14	6	avoided	avoid	VERB
dpc-3378	14	7	in	in	ADP
dpc-3378	14	8	these	these	DET
dpc-3378	14	9	categories	category	NOUN
dpc-3378	14	10	of	of	ADP
dpc-3378	14	11	patients	patient	NOUN
dpc-3378	14	12	.	.	PUNCT
dpc-3378	15	1	second	second	ADJ
dpc-3378	15	2	,	,	PUNCT
dpc-3378	15	3	in	in	ADP
dpc-3378	15	4	iib	iib	PROPN
dpc-3378	15	5	and	and	CCONJ
dpc-3378	15	6	iic	iic	PROPN
dpc-3378	15	7	,	,	PUNCT
dpc-3378	15	8	melanoma	melanoma	NOUN
dpc-3378	15	9	patients	patient	NOUN
dpc-3378	15	10	are	be	AUX
dpc-3378	15	11	already	already	ADV
dpc-3378	15	12	candidates	candidate	NOUN
dpc-3378	15	13	for	for	ADP
dpc-3378	15	14	adjuvant	adjuvant	ADJ
dpc-3378	15	15	treatment	treatment	NOUN
dpc-3378	15	16	;	;	PUNCT
dpc-3378	15	17	therefore	therefore	ADV
dpc-3378	15	18	,	,	PUNCT
dpc-3378	15	19	slnb	slnb	VERB
dpc-3378	15	20	in	in	ADP
dpc-3378	15	21	patients	patient	NOUN
dpc-3378	15	22	with	with	ADP
dpc-3378	15	23	t3b	t3b	ADJ
dpc-3378	15	24	,	,	PUNCT
dpc-3378	15	25	t4a	t4a	ADJ
dpc-3378	15	26	,	,	PUNCT
dpc-3378	15	27	or	or	CCONJ
dpc-3378	15	28	t4b	t4b	PRON
dpc-3378	15	29	melanoma	melanoma	NOUN
dpc-3378	15	30	would	would	AUX
dpc-3378	15	31	not	not	PART
dpc-3378	15	32	change	change	VERB
dpc-3378	15	33	treatment	treatment	NOUN
dpc-3378	15	34	decisions	decision	NOUN
dpc-3378	15	35	.	.	PUNCT
dpc-3378	16	1	on	on	ADP
dpc-3378	16	2	the	the	DET
dpc-3378	16	3	other	other	ADJ
dpc-3378	16	4	end	end	NOUN
dpc-3378	16	5	of	of	ADP
dpc-3378	16	6	the	the	DET
dpc-3378	16	7	spectrum	spectrum	NOUN
dpc-3378	16	8	,	,	PUNCT
dpc-3378	16	9	patients	patient	NOUN
dpc-3378	16	10	with	with	ADP
dpc-3378	16	11	pt2b	pt2b	PROPN
dpc-3378	16	12	and	and	CCONJ
dpc-3378	16	13	pt3a	pt3a	VERB
dpc-3378	16	14	melanomas	melanomas	NOUN
dpc-3378	16	15	(	(	PUNCT
dpc-3378	16	16	clinical	clinical	ADJ
dpc-3378	16	17	stage	stage	NOUN
dpc-3378	16	18	iia	iia	PROPN
dpc-3378	16	19	)	)	PUNCT
dpc-3378	16	20	represent	represent	VERB
dpc-3378	16	21	the	the	DET
dpc-3378	16	22	only	only	ADJ
dpc-3378	16	23	two	two	NUM
dpc-3378	16	24	groups	group	NOUN
dpc-3378	16	25	whose	whose	DET
dpc-3378	16	26	management	management	NOUN
dpc-3378	16	27	would	would	AUX
dpc-3378	16	28	be	be	AUX
dpc-3378	16	29	significantly	significantly	ADV
dpc-3378	16	30	affected	affect	VERB
dpc-3378	16	31	by	by	ADP
dpc-3378	16	32	the	the	DET
dpc-3378	16	33	slnb	slnb	NOUN
dpc-3378	16	34	status	status	NOUN
dpc-3378	16	35	,	,	PUNCT
dpc-3378	16	36	being	be	AUX
dpc-3378	16	37	adjuvant	adjuvant	ADJ
dpc-3378	16	38	therapy	therapy	NOUN
dpc-3378	16	39	only	only	ADV
dpc-3378	16	40	indicated	indicate	VERB
dpc-3378	16	41	for	for	ADP
dpc-3378	16	42	sln	sln	NOUN
dpc-3378	16	43	-	-	ADJ
dpc-3378	16	44	positive	positive	ADJ
dpc-3378	16	45	patients	patient	NOUN
dpc-3378	16	46	.	.	PUNCT
dpc-3378	17	1	further	further	ADJ
dpc-3378	17	2	studies	study	NOUN
dpc-3378	17	3	are	be	AUX
dpc-3378	17	4	needed	need	VERB
dpc-3378	17	5	to	to	PART
dpc-3378	17	6	investigate	investigate	VERB
dpc-3378	17	7	which	which	DET
dpc-3378	17	8	melanoma	melanoma	NOUN
dpc-3378	17	9	patient	patient	NOUN
dpc-3378	17	10	deserves	deserve	VERB
dpc-3378	17	11	slnb	slnb	VERB
dpc-3378	17	12	.	.	PUNCT
dpc-3378	18	1	abstract	abstract	ADJ
dpc-3378	18	2	2	2	NUM
dpc-3378	18	3	review	review	NOUN
dpc-3378	18	4	|	|	ADV
dpc-3378	18	5	dermatol	dermatol	ADJ
dpc-3378	18	6	pract	pract	NOUN
dpc-3378	18	7	concept	concept	NOUN
dpc-3378	18	8	.	.	PUNCT
dpc-3378	19	1	2024;14(1):e2024038	2024;14(1):e2024038	NUM
dpc-3378	19	2	corresponding	corresponding	ADJ
dpc-3378	19	3	author	author	NOUN
dpc-3378	19	4	:	:	PUNCT
dpc-3378	19	5	giuseppe	giuseppe	PROPN
dpc-3378	19	6	argenziano	argenziano	PROPN
dpc-3378	19	7	,	,	PUNCT
dpc-3378	19	8	md	md	PROPN
dpc-3378	19	9	,	,	PUNCT
dpc-3378	19	10	phd	phd	NOUN
dpc-3378	19	11	,	,	PUNCT
dpc-3378	19	12	university	university	PROPN
dpc-3378	19	13	of	of	ADP
dpc-3378	19	14	campania	campania	PROPN
dpc-3378	19	15	“	"	PUNCT
dpc-3378	19	16	luigi	luigi	PROPN
dpc-3378	19	17	vanvitelli	vanvitelli	PROPN
dpc-3378	19	18	”	"	PUNCT
dpc-3378	19	19	,	,	PUNCT
dpc-3378	19	20	dermatology	dermatology	NOUN
dpc-3378	19	21	unit	unit	NOUN
dpc-3378	19	22	,	,	PUNCT
dpc-3378	19	23	viale	viale	NOUN
dpc-3378	19	24	pansini	pansini	NOUN
dpc-3378	19	25	5	5	NUM
dpc-3378	19	26	,	,	PUNCT
dpc-3378	19	27	9c	9c	NUM
dpc-3378	19	28	,	,	PUNCT
dpc-3378	19	29	80131	80131	NUM
dpc-3378	19	30	,	,	PUNCT
dpc-3378	19	31	naples	naples	PROPN
dpc-3378	19	32	,	,	PUNCT
dpc-3378	19	33	italy	italy	PROPN
dpc-3378	19	34	.	.	PUNCT
dpc-3378	20	1	phone	phone	NOUN
dpc-3378	20	2	:	:	PUNCT
dpc-3378	20	3	0039335415093	0039335415093	NUM
dpc-3378	20	4	email	email	NOUN
dpc-3378	20	5	:	:	PUNCT
dpc-3378	20	6	g.argenziano@gmail.com	g.argenziano@gmail.com	X
dpc-3378	20	7	introduction	introduction	NOUN
dpc-3378	20	8	sentinel	sentinel	PROPN
dpc-3378	20	9	lymph	lymph	PROPN
dpc-3378	20	10	node	node	PROPN
dpc-3378	20	11	biopsy	biopsy	NOUN
dpc-3378	20	12	(	(	PUNCT
dpc-3378	20	13	slnb	slnb	NOUN
dpc-3378	20	14	)	)	PUNCT
dpc-3378	20	15	is	be	AUX
dpc-3378	20	16	a	a	DET
dpc-3378	20	17	surgical	surgical	ADJ
dpc-3378	20	18	procedure	procedure	NOUN
dpc-3378	20	19	aimed	aim	VERB
dpc-3378	20	20	to	to	PART
dpc-3378	20	21	detect	detect	VERB
dpc-3378	20	22	nodal	nodal	NOUN
dpc-3378	20	23	metastases	metastasis	NOUN
dpc-3378	20	24	in	in	ADP
dpc-3378	20	25	patients	patient	NOUN
dpc-3378	20	26	with	with	ADP
dpc-3378	20	27	clinically	clinically	ADV
dpc-3378	20	28	occult	occult	NOUN
dpc-3378	20	29	disease	disease	NOUN
dpc-3378	20	30	.	.	PUNCT
dpc-3378	21	1	the	the	DET
dpc-3378	21	2	role	role	NOUN
dpc-3378	21	3	of	of	ADP
dpc-3378	21	4	slnb	slnb	NOUN
dpc-3378	21	5	in	in	ADP
dpc-3378	21	6	melanoma	melanoma	NOUN
dpc-3378	21	7	has	have	AUX
dpc-3378	21	8	been	be	AUX
dpc-3378	21	9	extensively	extensively	ADV
dpc-3378	21	10	debated	debate	VERB
dpc-3378	21	11	over	over	ADP
dpc-3378	21	12	the	the	DET
dpc-3378	21	13	last	last	ADJ
dpc-3378	21	14	years	year	NOUN
dpc-3378	21	15	.	.	PUNCT
dpc-3378	22	1	slnb	slnb	PROPN
dpc-3378	22	2	intended	intend	VERB
dpc-3378	22	3	as	as	ADP
dpc-3378	22	4	a	a	DET
dpc-3378	22	5	therapeutic	therapeutic	ADJ
dpc-3378	22	6	technique	technique	NOUN
dpc-3378	22	7	evolved	evolve	VERB
dpc-3378	22	8	from	from	ADP
dpc-3378	22	9	the	the	DET
dpc-3378	22	10	observation	observation	NOUN
dpc-3378	22	11	that	that	SCONJ
dpc-3378	22	12	most	most	ADJ
dpc-3378	22	13	primary	primary	ADJ
dpc-3378	22	14	cutaneous	cutaneous	ADJ
dpc-3378	22	15	melanomas	melanomas	NOUN
dpc-3378	22	16	spread	spread	VERB
dpc-3378	22	17	initially	initially	ADV
dpc-3378	22	18	through	through	ADP
dpc-3378	22	19	the	the	DET
dpc-3378	22	20	intradermal	intradermal	ADJ
dpc-3378	22	21	lymphatics	lymphatic	NOUN
dpc-3378	22	22	to	to	ADP
dpc-3378	22	23	the	the	DET
dpc-3378	22	24	regional	regional	ADJ
dpc-3378	22	25	nodes	node	NOUN
dpc-3378	22	26	and	and	CCONJ
dpc-3378	22	27	then	then	ADV
dpc-3378	22	28	move	move	VERB
dpc-3378	22	29	to	to	ADP
dpc-3378	22	30	distant	distant	ADJ
dpc-3378	22	31	sites	site	NOUN
dpc-3378	22	32	[	[	X
dpc-3378	22	33	1	1	NUM
dpc-3378	22	34	]	]	PUNCT
dpc-3378	22	35	.	.	PUNCT
dpc-3378	23	1	this	this	DET
dpc-3378	23	2	sequential	sequential	ADJ
dpc-3378	23	3	model	model	NOUN
dpc-3378	23	4	of	of	ADP
dpc-3378	23	5	melanoma	melanoma	NOUN
dpc-3378	23	6	metastasis	metastasis	NOUN
dpc-3378	23	7	has	have	AUX
dpc-3378	23	8	been	be	AUX
dpc-3378	23	9	lately	lately	ADV
dpc-3378	23	10	disproved	disprove	VERB
dpc-3378	23	11	[	[	X
dpc-3378	23	12	2,3	2,3	NUM
dpc-3378	23	13	]	]	PUNCT
dpc-3378	23	14	and	and	CCONJ
dpc-3378	23	15	sentinel	sentinel	ADJ
dpc-3378	23	16	node	node	NOUN
dpc-3378	23	17	is	be	AUX
dpc-3378	23	18	now	now	ADV
dpc-3378	23	19	considered	consider	VERB
dpc-3378	23	20	an	an	DET
dpc-3378	23	21	“	"	PUNCT
dpc-3378	23	22	indicator	indicator	NOUN
dpc-3378	23	23	”	"	PUNCT
dpc-3378	23	24	of	of	ADP
dpc-3378	23	25	disease	disease	NOUN
dpc-3378	23	26	as	as	SCONJ
dpc-3378	23	27	its	its	PRON
dpc-3378	23	28	status	status	NOUN
dpc-3378	23	29	illustrates	illustrate	VERB
dpc-3378	23	30	metastatic	metastatic	ADJ
dpc-3378	23	31	potential	potential	NOUN
dpc-3378	23	32	,	,	PUNCT
dpc-3378	23	33	but	but	CCONJ
dpc-3378	23	34	its	its	PRON
dpc-3378	23	35	removal	removal	NOUN
dpc-3378	23	36	can	can	AUX
dpc-3378	23	37	not	not	PART
dpc-3378	23	38	prevent	prevent	VERB
dpc-3378	23	39	further	further	ADJ
dpc-3378	23	40	spread	spread	NOUN
dpc-3378	23	41	.	.	PUNCT
dpc-3378	24	1	although	although	SCONJ
dpc-3378	24	2	slnb	slnb	NOUN
dpc-3378	24	3	does	do	AUX
dpc-3378	24	4	not	not	PART
dpc-3378	24	5	impact	impact	VERB
dpc-3378	24	6	survival	survival	NOUN
dpc-3378	24	7	,	,	PUNCT
dpc-3378	24	8	it	it	PRON
dpc-3378	24	9	is	be	AUX
dpc-3378	24	10	associated	associate	VERB
dpc-3378	24	11	with	with	ADP
dpc-3378	24	12	a	a	DET
dpc-3378	24	13	benefit	benefit	NOUN
dpc-3378	24	14	in	in	ADP
dpc-3378	24	15	terms	term	NOUN
dpc-3378	24	16	of	of	ADP
dpc-3378	24	17	rate	rate	NOUN
dpc-3378	24	18	of	of	ADP
dpc-3378	24	19	recurrence	recurrence	NOUN
dpc-3378	24	20	within	within	ADP
dpc-3378	24	21	the	the	DET
dpc-3378	24	22	primary	primary	ADJ
dpc-3378	24	23	tumor	tumor	NOUN
dpc-3378	24	24	region	region	NOUN
dpc-3378	25	1	[	[	X
dpc-3378	25	2	4	4	NUM
dpc-3378	25	3	]	]	PUNCT
dpc-3378	25	4	.	.	PUNCT
dpc-3378	26	1	currently	currently	ADV
dpc-3378	26	2	slnb	slnb	NOUN
dpc-3378	26	3	is	be	AUX
dpc-3378	26	4	recommended	recommend	VERB
dpc-3378	26	5	as	as	ADP
dpc-3378	26	6	a	a	DET
dpc-3378	26	7	staging	staging	NOUN
dpc-3378	26	8	procedure	procedure	NOUN
dpc-3378	26	9	that	that	PRON
dpc-3378	26	10	can	can	AUX
dpc-3378	26	11	help	help	AUX
dpc-3378	26	12	identify	identify	VERB
dpc-3378	26	13	those	those	DET
dpc-3378	26	14	patients	patient	NOUN
dpc-3378	26	15	with	with	ADP
dpc-3378	26	16	at	at	ADV
dpc-3378	26	17	least	least	ADJ
dpc-3378	26	18	pt1b	pt1b	ADJ
dpc-3378	26	19	melanoma	melanoma	NOUN
dpc-3378	26	20	(	(	PUNCT
dpc-3378	26	21	tables	table	NOUN
dpc-3378	26	22	1	1	NUM
dpc-3378	26	23	and	and	CCONJ
dpc-3378	26	24	2	2	NUM
dpc-3378	26	25	)	)	PUNCT
dpc-3378	26	26	who	who	PRON
dpc-3378	26	27	may	may	AUX
dpc-3378	26	28	benefit	benefit	VERB
dpc-3378	26	29	from	from	ADP
dpc-3378	26	30	adjuvant	adjuvant	ADJ
dpc-3378	26	31	table	table	NOUN
dpc-3378	26	32	1	1	NUM
dpc-3378	26	33	.	.	PUNCT
dpc-3378	27	1	melanoma	melanoma	NOUN
dpc-3378	27	2	stage	stage	NOUN
dpc-3378	27	3	i	i	PRON
dpc-3378	27	4	and	and	CCONJ
dpc-3378	27	5	ii	ii	PROPN
dpc-3378	27	6	(	(	PUNCT
dpc-3378	27	7	slnb	slnb	NOUN
dpc-3378	27	8	-	-	PUNCT
dpc-3378	27	9	)	)	PUNCT
dpc-3378	27	10	according	accord	VERB
dpc-3378	27	11	to	to	ADP
dpc-3378	27	12	the	the	DET
dpc-3378	27	13	ajcc	ajcc	PROPN
dpc-3378	27	14	classification	classification	NOUN
dpc-3378	27	15	system	system	NOUN
dpc-3378	27	16	8th	8th	ADJ
dpc-3378	27	17	 	 	SPACE
dpc-3378	27	18	edition	edition	NOUN
dpc-3378	27	19	.	.	PUNCT
dpc-3378	28	1	breslow	breslow	ADJ
dpc-3378	28	2	thickness	thickness	NOUN
dpc-3378	28	3	ulceration	ulceration	NOUN
dpc-3378	28	4	t	t	NOUN
dpc-3378	28	5	category	category	NOUN
dpc-3378	28	6	n	n	ADP
dpc-3378	28	7	category	category	NOUN
dpc-3378	28	8	stage	stage	NOUN
dpc-3378	28	9	<	<	X
dpc-3378	28	10	0.8	0.8	NUM
dpc-3378	28	11	mm	mm	NUM
dpc-3378	28	12	no	no	DET
dpc-3378	28	13	t1a	t1a	PROPN
dpc-3378	28	14	n0	n0	PROPN
dpc-3378	28	15	ia	ia	PROPN
dpc-3378	28	16	<	<	X
dpc-3378	28	17	0.8	0.8	NUM
dpc-3378	28	18	mm	mm	INTJ
dpc-3378	29	1	yes	yes	INTJ
dpc-3378	29	2	t1b	t1b	PROPN
dpc-3378	29	3	n0	n0	PROPN
dpc-3378	29	4	ib	ib	PROPN
dpc-3378	29	5	0.8	0.8	NUM
dpc-3378	29	6	-	-	SYM
dpc-3378	29	7	1.0	1.0	NUM
dpc-3378	29	8	mm	mm	INTJ
dpc-3378	30	1	yes	yes	INTJ
dpc-3378	30	2	/	/	SYM
dpc-3378	30	3	no	no	DET
dpc-3378	30	4	t1b	t1b	PROPN
dpc-3378	30	5	n0	n0	PROPN
dpc-3378	30	6	ib	ib	PROPN
dpc-3378	30	7	>	>	PROPN
dpc-3378	30	8	1.0	1.0	NUM
dpc-3378	30	9	-	-	SYM
dpc-3378	30	10	2.0	2.0	NUM
dpc-3378	30	11	mm	mm	INTJ
dpc-3378	31	1	no	no	DET
dpc-3378	31	2	t2a	t2a	PROPN
dpc-3378	31	3	n0	n0	PROPN
dpc-3378	31	4	ib	ib	PROPN
dpc-3378	31	5	>	>	PROPN
dpc-3378	31	6	1.0	1.0	NUM
dpc-3378	31	7	-	-	SYM
dpc-3378	31	8	2.0	2.0	NUM
dpc-3378	31	9	mm	mm	INTJ
dpc-3378	32	1	yes	yes	INTJ
dpc-3378	32	2	t2b	t2b	PROPN
dpc-3378	32	3	n0	n0	PROPN
dpc-3378	32	4	iia	iia	PROPN
dpc-3378	32	5	>	>	PUNCT
dpc-3378	32	6	2.0	2.0	NUM
dpc-3378	32	7	-	-	SYM
dpc-3378	32	8	4.0	4.0	NUM
dpc-3378	32	9	mm	mm	NOUN
dpc-3378	33	1	no	no	DET
dpc-3378	33	2	t3a	t3a	PROPN
dpc-3378	33	3	n0	n0	PROPN
dpc-3378	33	4	iia	iia	PROPN
dpc-3378	33	5	>	>	PUNCT
dpc-3378	33	6	2.0	2.0	NUM
dpc-3378	33	7	-	-	SYM
dpc-3378	33	8	4.0	4.0	NUM
dpc-3378	33	9	mm	mm	NOUN
dpc-3378	33	10	yes	yes	INTJ
dpc-3378	33	11	t3b	t3b	PROPN
dpc-3378	33	12	n0	n0	X
dpc-3378	33	13	iib	iib	PROPN
dpc-3378	33	14	>	>	PROPN
dpc-3378	33	15	4.0	4.0	NUM
dpc-3378	33	16	mm	mm	NOUN
dpc-3378	33	17	no	no	DET
dpc-3378	33	18	t4a	t4a	PROPN
dpc-3378	33	19	n0	n0	PROPN
dpc-3378	33	20	iib	iib	PROPN
dpc-3378	33	21	>	>	PROPN
dpc-3378	33	22	4.0	4.0	NUM
dpc-3378	33	23	mm	mm	INTJ
dpc-3378	33	24	yes	yes	INTJ
dpc-3378	33	25	t4b	t4b	PROPN
dpc-3378	33	26	n0	n0	PROPN
dpc-3378	33	27	iic	iic	PROPN
dpc-3378	33	28	adapted	adapt	VERB
dpc-3378	33	29	from	from	ADP
dpc-3378	33	30	:	:	PUNCT
dpc-3378	33	31	gershenwald	gershenwald	PROPN
dpc-3378	33	32	je	je	PROPN
dpc-3378	33	33	,	,	PUNCT
dpc-3378	33	34	scolyer	scolyer	PROPN
dpc-3378	33	35	ra	ra	PROPN
dpc-3378	33	36	,	,	PUNCT
dpc-3378	33	37	hess	hess	PROPN
dpc-3378	33	38	kr	kr	PROPN
dpc-3378	33	39	,	,	PUNCT
dpc-3378	33	40	et	et	PROPN
dpc-3378	33	41	al	al	PROPN
dpc-3378	33	42	.	.	PUNCT
dpc-3378	33	43	melanoma	melanoma	PROPN
dpc-3378	33	44	staging	staging	NOUN
dpc-3378	33	45	:	:	PUNCT
dpc-3378	33	46	evidence	evidence	NOUN
dpc-3378	33	47	-	-	PUNCT
dpc-3378	33	48	based	base	VERB
dpc-3378	33	49	changes	change	NOUN
dpc-3378	33	50	in	in	ADP
dpc-3378	33	51	the	the	DET
dpc-3378	33	52	american	american	PROPN
dpc-3378	33	53	joint	joint	PROPN
dpc-3378	33	54	committee	committee	PROPN
dpc-3378	33	55	on	on	ADP
dpc-3378	33	56	cancer	cancer	NOUN
dpc-3378	33	57	eighth	eighth	PROPN
dpc-3378	33	58	edition	edition	NOUN
dpc-3378	33	59	cancer	cancer	NOUN
dpc-3378	33	60	staging	staging	NOUN
dpc-3378	33	61	manual	manual	NOUN
dpc-3378	33	62	.	.	PUNCT
dpc-3378	34	1	ca	can	AUX
dpc-3378	34	2	 	 	SPACE
dpc-3378	34	3	cancer	cancer	NOUN
dpc-3378	34	4	j	j	PROPN
dpc-3378	34	5	clin	clin	PROPN
dpc-3378	34	6	.	.	PROPN
dpc-3378	35	1	2017	2017	NUM
dpc-3378	35	2	;	;	PUNCT
dpc-3378	35	3	doi:10.3322	doi:10.3322	NOUN
dpc-3378	35	4	/	/	SYM
dpc-3378	35	5	caac.21409	caac.21409	PROPN
dpc-3378	35	6	.	.	NOUN
dpc-3378	35	7	table	table	NOUN
dpc-3378	35	8	2	2	NUM
dpc-3378	35	9	.	.	PUNCT
dpc-3378	36	1	melanoma	melanoma	PROPN
dpc-3378	36	2	stage	stage	NOUN
dpc-3378	36	3	iii	iii	NUM
dpc-3378	36	4	subgroups	subgroup	NOUN
dpc-3378	36	5	according	accord	VERB
dpc-3378	36	6	to	to	ADP
dpc-3378	36	7	the	the	DET
dpc-3378	36	8	ajcc	ajcc	PROPN
dpc-3378	36	9	classification	classification	NOUN
dpc-3378	36	10	system	system	NOUN
dpc-3378	36	11	8th	8th	PROPN
dpc-3378	36	12	edition	edition	NOUN
dpc-3378	36	13	.	.	PUNCT
dpc-3378	37	1	t	t	PROPN
dpc-3378	37	2	category	category	NOUN
dpc-3378	37	3	n	n	ADP
dpc-3378	37	4	category	category	NOUN
dpc-3378	37	5	t0	t0	PROPN
dpc-3378	37	6	occult	occult	VERB
dpc-3378	37	7	primary	primary	ADJ
dpc-3378	37	8	tumor	tumor	NOUN
dpc-3378	37	9	t1a	t1a	NOUN
dpc-3378	37	10	<	<	X
dpc-3378	37	11	0.8	0.8	NUM
dpc-3378	37	12	t1b	t1b	PROPN
dpc-3378	37	13	<	<	X
dpc-3378	37	14	0.8	0.8	NUM
dpc-3378	37	15	u	u	NOUN
dpc-3378	37	16	or	or	CCONJ
dpc-3378	37	17	0.8	0.8	NUM
dpc-3378	37	18	-	-	SYM
dpc-3378	37	19	1.0	1.0	NUM
dpc-3378	37	20	t2a	t2a	ADP
dpc-3378	37	21	>	>	PUNCT
dpc-3378	37	22	1.0	1.0	NUM
dpc-3378	37	23	-	-	SYM
dpc-3378	37	24	2.0	2.0	NUM
dpc-3378	37	25	t2b	t2b	PROPN
dpc-3378	37	26	>	>	PUNCT
dpc-3378	37	27	1.0	1.0	NUM
dpc-3378	37	28	-	-	SYM
dpc-3378	37	29	2.0	2.0	NUM
dpc-3378	37	30	u	u	NOUN
dpc-3378	37	31	t3a	t3a	X
dpc-3378	37	32	>	>	X
dpc-3378	37	33	2.0	2.0	NUM
dpc-3378	37	34	-	-	SYM
dpc-3378	37	35	4.0	4.0	NUM
dpc-3378	37	36	t3b	t3b	NOUN
dpc-3378	37	37	>	>	X
dpc-3378	37	38	2.0	2.0	NUM
dpc-3378	37	39	-	-	SYM
dpc-3378	37	40	4.0	4.0	NUM
dpc-3378	37	41	u	u	NOUN
dpc-3378	37	42	t4a	t4a	NOUN
dpc-3378	37	43	>	>	X
dpc-3378	37	44	4.0	4.0	NUM
dpc-3378	37	45	t4b	t4b	NOUN
dpc-3378	37	46	>	>	X
dpc-3378	37	47	4.0	4.0	NUM
dpc-3378	37	48	u	u	NOUN
dpc-3378	37	49	n1a	n1a	NOUN
dpc-3378	37	50	1	1	NUM
dpc-3378	37	51	node	node	PROPN
dpc-3378	37	52	c.o	c.o	PROPN
dpc-3378	37	53	.	.	PROPN
dpc-3378	37	54	n	n	PROPN
dpc-3378	37	55	/	/	SYM
dpc-3378	37	56	a	a	PRON
dpc-3378	37	57	a	a	DET
dpc-3378	37	58	a	a	DET
dpc-3378	37	59	a	a	DET
dpc-3378	37	60	b	b	NOUN
dpc-3378	37	61	b	b	PROPN
dpc-3378	37	62	c	c	NOUN
dpc-3378	37	63	c	c	PROPN
dpc-3378	37	64	c	c	PROPN
dpc-3378	37	65	n1b	n1b	PROPN
dpc-3378	37	66	1	1	NUM
dpc-3378	37	67	node	node	PROPN
dpc-3378	37	68	c.d	c.d	PROPN
dpc-3378	37	69	b	b	PROPN
dpc-3378	37	70	b	b	PROPN
dpc-3378	37	71	b	b	PROPN
dpc-3378	37	72	b	b	PROPN
dpc-3378	37	73	b	b	PROPN
dpc-3378	37	74	b	b	PROPN
dpc-3378	37	75	c	c	NOUN
dpc-3378	37	76	c	c	NOUN
dpc-3378	37	77	c	c	X
dpc-3378	37	78	n1c	n1c	CCONJ
dpc-3378	37	79	only	only	ADV
dpc-3378	37	80	s	s	PROPN
dpc-3378	37	81	/	/	SYM
dpc-3378	37	82	t	t	PROPN
dpc-3378	37	83	mets	mets	PROPN
dpc-3378	37	84	b	b	PROPN
dpc-3378	37	85	b	b	PROPN
dpc-3378	37	86	b	b	PROPN
dpc-3378	37	87	b	b	PROPN
dpc-3378	37	88	b	b	PROPN
dpc-3378	37	89	b	b	PROPN
dpc-3378	37	90	c	c	NOUN
dpc-3378	37	91	c	c	NOUN
dpc-3378	37	92	c	c	NOUN
dpc-3378	37	93	n2a	n2a	PROPN
dpc-3378	37	94	2/3	2/3	NUM
dpc-3378	37	95	node	node	PROPN
dpc-3378	37	96	c.o	c.o	PROPN
dpc-3378	37	97	.	.	PROPN
dpc-3378	37	98	n	n	PROPN
dpc-3378	37	99	/	/	SYM
dpc-3378	37	100	a	a	PRON
dpc-3378	37	101	a	a	DET
dpc-3378	37	102	a	a	DET
dpc-3378	37	103	a	a	DET
dpc-3378	37	104	b	b	NOUN
dpc-3378	37	105	b	b	NOUN
dpc-3378	37	106	c	c	NOUN
dpc-3378	37	107	c	c	NOUN
dpc-3378	37	108	c	c	NOUN
dpc-3378	37	109	n2b	n2b	PROPN
dpc-3378	37	110	2/3	2/3	NUM
dpc-3378	37	111	node	node	NOUN
dpc-3378	37	112	,	,	PUNCT
dpc-3378	37	113	at	at	ADP
dpc-3378	37	114	least	least	ADJ
dpc-3378	37	115	1	1	NUM
dpc-3378	37	116	c.d	c.d	NOUN
dpc-3378	37	117	.	.	PUNCT
dpc-3378	38	1	c	c	PROPN
dpc-3378	38	2	b	b	PROPN
dpc-3378	38	3	b	b	PROPN
dpc-3378	38	4	b	b	PROPN
dpc-3378	38	5	b	b	PROPN
dpc-3378	38	6	b	b	PROPN
dpc-3378	38	7	c	c	NOUN
dpc-3378	38	8	c	c	NOUN
dpc-3378	38	9	c	c	PROPN
dpc-3378	38	10	n2c	n2c	PROPN
dpc-3378	38	11	s	s	PROPN
dpc-3378	38	12	/	/	SYM
dpc-3378	38	13	t	t	NOUN
dpc-3378	38	14	mets	met	NOUN
dpc-3378	38	15	+	+	CCONJ
dpc-3378	38	16	1	1	NUM
dpc-3378	38	17	nodea	nodea	VERB
dpc-3378	39	1	c	c	NOUN
dpc-3378	39	2	c	c	NOUN
dpc-3378	39	3	c	c	NOUN
dpc-3378	39	4	c	c	NOUN
dpc-3378	39	5	c	c	NOUN
dpc-3378	39	6	c	c	NOUN
dpc-3378	39	7	c	c	NOUN
dpc-3378	39	8	c	c	NOUN
dpc-3378	39	9	c	c	NOUN
dpc-3378	39	10	n3a	n3a	PUNCT
dpc-3378	39	11	≥4	≥4	PROPN
dpc-3378	39	12	node	node	PROPN
dpc-3378	39	13	c.o	c.o	PROPN
dpc-3378	39	14	.	.	PROPN
dpc-3378	39	15	n	n	CCONJ
dpc-3378	39	16	/	/	SYM
dpc-3378	39	17	a	a	DET
dpc-3378	39	18	c	c	NOUN
dpc-3378	39	19	c	c	NOUN
dpc-3378	39	20	c	c	NOUN
dpc-3378	39	21	c	c	NOUN
dpc-3378	39	22	c	c	NOUN
dpc-3378	39	23	c	c	NOUN
dpc-3378	39	24	c	c	PROPN
dpc-3378	39	25	d	d	X
dpc-3378	39	26	n3b	n3b	X
dpc-3378	39	27	≥4	≥4	PROPN
dpc-3378	39	28	node	node	PROPN
dpc-3378	39	29	,	,	PUNCT
dpc-3378	39	30	at	at	ADP
dpc-3378	39	31	least	least	ADJ
dpc-3378	39	32	1	1	NUM
dpc-3378	39	33	c.d	c.d	NOUN
dpc-3378	39	34	.	.	PROPN
dpc-3378	40	1	or	or	CCONJ
dpc-3378	40	2	matted	matted	ADJ
dpc-3378	40	3	nodes	node	NOUN
dpc-3378	40	4	c	c	X
dpc-3378	40	5	c	c	NOUN
dpc-3378	40	6	c	c	NOUN
dpc-3378	40	7	c	c	NOUN
dpc-3378	40	8	c	c	NOUN
dpc-3378	40	9	c	c	NOUN
dpc-3378	40	10	c	c	NOUN
dpc-3378	40	11	c	c	PROPN
dpc-3378	40	12	d	d	X
dpc-3378	40	13	n3c	n3c	PROPN
dpc-3378	40	14	s	s	PART
dpc-3378	40	15	/	/	SYM
dpc-3378	40	16	t	t	NOUN
dpc-3378	40	17	mets	met	NOUN
dpc-3378	41	1	+	+	CCONJ
dpc-3378	41	2	≥2	≥2	NUM
dpc-3378	41	3	nodea	nodea	ADJ
dpc-3378	41	4	or	or	CCONJ
dpc-3378	41	5	matted	matted	ADJ
dpc-3378	41	6	nodes	node	NOUN
dpc-3378	41	7	c	c	X
dpc-3378	41	8	c	c	NOUN
dpc-3378	41	9	c	c	NOUN
dpc-3378	41	10	c	c	NOUN
dpc-3378	41	11	c	c	NOUN
dpc-3378	41	12	c	c	NOUN
dpc-3378	41	13	c	c	NOUN
dpc-3378	41	14	c	c	PROPN
dpc-3378	41	15	d	d	PROPN
dpc-3378	41	16	c.o	c.o	PROPN
dpc-3378	41	17	.	.	PUNCT
dpc-3378	42	1	=	=	PRON
dpc-3378	42	2	clinically	clinically	ADV
dpc-3378	42	3	occult	occult	NOUN
dpc-3378	42	4	(	(	PUNCT
dpc-3378	42	5	diagnosed	diagnose	VERB
dpc-3378	42	6	by	by	ADP
dpc-3378	42	7	sentinel	sentinel	ADJ
dpc-3378	42	8	node	node	ADJ
dpc-3378	42	9	biopsy	biopsy	NOUN
dpc-3378	42	10	)	)	PUNCT
dpc-3378	42	11	;	;	PUNCT
dpc-3378	42	12	c.d	c.d	X
dpc-3378	42	13	.	.	PUNCT
dpc-3378	42	14	=	=	PRON
dpc-3378	42	15	clinically	clinically	ADV
dpc-3378	42	16	detected	detect	VERB
dpc-3378	42	17	(	(	PUNCT
dpc-3378	42	18	by	by	ADP
dpc-3378	42	19	palpation	palpation	NOUN
dpc-3378	42	20	or	or	CCONJ
dpc-3378	42	21	imaging	imaging	NOUN
dpc-3378	42	22	)	)	PUNCT
dpc-3378	42	23	;	;	PUNCT
dpc-3378	42	24	n	n	CCONJ
dpc-3378	42	25	/	/	SYM
dpc-3378	42	26	a	a	PRON
dpc-3378	42	27	=	=	NOUN
dpc-3378	42	28	not	not	PART
dpc-3378	42	29	applicable	applicable	ADJ
dpc-3378	42	30	.	.	PUNCT
dpc-3378	43	1	s	s	X
dpc-3378	43	2	/	/	SYM
dpc-3378	43	3	t	t	PROPN
dpc-3378	43	4	 	 	SPACE
dpc-3378	43	5	mets	met	NOUN
dpc-3378	43	6	 	 	SPACE
dpc-3378	43	7	=	=	PROPN
dpc-3378	43	8	satellite	satellite	NOUN
dpc-3378	43	9	and/or	and/or	CCONJ
dpc-3378	43	10	in	in	ADP
dpc-3378	43	11	-	-	PUNCT
dpc-3378	43	12	transit	transit	NOUN
dpc-3378	43	13	metastases	metastasis	NOUN
dpc-3378	43	14	.	.	PUNCT
dpc-3378	44	1	t	t	NOUN
dpc-3378	44	2	category	category	NOUN
dpc-3378	44	3	is	be	AUX
dpc-3378	44	4	expressed	express	VERB
dpc-3378	44	5	in	in	ADP
dpc-3378	44	6	mm.u	mm.u	NOUN
dpc-3378	44	7	=	=	SYM
dpc-3378	44	8	ulceration	ulceration	NOUN
dpc-3378	44	9	;	;	PUNCT
dpc-3378	44	10	a	a	DET
dpc-3378	44	11	in	in	ADP
dpc-3378	44	12	n2c	n2c	NOUN
dpc-3378	44	13	and	and	CCONJ
dpc-3378	44	14	n3c	n3c	PROPN
dpc-3378	44	15	subcategories	subcategorie	NOUN
dpc-3378	44	16	involved	involve	VERB
dpc-3378	44	17	nodes	node	NOUN
dpc-3378	44	18	may	may	AUX
dpc-3378	44	19	be	be	AUX
dpc-3378	44	20	either	either	CCONJ
dpc-3378	44	21	clinically	clinically	ADV
dpc-3378	44	22	occult	occult	NOUN
dpc-3378	44	23	or	or	CCONJ
dpc-3378	44	24	clinically	clinically	ADV
dpc-3378	44	25	detected	detect	VERB
dpc-3378	44	26	.	.	PUNCT
dpc-3378	45	1	adapted	adapt	VERB
dpc-3378	45	2	from	from	ADP
dpc-3378	45	3	:	:	PUNCT
dpc-3378	45	4	gershenwald	gershenwald	PROPN
dpc-3378	45	5	je	je	PROPN
dpc-3378	45	6	,	,	PUNCT
dpc-3378	45	7	scolyer	scolyer	PROPN
dpc-3378	45	8	ra	ra	PROPN
dpc-3378	45	9	,	,	PUNCT
dpc-3378	45	10	hess	hess	PROPN
dpc-3378	45	11	kr	kr	PROPN
dpc-3378	45	12	,	,	PUNCT
dpc-3378	45	13	et	et	PROPN
dpc-3378	46	1	al	al	PROPN
dpc-3378	46	2	.	.	PUNCT
dpc-3378	46	3	melanoma	melanoma	PROPN
dpc-3378	46	4	staging	staging	NOUN
dpc-3378	46	5	:	:	PUNCT
dpc-3378	46	6	evidence	evidence	NOUN
dpc-3378	46	7	-	-	PUNCT
dpc-3378	46	8	based	base	VERB
dpc-3378	46	9	changes	change	NOUN
dpc-3378	46	10	in	in	ADP
dpc-3378	46	11	the	the	DET
dpc-3378	46	12	american	american	PROPN
dpc-3378	46	13	joint	joint	PROPN
dpc-3378	46	14	committee	committee	PROPN
dpc-3378	46	15	on	on	ADP
dpc-3378	46	16	cancer	cancer	NOUN
dpc-3378	46	17	eighth	eighth	PROPN
dpc-3378	46	18	edition	edition	NOUN
dpc-3378	46	19	cancer	cancer	NOUN
dpc-3378	46	20	staging	staging	NOUN
dpc-3378	46	21	manual	manual	NOUN
dpc-3378	46	22	.	.	PUNCT
dpc-3378	47	1	ca	can	AUX
dpc-3378	47	2	cancer	cancer	PROPN
dpc-3378	47	3	j	j	PROPN
dpc-3378	47	4	clin	clin	PROPN
dpc-3378	47	5	.	.	PROPN
dpc-3378	48	1	2017	2017	NUM
dpc-3378	48	2	;	;	PUNCT
dpc-3378	48	3	doi:10.3322	doi:10.3322	NOUN
dpc-3378	48	4	/	/	SYM
dpc-3378	48	5	caac.21409	caac.21409	PROPN
dpc-3378	48	6	.	.	NOUN
dpc-3378	48	7	therapy	therapy	NOUN
dpc-3378	49	1	[	[	X
dpc-3378	49	2	3,5,6	3,5,6	X
dpc-3378	49	3	]	]	X
dpc-3378	49	4	.	.	PUNCT
dpc-3378	50	1	slnb	slnb	NOUN
dpc-3378	50	2	positivity	positivity	NOUN
dpc-3378	50	3	rates	rate	NOUN
dpc-3378	50	4	vary	vary	VERB
dpc-3378	50	5	depending	depend	VERB
dpc-3378	50	6	on	on	ADP
dpc-3378	50	7	histopathological	histopathological	ADJ
dpc-3378	50	8	procedures	procedure	NOUN
dpc-3378	50	9	,	,	PUNCT
dpc-3378	50	10	with	with	ADP
dpc-3378	50	11	a	a	DET
dpc-3378	50	12	reported	report	VERB
dpc-3378	50	13	false	false	ADJ
dpc-3378	50	14	negative	negative	ADJ
dpc-3378	50	15	rate	rate	NOUN
dpc-3378	50	16	up	up	ADP
dpc-3378	50	17	to	to	PART
dpc-3378	50	18	10	10	NUM
dpc-3378	50	19	%	%	NOUN
dpc-3378	50	20	[	[	X
dpc-3378	50	21	7	7	NUM
dpc-3378	50	22	]	]	PUNCT
dpc-3378	50	23	.	.	PUNCT
dpc-3378	51	1	adjuvant	adjuvant	ADJ
dpc-3378	51	2	treatment	treatment	NOUN
dpc-3378	51	3	in	in	ADP
dpc-3378	51	4	stage	stage	NOUN
dpc-3378	51	5	iii	iii	NUM
dpc-3378	51	6	melanoma	melanoma	NOUN
dpc-3378	51	7	patients	patient	NOUN
dpc-3378	51	8	is	be	AUX
dpc-3378	51	9	the	the	DET
dpc-3378	51	10	standard	standard	NOUN
dpc-3378	51	11	of	of	ADP
dpc-3378	51	12	care	care	NOUN
dpc-3378	51	13	from	from	ADP
dpc-3378	51	14	2018	2018	NUM
dpc-3378	51	15	,	,	PUNCT
dpc-3378	51	16	when	when	SCONJ
dpc-3378	51	17	both	both	DET
dpc-3378	51	18	immunotherapy	immunotherapy	NOUN
dpc-3378	51	19	(	(	PUNCT
dpc-3378	51	20	pd-1	pd-1	ADP
dpc-3378	51	21	inhibitors	inhibitor	NOUN
dpc-3378	51	22	)	)	PUNCT
dpc-3378	51	23	and	and	CCONJ
dpc-3378	51	24	molecular	molecular	ADJ
dpc-3378	51	25	targeted	target	VERB
dpc-3378	51	26	therapy	therapy	NOUN
dpc-3378	51	27	were	be	AUX
dpc-3378	51	28	worldwide	worldwide	ADV
dpc-3378	51	29	approved	approve	VERB
dpc-3378	51	30	thanks	thank	NOUN
dpc-3378	51	31	to	to	ADP
dpc-3378	51	32	the	the	DET
dpc-3378	51	33	excellent	excellent	ADJ
dpc-3378	51	34	results	result	NOUN
dpc-3378	51	35	obtained	obtain	VERB
dpc-3378	51	36	from	from	ADP
dpc-3378	51	37	checkmate	checkmate	NOUN
dpc-3378	51	38	238	238	NUM
dpc-3378	51	39	,	,	PUNCT
dpc-3378	51	40	keynote-054	keynote-054	ADJ
dpc-3378	51	41	and	and	CCONJ
dpc-3378	51	42	combi	combi	PROPN
dpc-3378	51	43	-	-	PUNCT
dpc-3378	51	44	ad	ad	NOUN
dpc-3378	51	45	trials	trial	NOUN
dpc-3378	51	46	[	[	X
dpc-3378	51	47	8	8	NUM
dpc-3378	51	48	-	-	SYM
dpc-3378	51	49	10	10	NUM
dpc-3378	51	50	]	]	PUNCT
dpc-3378	51	51	.	.	PUNCT
dpc-3378	52	1	these	these	DET
dpc-3378	52	2	clinical	clinical	ADJ
dpc-3378	52	3	trials	trial	NOUN
dpc-3378	52	4	recruited	recruit	VERB
dpc-3378	52	5	review	review	NOUN
dpc-3378	52	6	|	|	ADV
dpc-3378	52	7	dermatol	dermatol	ADJ
dpc-3378	52	8	pract	pract	NOUN
dpc-3378	52	9	concept	concept	NOUN
dpc-3378	52	10	.	.	PUNCT
dpc-3378	53	1	2024;14(1):e2024038	2024;14(1):e2024038	NUM
dpc-3378	53	2	3	3	NUM
dpc-3378	53	3	only	only	ADV
dpc-3378	53	4	high	high	ADJ
dpc-3378	53	5	-	-	PUNCT
dpc-3378	53	6	risk	risk	NOUN
dpc-3378	53	7	stage	stage	NOUN
dpc-3378	53	8	iii	iii	NUM
dpc-3378	53	9	patients	patient	NOUN
dpc-3378	53	10	,	,	PUNCT
dpc-3378	53	11	meaning	mean	VERB
dpc-3378	53	12	that	that	SCONJ
dpc-3378	53	13	patients	patient	NOUN
dpc-3378	53	14	with	with	ADP
dpc-3378	53	15	stage	stage	NOUN
dpc-3378	53	16	iiia	iiia	NOUN
dpc-3378	53	17	(	(	PUNCT
dpc-3378	53	18	table	table	NOUN
dpc-3378	53	19	2	2	NUM
dpc-3378	53	20	)	)	PUNCT
dpc-3378	53	21	melanoma	melanoma	NOUN
dpc-3378	53	22	could	could	AUX
dpc-3378	53	23	only	only	ADV
dpc-3378	53	24	be	be	AUX
dpc-3378	53	25	included	include	VERB
dpc-3378	53	26	if	if	SCONJ
dpc-3378	53	27	the	the	DET
dpc-3378	53	28	metastasis	metastasis	NOUN
dpc-3378	53	29	in	in	ADP
dpc-3378	53	30	the	the	DET
dpc-3378	53	31	sln	sln	NOUN
dpc-3378	53	32	were	be	AUX
dpc-3378	53	33	larger	large	ADJ
dpc-3378	53	34	than	than	ADP
dpc-3378	53	35	1	1	NUM
dpc-3378	53	36	mm	mm	NOUN
dpc-3378	53	37	.	.	PUNCT
dpc-3378	54	1	however	however	ADV
dpc-3378	54	2	,	,	PUNCT
dpc-3378	54	3	adjuvant	adjuvant	ADJ
dpc-3378	54	4	therapies	therapy	NOUN
dpc-3378	54	5	are	be	AUX
dpc-3378	54	6	approved	approve	VERB
dpc-3378	54	7	in	in	ADP
dpc-3378	54	8	all	all	DET
dpc-3378	54	9	stage	stage	NOUN
dpc-3378	54	10	iii	iii	NUM
dpc-3378	54	11	subgroups	subgroup	NOUN
dpc-3378	54	12	[	[	X
dpc-3378	54	13	11	11	NUM
dpc-3378	54	14	]	]	PUNCT
dpc-3378	54	15	.	.	PUNCT
dpc-3378	55	1	adjuvant	adjuvant	ADJ
dpc-3378	55	2	treatment	treatment	NOUN
dpc-3378	55	3	in	in	ADP
dpc-3378	55	4	stage	stage	NOUN
dpc-3378	55	5	ii	ii	PROPN
dpc-3378	55	6	melanoma	melanoma	NOUN
dpc-3378	55	7	patients	patient	NOUN
dpc-3378	55	8	is	be	AUX
dpc-3378	55	9	the	the	DET
dpc-3378	55	10	current	current	ADJ
dpc-3378	55	11	focus	focus	NOUN
dpc-3378	55	12	of	of	ADP
dpc-3378	55	13	oncology	oncology	NOUN
dpc-3378	55	14	research	research	NOUN
dpc-3378	55	15	[	[	X
dpc-3378	55	16	12	12	NUM
dpc-3378	55	17	]	]	PUNCT
dpc-3378	55	18	.	.	PUNCT
dpc-3378	56	1	despite	despite	SCONJ
dpc-3378	56	2	the	the	DET
dpc-3378	56	3	absence	absence	NOUN
dpc-3378	56	4	of	of	ADP
dpc-3378	56	5	identified	identify	VERB
dpc-3378	56	6	lymph	lymph	NOUN
dpc-3378	56	7	node	node	NOUN
dpc-3378	56	8	involvement	involvement	NOUN
dpc-3378	56	9	,	,	PUNCT
dpc-3378	56	10	patients	patient	NOUN
dpc-3378	56	11	with	with	ADP
dpc-3378	56	12	stage	stage	NOUN
dpc-3378	56	13	iib	iib	PROPN
dpc-3378	56	14	and	and	CCONJ
dpc-3378	56	15	iic	iic	PROPN
dpc-3378	56	16	(	(	PUNCT
dpc-3378	56	17	table	table	NOUN
dpc-3378	56	18	1	1	NUM
dpc-3378	56	19	)	)	PUNCT
dpc-3378	56	20	melanoma	melanoma	NOUN
dpc-3378	56	21	have	have	VERB
dpc-3378	56	22	a	a	DET
dpc-3378	56	23	greater	great	ADJ
dpc-3378	56	24	risk	risk	NOUN
dpc-3378	56	25	of	of	ADP
dpc-3378	56	26	recurrence	recurrence	NOUN
dpc-3378	56	27	/	/	SYM
dpc-3378	56	28	death	death	NOUN
dpc-3378	56	29	than	than	ADP
dpc-3378	56	30	those	those	PRON
dpc-3378	56	31	with	with	ADP
dpc-3378	56	32	stage	stage	NOUN
dpc-3378	56	33	iiia	iiia	ADP
dpc-3378	56	34	disease	disease	NOUN
dpc-3378	56	35	and	and	CCONJ
dpc-3378	56	36	similar	similar	ADJ
dpc-3378	56	37	to	to	ADP
dpc-3378	56	38	those	those	PRON
dpc-3378	56	39	with	with	ADP
dpc-3378	56	40	stage	stage	NOUN
dpc-3378	56	41	iiib	iiib	NOUN
dpc-3378	56	42	disease	disease	NOUN
dpc-3378	56	43	.	.	PUNCT
dpc-3378	57	1	pembrolizumab	pembrolizumab	NOUN
dpc-3378	57	2	200	200	NUM
dpc-3378	57	3	 	 	SPACE
dpc-3378	57	4	mg	mg	NOUN
dpc-3378	57	5	for	for	ADP
dpc-3378	57	6	one	one	NUM
dpc-3378	57	7	year	year	NOUN
dpc-3378	57	8	was	be	AUX
dpc-3378	57	9	compared	compare	VERB
dpc-3378	57	10	against	against	ADP
dpc-3378	57	11	placebo	placebo	NOUN
dpc-3378	57	12	in	in	ADP
dpc-3378	57	13	more	more	ADJ
dpc-3378	57	14	than	than	ADP
dpc-3378	57	15	900	900	NUM
dpc-3378	57	16	  	  	SPACE
dpc-3378	57	17	patients	patient	NOUN
dpc-3378	57	18	with	with	ADP
dpc-3378	57	19	stage	stage	NOUN
dpc-3378	57	20	iib	iib	PROPN
dpc-3378	57	21	and	and	CCONJ
dpc-3378	57	22	iic	iic	PROPN
dpc-3378	57	23	melanoma	melanoma	PROPN
dpc-3378	57	24	in	in	ADP
dpc-3378	57	25	keynote	keynote	NOUN
dpc-3378	57	26	716	716	NUM
dpc-3378	57	27	trial	trial	NOUN
dpc-3378	57	28	resulting	result	VERB
dpc-3378	57	29	in	in	ADP
dpc-3378	57	30	a	a	DET
dpc-3378	57	31	18	18	NUM
dpc-3378	57	32	-	-	PUNCT
dpc-3378	57	33	months	month	NOUN
dpc-3378	57	34	recurrence	recurrence	NOUN
dpc-3378	57	35	-	-	PUNCT
dpc-3378	57	36	free	free	ADJ
dpc-3378	57	37	-	-	PUNCT
dpc-3378	57	38	survival	survival	NOUN
dpc-3378	57	39	rate	rate	NOUN
dpc-3378	57	40	of	of	ADP
dpc-3378	57	41	86	86	NUM
dpc-3378	57	42	%	%	NOUN
dpc-3378	57	43	(	(	PUNCT
dpc-3378	57	44	95	95	NUM
dpc-3378	57	45	%	%	NOUN
dpc-3378	57	46	ci	ci	NOUN
dpc-3378	57	47	82	82	NUM
dpc-3378	57	48	-	-	SYM
dpc-3378	57	49	89	89	NUM
dpc-3378	57	50	)	)	PUNCT
dpc-3378	57	51	in	in	ADP
dpc-3378	57	52	the	the	DET
dpc-3378	57	53	treatment	treatment	NOUN
dpc-3378	57	54	group	group	NOUN
dpc-3378	57	55	versus	versus	ADP
dpc-3378	57	56	77	77	NUM
dpc-3378	57	57	%	%	NOUN
dpc-3378	57	58	(	(	PUNCT
dpc-3378	57	59	95	95	NUM
dpc-3378	57	60	%	%	NOUN
dpc-3378	57	61	ci	ci	NOUN
dpc-3378	57	62	73	73	NUM
dpc-3378	57	63	-	-	SYM
dpc-3378	57	64	81	81	NUM
dpc-3378	57	65	)	)	PUNCT
dpc-3378	57	66	in	in	ADP
dpc-3378	57	67	the	the	DET
dpc-3378	57	68	placebo	placebo	NOUN
dpc-3378	57	69	group	group	NOUN
dpc-3378	57	70	,	,	PUNCT
dpc-3378	57	71	which	which	PRON
dpc-3378	57	72	led	lead	VERB
dpc-3378	57	73	to	to	ADP
dpc-3378	57	74	approval	approval	NOUN
dpc-3378	57	75	by	by	ADP
dpc-3378	57	76	the	the	DET
dpc-3378	57	77	fda	fda	PROPN
dpc-3378	57	78	and	and	CCONJ
dpc-3378	57	79	ema	ema	PROPN
dpc-3378	58	1	[	[	X
dpc-3378	58	2	13	13	NUM
dpc-3378	58	3	]	]	PUNCT
dpc-3378	58	4	.	.	PUNCT
dpc-3378	59	1	final	final	ADJ
dpc-3378	59	2	results	result	NOUN
dpc-3378	59	3	from	from	ADP
dpc-3378	59	4	the	the	DET
dpc-3378	59	5	checkmate	checkmate	NOUN
dpc-3378	59	6	-76k	-76k	PROPN
dpc-3378	59	7	trial	trial	NOUN
dpc-3378	59	8	(	(	PUNCT
dpc-3378	59	9	expected	expect	VERB
dpc-3378	59	10	soon	soon	ADV
dpc-3378	59	11	)	)	PUNCT
dpc-3378	59	12	seem	seem	VERB
dpc-3378	59	13	to	to	PART
dpc-3378	59	14	confirm	confirm	VERB
dpc-3378	59	15	the	the	DET
dpc-3378	59	16	efficacy	efficacy	NOUN
dpc-3378	59	17	of	of	ADP
dpc-3378	59	18	nivolumab	nivolumab	NOUN
dpc-3378	59	19	in	in	ADP
dpc-3378	59	20	stage	stage	NOUN
dpc-3378	59	21	iib	iib	PROPN
dpc-3378	59	22	and	and	CCONJ
dpc-3378	59	23	iic	iic	PROPN
dpc-3378	59	24	melanoma	melanoma	PROPN
dpc-3378	59	25	patients	patient	NOUN
dpc-3378	59	26	[	[	X
dpc-3378	59	27	14	14	NUM
dpc-3378	59	28	]	]	PUNCT
dpc-3378	59	29	.	.	PUNCT
dpc-3378	60	1	with	with	ADP
dpc-3378	60	2	regards	regard	NOUN
dpc-3378	60	3	to	to	ADP
dpc-3378	60	4	target	target	NOUN
dpc-3378	60	5	therapy	therapy	NOUN
dpc-3378	60	6	,	,	PUNCT
dpc-3378	60	7	a	a	DET
dpc-3378	60	8	phase	phase	NOUN
dpc-3378	60	9	iii	iii	NOUN
dpc-3378	60	10	trial	trial	NOUN
dpc-3378	60	11	comparing	compare	VERB
dpc-3378	60	12	encorafenib	encorafenib	NOUN
dpc-3378	60	13	plus	plus	CCONJ
dpc-3378	60	14	binimetinib	binimetinib	NOUN
dpc-3378	60	15	versus	versus	ADP
dpc-3378	60	16	placebo	placebo	NOUN
dpc-3378	60	17	in	in	ADP
dpc-3378	60	18	these	these	DET
dpc-3378	60	19	subsets	subset	NOUN
dpc-3378	60	20	of	of	ADP
dpc-3378	60	21	patients	patient	NOUN
dpc-3378	60	22	is	be	AUX
dpc-3378	60	23	currently	currently	ADV
dpc-3378	60	24	enrolling	enrol	VERB
dpc-3378	60	25	(	(	PUNCT
dpc-3378	60	26	columbus	columbus	NOUN
dpc-3378	60	27	-	-	PUNCT
dpc-3378	60	28	ad	ad	NOUN
dpc-3378	60	29	study	study	NOUN
dpc-3378	60	30	,	,	PUNCT
dpc-3378	60	31	nct05270044	nct05270044	PROPN
dpc-3378	60	32	)	)	PUNCT
dpc-3378	60	33	.	.	PUNCT
dpc-3378	61	1	objectives	objective	NOUN
dpc-3378	61	2	with	with	ADP
dpc-3378	61	3	the	the	DET
dpc-3378	61	4	access	access	NOUN
dpc-3378	61	5	of	of	ADP
dpc-3378	61	6	negative	negative	ADJ
dpc-3378	61	7	-	-	PUNCT
dpc-3378	61	8	sln	sln	NOUN
dpc-3378	61	9	patients	patient	NOUN
dpc-3378	61	10	to	to	PART
dpc-3378	61	11	adjuvant	adjuvant	VERB
dpc-3378	61	12	treatment	treatment	NOUN
dpc-3378	61	13	a	a	DET
dpc-3378	61	14	question	question	NOUN
dpc-3378	61	15	rises	rise	VERB
dpc-3378	61	16	accordingly	accordingly	ADV
dpc-3378	61	17	:	:	PUNCT
dpc-3378	61	18	is	be	AUX
dpc-3378	61	19	slnb	slnb	ADJ
dpc-3378	61	20	still	still	ADV
dpc-3378	61	21	needed	need	VERB
dpc-3378	61	22	[	[	X
dpc-3378	61	23	15	15	NUM
dpc-3378	61	24	]	]	PUNCT
dpc-3378	61	25	?	?	PUNCT
dpc-3378	62	1	which	which	DET
dpc-3378	62	2	melanoma	melanoma	NOUN
dpc-3378	62	3	patient	patient	NOUN
dpc-3378	62	4	does	do	AUX
dpc-3378	62	5	deserve	deserve	VERB
dpc-3378	62	6	it	it	PRON
dpc-3378	62	7	?	?	PUNCT
dpc-3378	63	1	results	result	VERB
dpc-3378	63	2	impact	impact	NOUN
dpc-3378	63	3	of	of	ADP
dpc-3378	63	4	slnb	slnb	NOUN
dpc-3378	63	5	on	on	ADP
dpc-3378	63	6	staging	stage	VERB
dpc-3378	63	7	workup	workup	NOUN
dpc-3378	63	8	:	:	PUNCT
dpc-3378	63	9	potential	potential	ADJ
dpc-3378	63	10	scenarios	scenario	NOUN
dpc-3378	63	11	after	after	ADP
dpc-3378	63	12	the	the	DET
dpc-3378	63	13	indication	indication	NOUN
dpc-3378	63	14	of	of	ADP
dpc-3378	63	15	adjuvant	adjuvant	ADJ
dpc-3378	63	16	therapy	therapy	NOUN
dpc-3378	63	17	in	in	ADP
dpc-3378	63	18	stage	stage	NOUN
dpc-3378	63	19	iib	iib	PROPN
dpc-3378	63	20	and	and	CCONJ
dpc-3378	63	21	iic	iic	PROPN
dpc-3378	63	22	patients	patient	NOUN
dpc-3378	63	23	in	in	ADP
dpc-3378	63	24	table	table	NOUN
dpc-3378	63	25	3	3	NUM
dpc-3378	63	26	the	the	DET
dpc-3378	63	27	staging	staging	NOUN
dpc-3378	63	28	workups	workup	NOUN
dpc-3378	63	29	with	with	ADP
dpc-3378	63	30	indication	indication	NOUN
dpc-3378	63	31	to	to	PART
dpc-3378	63	32	slnb	slnb	VERB
dpc-3378	63	33	are	be	AUX
dpc-3378	63	34	reported	report	VERB
dpc-3378	63	35	.	.	PUNCT
dpc-3378	64	1	according	accord	VERB
dpc-3378	64	2	to	to	ADP
dpc-3378	64	3	nccn	nccn	ADJ
dpc-3378	64	4	guidelines	guideline	NOUN
dpc-3378	64	5	,	,	PUNCT
dpc-3378	64	6	slnb	slnb	NOUN
dpc-3378	64	7	should	should	AUX
dpc-3378	64	8	be	be	AUX
dpc-3378	64	9	discussed	discuss	VERB
dpc-3378	64	10	in	in	ADP
dpc-3378	64	11	patients	patient	NOUN
dpc-3378	64	12	with	with	ADP
dpc-3378	64	13	microsatellites	microsatellite	NOUN
dpc-3378	64	14	,	,	PUNCT
dpc-3378	64	15	as	as	SCONJ
dpc-3378	64	16	sln	sln	PROPN
dpc-3378	64	17	status	status	NOUN
dpc-3378	64	18	does	do	AUX
dpc-3378	64	19	have	have	VERB
dpc-3378	64	20	prognostic	prognostic	ADJ
dpc-3378	64	21	significance	significance	NOUN
dpc-3378	64	22	,	,	PUNCT
dpc-3378	64	23	with	with	ADP
dpc-3378	64	24	a	a	DET
dpc-3378	64	25	positive	positive	ADJ
dpc-3378	64	26	sln	sln	NOUN
dpc-3378	64	27	upstaging	upstage	VERB
dpc-3378	64	28	a	a	DET
dpc-3378	64	29	patient	patient	NOUN
dpc-3378	64	30	from	from	ADP
dpc-3378	64	31	at	at	ADP
dpc-3378	64	32	least	least	ADJ
dpc-3378	64	33	n1c	n1c	ADV
dpc-3378	64	34	and	and	CCONJ
dpc-3378	64	35	at	at	ADP
dpc-3378	64	36	least	least	ADJ
dpc-3378	64	37	stage	stage	NOUN
dpc-3378	64	38	iiib	iiib	NOUN
dpc-3378	64	39	disease	disease	NOUN
dpc-3378	64	40	,	,	PUNCT
dpc-3378	64	41	to	to	ADP
dpc-3378	64	42	at	at	ADV
dpc-3378	64	43	least	least	ADJ
dpc-3378	64	44	n2c	n2c	NOUN
dpc-3378	64	45	,	,	PUNCT
dpc-3378	64	46	which	which	PRON
dpc-3378	64	47	corresponds	correspond	VERB
dpc-3378	64	48	to	to	ADP
dpc-3378	64	49	stage	stage	NOUN
dpc-3378	64	50	iiic	iiic	PROPN
dpc-3378	64	51	disease	disease	NOUN
dpc-3378	64	52	(	(	PUNCT
dpc-3378	64	53	table	table	NOUN
dpc-3378	64	54	2	2	NUM
dpc-3378	64	55	)	)	PUNCT
dpc-3378	65	1	[	[	X
dpc-3378	65	2	5	5	NUM
dpc-3378	65	3	]	]	PUNCT
dpc-3378	65	4	.	.	PUNCT
dpc-3378	66	1	however	however	ADV
dpc-3378	66	2	,	,	PUNCT
dpc-3378	66	3	although	although	SCONJ
dpc-3378	66	4	this	this	PRON
dpc-3378	66	5	may	may	AUX
dpc-3378	66	6	have	have	VERB
dpc-3378	66	7	a	a	DET
dpc-3378	66	8	prognostic	prognostic	ADJ
dpc-3378	66	9	table	table	NOUN
dpc-3378	66	10	3	3	NUM
dpc-3378	66	11	.	.	PUNCT
dpc-3378	66	12	staging	stage	VERB
dpc-3378	66	13	workup	workup	NOUN
dpc-3378	66	14	and	and	CCONJ
dpc-3378	66	15	consequent	consequent	ADJ
dpc-3378	66	16	indication	indication	NOUN
dpc-3378	66	17	to	to	ADP
dpc-3378	66	18	adjuvant	adjuvant	ADJ
dpc-3378	66	19	therapy	therapy	NOUN
dpc-3378	66	20	.	.	PUNCT
dpc-3378	67	1	subcategory	subcategory	PROPN
dpc-3378	67	2	t	t	PROPN
dpc-3378	67	3	snb	snb	PROPN
dpc-3378	67	4	results	result	VERB
dpc-3378	67	5	pathological	pathological	ADJ
dpc-3378	67	6	stage	stage	NOUN
dpc-3378	67	7	5	5	NUM
dpc-3378	67	8	-	-	PUNCT
dpc-3378	67	9	year	year	NOUN
dpc-3378	67	10	survival	survival	NOUN
dpc-3378	67	11	(	(	PUNCT
dpc-3378	67	12	%	%	NOUN
dpc-3378	67	13	)	)	PUNCT
dpc-3378	67	14	10	10	NUM
dpc-3378	67	15	-	-	PUNCT
dpc-3378	67	16	year	year	NOUN
dpc-3378	67	17	survival	survival	NOUN
dpc-3378	67	18	(	(	PUNCT
dpc-3378	67	19	%	%	INTJ
dpc-3378	67	20	)	)	PUNCT
dpc-3378	67	21	indication	indication	NOUN
dpc-3378	67	22	to	to	PART
dpc-3378	67	23	adjuvant	adjuvant	VERB
dpc-3378	67	24	therapy	therapy	NOUN
dpc-3378	67	25	pt1b	pt1b	PROPN
dpc-3378	67	26	n0	n0	X
dpc-3378	67	27	1a	1a	NUM
dpc-3378	67	28	99	99	NUM
dpc-3378	67	29	96	96	NUM
dpc-3378	68	1	no	no	DET
dpc-3378	68	2	n1a	n1a	NOUN
dpc-3378	68	3	,	,	PUNCT
dpc-3378	68	4	n2ba	n2ba	NOUN
dpc-3378	68	5	3a	3a	NUM
dpc-3378	68	6	*	*	SYM
dpc-3378	68	7	93	93	NUM
dpc-3378	68	8	88	88	NUM
dpc-3378	68	9	questionable	questionable	ADJ
dpc-3378	68	10	pt2a	pt2a	PROPN
dpc-3378	68	11	n0	n0	ADJ
dpc-3378	68	12	1b	1b	NUM
dpc-3378	68	13	97	97	NUM
dpc-3378	68	14	94	94	NUM
dpc-3378	68	15	no	no	DET
dpc-3378	68	16	n1a	n1a	NOUN
dpc-3378	68	17	,	,	PUNCT
dpc-3378	68	18	n2aa	n2aa	X
dpc-3378	68	19	3a	3a	NUM
dpc-3378	68	20	*	*	SYM
dpc-3378	68	21	93	93	NUM
dpc-3378	68	22	88	88	NUM
dpc-3378	68	23	questionable	questionable	ADJ
dpc-3378	68	24	pt2b	pt2b	PROPN
dpc-3378	68	25	n0	n0	ADJ
dpc-3378	68	26	2a	2a	NUM
dpc-3378	68	27	94	94	NUM
dpc-3378	68	28	88	88	NUM
dpc-3378	68	29	no	no	DET
dpc-3378	68	30	n1a	n1a	NOUN
dpc-3378	68	31	,	,	PUNCT
dpc-3378	68	32	n2a	n2a	PROPN
dpc-3378	68	33	,	,	PUNCT
dpc-3378	68	34	n3a	n3a	NOUN
dpc-3378	68	35	3b-3c	3b-3c	NOUN
dpc-3378	68	36	83	83	NUM
dpc-3378	68	37	-	-	SYM
dpc-3378	68	38	69	69	NUM
dpc-3378	68	39	77	77	NUM
dpc-3378	68	40	-	-	SYM
dpc-3378	68	41	60	60	NUM
dpc-3378	68	42	yes	yes	INTJ
dpc-3378	68	43	pt3a	pt3a	PROPN
dpc-3378	68	44	n0	n0	NUM
dpc-3378	68	45	2a	2a	NUM
dpc-3378	68	46	97	97	NUM
dpc-3378	68	47	88	88	NUM
dpc-3378	68	48	no	no	DET
dpc-3378	68	49	n1a	n1a	NOUN
dpc-3378	68	50	,	,	PUNCT
dpc-3378	68	51	n2a	n2a	PROPN
dpc-3378	68	52	,	,	PUNCT
dpc-3378	68	53	n3a	n3a	NOUN
dpc-3378	68	54	3b-3c	3b-3c	NOUN
dpc-3378	68	55	83	83	NUM
dpc-3378	68	56	-	-	SYM
dpc-3378	68	57	69	69	NUM
dpc-3378	68	58	77	77	NUM
dpc-3378	68	59	-	-	SYM
dpc-3378	68	60	60	60	NUM
dpc-3378	68	61	yes	yes	NUM
dpc-3378	68	62	pt3b	pt3b	PROPN
dpc-3378	68	63	n0	n0	PROPN
dpc-3378	68	64	2b	2b	NUM
dpc-3378	68	65	87	87	NUM
dpc-3378	68	66	82	82	NUM
dpc-3378	68	67	yes	yes	INTJ
dpc-3378	68	68	n1a	n1a	NOUN
dpc-3378	68	69	,	,	PUNCT
dpc-3378	68	70	n2a	n2a	PROPN
dpc-3378	68	71	,	,	PUNCT
dpc-3378	68	72	n3a	n3a	NOUN
dpc-3378	68	73	3c	3c	NUM
dpc-3378	68	74	69	69	NUM
dpc-3378	68	75	60	60	NUM
dpc-3378	68	76	yes	yes	INTJ
dpc-3378	68	77	pt4a	pt4a	PROPN
dpc-3378	68	78	n0	n0	X
dpc-3378	68	79	2b	2b	NUM
dpc-3378	68	80	87	87	NUM
dpc-3378	68	81	82	82	NUM
dpc-3378	68	82	yes	yes	INTJ
dpc-3378	68	83	n1a	n1a	NOUN
dpc-3378	68	84	,	,	PUNCT
dpc-3378	68	85	n2a	n2a	PROPN
dpc-3378	68	86	,	,	PUNCT
dpc-3378	68	87	n3a	n3a	NOUN
dpc-3378	68	88	3c	3c	NUM
dpc-3378	68	89	69	69	NUM
dpc-3378	68	90	60	60	NUM
dpc-3378	68	91	yes	yes	INTJ
dpc-3378	68	92	pt4b	pt4b	NOUN
dpc-3378	68	93	n0	n0	ADJ
dpc-3378	68	94	2c	2c	NOUN
dpc-3378	68	95	82	82	NUM
dpc-3378	68	96	75	75	NUM
dpc-3378	69	1	yes	yes	INTJ
dpc-3378	69	2	n1a	n1a	NOUN
dpc-3378	69	3	,	,	PUNCT
dpc-3378	69	4	n2a	n2a	PROPN
dpc-3378	69	5	,	,	PUNCT
dpc-3378	69	6	n3a	n3a	NOUN
dpc-3378	69	7	3c-3d	3c-3d	NOUN
dpc-3378	69	8	69	69	NUM
dpc-3378	69	9	-	-	SYM
dpc-3378	69	10	32	32	NUM
dpc-3378	69	11	60	60	NUM
dpc-3378	69	12	-	-	SYM
dpc-3378	69	13	24	24	NUM
dpc-3378	69	14	yes	yes	NOUN
dpc-3378	69	15	two	two	NUM
dpc-3378	69	16	different	different	ADJ
dpc-3378	69	17	scenarios	scenario	NOUN
dpc-3378	69	18	are	be	AUX
dpc-3378	69	19	provided	provide	VERB
dpc-3378	69	20	for	for	ADP
dpc-3378	69	21	each	each	DET
dpc-3378	69	22	pt	pt	NOUN
dpc-3378	69	23	subcategory	subcategory	NOUN
dpc-3378	69	24	.	.	PUNCT
dpc-3378	70	1	the	the	DET
dpc-3378	70	2	staging	staging	NOUN
dpc-3378	70	3	and	and	CCONJ
dpc-3378	70	4	the	the	DET
dpc-3378	70	5	workup	workup	NOUN
dpc-3378	70	6	in	in	ADP
dpc-3378	70	7	case	case	NOUN
dpc-3378	70	8	of	of	ADP
dpc-3378	70	9	a	a	DET
dpc-3378	70	10	negative	negative	ADJ
dpc-3378	70	11	snb	snb	PROPN
dpc-3378	70	12	result	result	NOUN
dpc-3378	70	13	are	be	AUX
dpc-3378	70	14	outlined	outline	VERB
dpc-3378	70	15	in	in	ADP
dpc-3378	70	16	light	light	ADJ
dpc-3378	70	17	green	green	NOUN
dpc-3378	70	18	,	,	PUNCT
dpc-3378	70	19	while	while	SCONJ
dpc-3378	70	20	those	those	PRON
dpc-3378	70	21	in	in	ADP
dpc-3378	70	22	case	case	NOUN
dpc-3378	70	23	of	of	ADP
dpc-3378	70	24	a	a	DET
dpc-3378	70	25	positive	positive	ADJ
dpc-3378	70	26	snb	snb	NOUN
dpc-3378	70	27	in	in	ADP
dpc-3378	70	28	light	light	ADJ
dpc-3378	70	29	red	red	PROPN
dpc-3378	70	30	.	.	PUNCT
dpc-3378	71	1	pt	pt	PROPN
dpc-3378	71	2	subcategories	subcategorie	NOUN
dpc-3378	71	3	in	in	ADP
dpc-3378	71	4	which	which	PRON
dpc-3378	71	5	performing	perform	VERB
dpc-3378	71	6	snb	snb	PROPN
dpc-3378	71	7	changes	change	VERB
dpc-3378	71	8	the	the	DET
dpc-3378	71	9	indication	indication	NOUN
dpc-3378	71	10	to	to	PART
dpc-3378	71	11	adjuvant	adjuvant	VERB
dpc-3378	71	12	therapy	therapy	NOUN
dpc-3378	71	13	are	be	AUX
dpc-3378	71	14	highlighted	highlight	VERB
dpc-3378	71	15	by	by	ADP
dpc-3378	71	16	a	a	DET
dpc-3378	71	17	yellow	yellow	ADJ
dpc-3378	71	18	square	square	NOUN
dpc-3378	71	19	.	.	PUNCT
dpc-3378	72	1	an3a	an3a	NOUN
dpc-3378	72	2	results	result	NOUN
dpc-3378	72	3	are	be	AUX
dpc-3378	72	4	deliberately	deliberately	ADV
dpc-3378	72	5	omitted	omit	VERB
dpc-3378	72	6	.	.	PUNCT
dpc-3378	73	1	the	the	DET
dpc-3378	73	2	probability	probability	NOUN
dpc-3378	73	3	to	to	PART
dpc-3378	73	4	find	find	VERB
dpc-3378	73	5	four	four	NUM
dpc-3378	73	6	or	or	CCONJ
dpc-3378	73	7	more	more	ADV
dpc-3378	73	8	metastatic	metastatic	ADJ
dpc-3378	73	9	nodes	node	NOUN
dpc-3378	73	10	(	(	PUNCT
dpc-3378	73	11	n3a	n3a	PROPN
dpc-3378	73	12	)	)	PUNCT
dpc-3378	73	13	through	through	ADP
dpc-3378	73	14	slnb	slnb	NOUN
dpc-3378	73	15	in	in	ADP
dpc-3378	73	16	pt1b	pt1b	ADJ
dpc-3378	73	17	and	and	CCONJ
dpc-3378	73	18	pt2a	pt2a	ADJ
dpc-3378	73	19	melanomas	melanoma	NOUN
dpc-3378	73	20	,	,	PUNCT
dpc-3378	73	21	which	which	PRON
dpc-3378	73	22	would	would	AUX
dpc-3378	73	23	be	be	AUX
dpc-3378	73	24	upgraded	upgrade	VERB
dpc-3378	73	25	to	to	ADP
dpc-3378	73	26	stage	stage	PROPN
dpc-3378	73	27	iiic	iiic	PROPN
dpc-3378	73	28	,	,	PUNCT
dpc-3378	73	29	can	can	AUX
dpc-3378	73	30	be	be	AUX
dpc-3378	73	31	considered	consider	VERB
dpc-3378	73	32	not	not	PART
dpc-3378	73	33	relevant	relevant	ADJ
dpc-3378	73	34	(	(	PUNCT
dpc-3378	73	35	0.1	0.1	NUM
dpc-3378	73	36	%	%	NOUN
dpc-3378	73	37	)	)	PUNCT
dpc-3378	73	38	.	.	PUNCT
dpc-3378	74	1	adapted	adapt	VERB
dpc-3378	74	2	from	from	ADP
dpc-3378	74	3	:	:	PUNCT
dpc-3378	74	4	gershenwald	gershenwald	PROPN
dpc-3378	74	5	je	je	PROPN
dpc-3378	74	6	,	,	PUNCT
dpc-3378	74	7	scolyer	scolyer	PROPN
dpc-3378	74	8	ra	ra	PROPN
dpc-3378	74	9	,	,	PUNCT
dpc-3378	74	10	hess	hess	PROPN
dpc-3378	74	11	kr	kr	PROPN
dpc-3378	74	12	,	,	PUNCT
dpc-3378	74	13	et	et	PROPN
dpc-3378	75	1	al	al	PROPN
dpc-3378	75	2	.	.	PUNCT
dpc-3378	75	3	melanoma	melanoma	PROPN
dpc-3378	75	4	staging	staging	NOUN
dpc-3378	75	5	:	:	PUNCT
dpc-3378	75	6	evidence	evidence	NOUN
dpc-3378	75	7	-	-	PUNCT
dpc-3378	75	8	based	base	VERB
dpc-3378	75	9	changes	change	NOUN
dpc-3378	75	10	in	in	ADP
dpc-3378	75	11	the	the	DET
dpc-3378	75	12	american	american	PROPN
dpc-3378	75	13	joint	joint	PROPN
dpc-3378	75	14	committee	committee	PROPN
dpc-3378	75	15	on	on	ADP
dpc-3378	75	16	cancer	cancer	NOUN
dpc-3378	75	17	eighth	eighth	PROPN
dpc-3378	75	18	edition	edition	NOUN
dpc-3378	75	19	cancer	cancer	NOUN
dpc-3378	75	20	staging	staging	NOUN
dpc-3378	75	21	manual	manual	NOUN
dpc-3378	75	22	.	.	PUNCT
dpc-3378	76	1	ca	can	AUX
dpc-3378	76	2	cancer	cancer	PROPN
dpc-3378	76	3	j	j	PROPN
dpc-3378	76	4	clin	clin	PROPN
dpc-3378	76	5	.	.	PROPN
dpc-3378	77	1	2017	2017	NUM
dpc-3378	77	2	;	;	PUNCT
dpc-3378	77	3	doi:10.3322	doi:10.3322	NOUN
dpc-3378	77	4	/	/	SYM
dpc-3378	77	5	caac.21409	caac.21409	PROPN
dpc-3378	77	6	.	.	NOUN
dpc-3378	77	7	4	4	NUM
dpc-3378	77	8	review	review	NOUN
dpc-3378	77	9	|	|	ADV
dpc-3378	77	10	dermatol	dermatol	ADJ
dpc-3378	77	11	pract	pract	NOUN
dpc-3378	77	12	concept	concept	NOUN
dpc-3378	77	13	.	.	PUNCT
dpc-3378	78	1	2024;14(1):e2024038	2024;14(1):e2024038	NUM
dpc-3378	78	2	mss	mss	PROPN
dpc-3378	78	3	.	.	PUNCT
dpc-3378	79	1	stage	stage	PROPN
dpc-3378	79	2	iia	iia	PROPN
dpc-3378	79	3	melanoma	melanoma	NOUN
dpc-3378	79	4	patients	patient	NOUN
dpc-3378	79	5	were	be	AUX
dpc-3378	79	6	not	not	PART
dpc-3378	79	7	included	include	VERB
dpc-3378	79	8	in	in	ADP
dpc-3378	79	9	adjuvant	adjuvant	ADJ
dpc-3378	79	10	therapy	therapy	NOUN
dpc-3378	79	11	registration	registration	NOUN
dpc-3378	79	12	trial	trial	NOUN
dpc-3378	79	13	due	due	ADP
dpc-3378	79	14	to	to	ADP
dpc-3378	79	15	their	their	PRON
dpc-3378	79	16	rather	rather	ADV
dpc-3378	79	17	favorable	favorable	ADJ
dpc-3378	79	18	prognosis	prognosis	NOUN
dpc-3378	79	19	.	.	PUNCT
dpc-3378	80	1	in	in	ADP
dpc-3378	80	2	contrast	contrast	NOUN
dpc-3378	80	3	,	,	PUNCT
dpc-3378	80	4	the	the	DET
dpc-3378	80	5	presence	presence	NOUN
dpc-3378	80	6	of	of	ADP
dpc-3378	80	7	a	a	DET
dpc-3378	80	8	metastatic	metastatic	ADJ
dpc-3378	80	9	node	node	NOUN
dpc-3378	80	10	detected	detect	VERB
dpc-3378	80	11	through	through	ADP
dpc-3378	80	12	slnb	slnb	ADJ
dpc-3378	80	13	upgrades	upgrade	NOUN
dpc-3378	80	14	pt2b	pt2b	PROPN
dpc-3378	80	15	and	and	CCONJ
dpc-3378	80	16	pt3a	pt3a	VERB
dpc-3378	80	17	melanoma	melanoma	NOUN
dpc-3378	80	18	patients	patient	NOUN
dpc-3378	80	19	to	to	PART
dpc-3378	80	20	stage	stage	VERB
dpc-3378	80	21	iiib	iiib	NOUN
dpc-3378	80	22	or	or	CCONJ
dpc-3378	80	23	iiic	iiic	PROPN
dpc-3378	80	24	according	accord	VERB
dpc-3378	80	25	to	to	ADP
dpc-3378	80	26	the	the	DET
dpc-3378	80	27	number	number	NOUN
dpc-3378	80	28	of	of	ADP
dpc-3378	80	29	nodes	node	NOUN
dpc-3378	80	30	involved	involve	VERB
dpc-3378	80	31	(	(	PUNCT
dpc-3378	80	32	table	table	NOUN
dpc-3378	80	33	3	3	NUM
dpc-3378	80	34	)	)	PUNCT
dpc-3378	80	35	.	.	PUNCT
dpc-3378	81	1	the	the	DET
dpc-3378	81	2	prognosis	prognosis	NOUN
dpc-3378	81	3	of	of	ADP
dpc-3378	81	4	stages	stage	NOUN
dpc-3378	81	5	iiib	iiib	NOUN
dpc-3378	81	6	and	and	CCONJ
dpc-3378	81	7	iiic	iiic	PROPN
dpc-3378	81	8	justifies	justify	VERB
dpc-3378	81	9	adjuvant	adjuvant	ADJ
dpc-3378	81	10	treatment	treatment	NOUN
dpc-3378	81	11	as	as	SCONJ
dpc-3378	81	12	5	5	NUM
dpc-3378	81	13	-	-	PUNCT
dpc-3378	81	14	year	year	NOUN
dpc-3378	81	15	mss	mss	NOUN
dpc-3378	81	16	ranges	range	VERB
dpc-3378	81	17	from	from	ADP
dpc-3378	81	18	83	83	NUM
dpc-3378	81	19	%	%	NOUN
dpc-3378	81	20	to	to	PART
dpc-3378	81	21	69	69	NUM
dpc-3378	81	22	%	%	NOUN
dpc-3378	81	23	and	and	CCONJ
dpc-3378	81	24	10	10	NUM
dpc-3378	81	25	-	-	PUNCT
dpc-3378	81	26	year	year	NOUN
dpc-3378	81	27	mss	mss	NOUN
dpc-3378	81	28	ranges	range	VERB
dpc-3378	81	29	from	from	ADP
dpc-3378	81	30	77	77	NUM
dpc-3378	81	31	%	%	NOUN
dpc-3378	81	32	to	to	PART
dpc-3378	81	33	60	60	NUM
dpc-3378	81	34	%	%	NOUN
dpc-3378	81	35	,	,	PUNCT
dpc-3378	81	36	respectively	respectively	ADV
dpc-3378	81	37	.	.	PUNCT
dpc-3378	82	1	thus	thus	ADV
dpc-3378	82	2	,	,	PUNCT
dpc-3378	82	3	performing	perform	VERB
dpc-3378	82	4	slnb	slnb	NOUN
dpc-3378	82	5	in	in	ADP
dpc-3378	82	6	this	this	DET
dpc-3378	82	7	group	group	NOUN
dpc-3378	82	8	of	of	ADP
dpc-3378	82	9	patients	patient	NOUN
dpc-3378	82	10	does	do	AUX
dpc-3378	82	11	actually	actually	ADV
dpc-3378	82	12	change	change	VERB
dpc-3378	82	13	the	the	DET
dpc-3378	82	14	management	management	NOUN
dpc-3378	82	15	by	by	ADP
dpc-3378	82	16	selecting	select	VERB
dpc-3378	82	17	those	those	DET
dpc-3378	82	18	patients	patient	NOUN
dpc-3378	82	19	who	who	PRON
dpc-3378	82	20	may	may	AUX
dpc-3378	82	21	benefit	benefit	VERB
dpc-3378	82	22	from	from	ADP
dpc-3378	82	23	adjuvant	adjuvant	ADJ
dpc-3378	82	24	therapy	therapy	NOUN
dpc-3378	82	25	.	.	PUNCT
dpc-3378	83	1	pt3b	pt3b	NOUN
dpc-3378	83	2	,	,	PUNCT
dpc-3378	83	3	pt4a	pt4a	NOUN
dpc-3378	83	4	and	and	CCONJ
dpc-3378	83	5	pt4b	pt4b	VERB
dpc-3378	83	6	melanomas	melanomas	NOUN
dpc-3378	83	7	patients	patient	NOUN
dpc-3378	83	8	with	with	ADP
dpc-3378	83	9	pt3b	pt3b	NOUN
dpc-3378	83	10	or	or	CCONJ
dpc-3378	83	11	pt4a	pt4a	NOUN
dpc-3378	83	12	n0	n0	NUM
dpc-3378	83	13	melanoma	melanoma	NOUN
dpc-3378	83	14	are	be	AUX
dpc-3378	83	15	included	include	VERB
dpc-3378	83	16	in	in	ADP
dpc-3378	83	17	stage	stage	NOUN
dpc-3378	83	18	iib	iib	NOUN
dpc-3378	83	19	,	,	PUNCT
dpc-3378	83	20	while	while	SCONJ
dpc-3378	83	21	those	those	PRON
dpc-3378	83	22	with	with	ADP
dpc-3378	83	23	pt4b	pt4b	NOUN
dpc-3378	83	24	n0	n0	ADJ
dpc-3378	83	25	melanoma	melanoma	NOUN
dpc-3378	83	26	in	in	ADP
dpc-3378	83	27	stage	stage	NOUN
dpc-3378	83	28	iic	iic	PROPN
dpc-3378	83	29	.	.	PUNCT
dpc-3378	84	1	5and	5and	NUM
dpc-3378	84	2	10	10	NUM
dpc-3378	84	3	-	-	PUNCT
dpc-3378	84	4	year	year	NOUN
dpc-3378	84	5	mss	mss	NOUN
dpc-3378	84	6	resulted	result	VERB
dpc-3378	84	7	to	to	PART
dpc-3378	84	8	be	be	AUX
dpc-3378	84	9	87	87	NUM
dpc-3378	84	10	%	%	NOUN
dpc-3378	84	11	and	and	CCONJ
dpc-3378	84	12	82	82	NUM
dpc-3378	84	13	%	%	NOUN
dpc-3378	84	14	for	for	ADP
dpc-3378	84	15	stage	stage	NOUN
dpc-3378	84	16	iib	iib	NOUN
dpc-3378	84	17	and	and	CCONJ
dpc-3378	84	18	82	82	NUM
dpc-3378	84	19	%	%	NOUN
dpc-3378	84	20	and	and	CCONJ
dpc-3378	84	21	75	75	NUM
dpc-3378	84	22	%	%	NOUN
dpc-3378	84	23	for	for	ADP
dpc-3378	84	24	stage	stage	NOUN
dpc-3378	84	25	iic	iic	PROPN
dpc-3378	84	26	.	.	PUNCT
dpc-3378	85	1	in	in	ADP
dpc-3378	85	2	case	case	NOUN
dpc-3378	85	3	of	of	ADP
dpc-3378	85	4	a	a	DET
dpc-3378	85	5	metastatic	metastatic	ADJ
dpc-3378	85	6	node	node	NOUN
dpc-3378	85	7	these	these	DET
dpc-3378	85	8	subsets	subset	NOUN
dpc-3378	85	9	of	of	ADP
dpc-3378	85	10	patients	patient	NOUN
dpc-3378	85	11	are	be	AUX
dpc-3378	85	12	upgraded	upgrade	VERB
dpc-3378	85	13	to	to	ADP
dpc-3378	85	14	stages	stage	NOUN
dpc-3378	85	15	iiiciiid	iiiciiid	VERB
dpc-3378	85	16	according	accord	VERB
dpc-3378	85	17	to	to	ADP
dpc-3378	85	18	the	the	DET
dpc-3378	85	19	number	number	NOUN
dpc-3378	85	20	of	of	ADP
dpc-3378	85	21	nodes	node	NOUN
dpc-3378	85	22	involved	involve	VERB
dpc-3378	85	23	.	.	PUNCT
dpc-3378	86	1	as	as	SCONJ
dpc-3378	86	2	mentioned	mention	VERB
dpc-3378	86	3	before	before	ADV
dpc-3378	86	4	,	,	PUNCT
dpc-3378	86	5	iib	iib	PROPN
dpc-3378	86	6	and	and	CCONJ
dpc-3378	86	7	iic	iic	PROPN
dpc-3378	86	8	melanoma	melanoma	PROPN
dpc-3378	86	9	patients	patient	NOUN
dpc-3378	86	10	are	be	AUX
dpc-3378	86	11	already	already	ADV
dpc-3378	86	12	candidates	candidate	NOUN
dpc-3378	86	13	for	for	ADP
dpc-3378	86	14	adjuvant	adjuvant	ADJ
dpc-3378	86	15	treatment	treatment	NOUN
dpc-3378	86	16	,	,	PUNCT
dpc-3378	86	17	therefore	therefore	ADV
dpc-3378	86	18	,	,	PUNCT
dpc-3378	86	19	slnb	slnb	VERB
dpc-3378	86	20	in	in	ADP
dpc-3378	86	21	patients	patient	NOUN
dpc-3378	86	22	with	with	ADP
dpc-3378	86	23	t3b	t3b	ADJ
dpc-3378	86	24	,	,	PUNCT
dpc-3378	86	25	t4a	t4a	ADJ
dpc-3378	86	26	,	,	PUNCT
dpc-3378	86	27	or	or	CCONJ
dpc-3378	86	28	t4b	t4b	PRON
dpc-3378	86	29	melanoma	melanoma	NOUN
dpc-3378	86	30	would	would	AUX
dpc-3378	86	31	not	not	PART
dpc-3378	86	32	change	change	VERB
dpc-3378	86	33	treatment	treatment	NOUN
dpc-3378	86	34	decisions	decision	NOUN
dpc-3378	86	35	and	and	CCONJ
dpc-3378	86	36	the	the	DET
dpc-3378	86	37	procedure	procedure	NOUN
dpc-3378	86	38	may	may	AUX
dpc-3378	86	39	be	be	AUX
dpc-3378	86	40	omitted	omit	VERB
dpc-3378	86	41	.	.	PUNCT
dpc-3378	87	1	conclusions	conclusion	NOUN
dpc-3378	87	2	slnb	slnb	VERB
dpc-3378	87	3	is	be	AUX
dpc-3378	87	4	a	a	DET
dpc-3378	87	5	surgical	surgical	ADJ
dpc-3378	87	6	staging	staging	NOUN
dpc-3378	87	7	procedure	procedure	NOUN
dpc-3378	87	8	aimed	aim	VERB
dpc-3378	87	9	at	at	ADP
dpc-3378	87	10	identifying	identify	VERB
dpc-3378	87	11	patient	patient	NOUN
dpc-3378	87	12	who	who	PRON
dpc-3378	87	13	may	may	AUX
dpc-3378	87	14	benefit	benefit	VERB
dpc-3378	87	15	from	from	ADP
dpc-3378	87	16	adjuvant	adjuvant	ADJ
dpc-3378	87	17	treatment	treatment	NOUN
dpc-3378	87	18	.	.	PUNCT
dpc-3378	88	1	since	since	SCONJ
dpc-3378	88	2	the	the	DET
dpc-3378	88	3	approval	approval	NOUN
dpc-3378	88	4	of	of	ADP
dpc-3378	88	5	adjuvant	adjuvant	ADJ
dpc-3378	88	6	therapy	therapy	NOUN
dpc-3378	88	7	in	in	ADP
dpc-3378	88	8	negative	negative	ADJ
dpc-3378	88	9	sln	sln	PROPN
dpc-3378	88	10	patients	patient	NOUN
dpc-3378	88	11	,	,	PUNCT
dpc-3378	88	12	namely	namely	ADV
dpc-3378	88	13	stages	stage	VERB
dpc-3378	88	14	iib	iib	PROPN
dpc-3378	88	15	and	and	CCONJ
dpc-3378	88	16	iic	iic	PROPN
dpc-3378	88	17	,	,	PUNCT
dpc-3378	88	18	its	its	PRON
dpc-3378	88	19	role	role	NOUN
dpc-3378	88	20	may	may	AUX
dpc-3378	88	21	be	be	AUX
dpc-3378	88	22	reappraised	reappraise	VERB
dpc-3378	88	23	.	.	PUNCT
dpc-3378	89	1	patients	patient	NOUN
dpc-3378	89	2	with	with	ADP
dpc-3378	89	3	pt3b	pt3b	NOUN
dpc-3378	89	4	,	,	PUNCT
dpc-3378	89	5	pt4a	pt4a	NOUN
dpc-3378	89	6	and	and	CCONJ
dpc-3378	89	7	pt4b	pt4b	VERB
dpc-3378	89	8	melanomas	melanomas	ADJ
dpc-3378	89	9	and	and	CCONJ
dpc-3378	89	10	negative	negative	ADJ
dpc-3378	89	11	slnb	slnb	NOUN
dpc-3378	89	12	(	(	PUNCT
dpc-3378	89	13	stages	stage	NOUN
dpc-3378	89	14	iib	iib	PROPN
dpc-3378	89	15	–	–	PUNCT
dpc-3378	89	16	iic	iic	PROPN
dpc-3378	89	17	)	)	PUNCT
dpc-3378	89	18	and	and	CCONJ
dpc-3378	89	19	those	those	PRON
dpc-3378	89	20	with	with	ADP
dpc-3378	89	21	positive	positive	ADJ
dpc-3378	89	22	slnb	slnb	NOUN
dpc-3378	89	23	(	(	PUNCT
dpc-3378	89	24	stages	stage	NOUN
dpc-3378	89	25	iiic	iiic	PROPN
dpc-3378	89	26	–	–	PUNCT
dpc-3378	89	27	iiid	iiid	NOUN
dpc-3378	89	28	)	)	PUNCT
dpc-3378	89	29	would	would	AUX
dpc-3378	89	30	all	all	PRON
dpc-3378	89	31	be	be	AUX
dpc-3378	89	32	candidates	candidate	NOUN
dpc-3378	89	33	for	for	ADP
dpc-3378	89	34	adjuvant	adjuvant	ADJ
dpc-3378	89	35	therapy	therapy	NOUN
dpc-3378	89	36	for	for	ADP
dpc-3378	89	37	a	a	DET
dpc-3378	89	38	duration	duration	NOUN
dpc-3378	89	39	of	of	ADP
dpc-3378	89	40	1	1	NUM
dpc-3378	89	41	year	year	NOUN
dpc-3378	89	42	.	.	PUNCT
dpc-3378	90	1	in	in	ADP
dpc-3378	90	2	these	these	DET
dpc-3378	90	3	patients	patient	NOUN
dpc-3378	90	4	slnb	slnb	VERB
dpc-3378	90	5	might	might	AUX
dpc-3378	90	6	be	be	AUX
dpc-3378	90	7	avoided	avoid	VERB
dpc-3378	90	8	since	since	SCONJ
dpc-3378	90	9	it	it	PRON
dpc-3378	90	10	does	do	AUX
dpc-3378	90	11	not	not	PART
dpc-3378	90	12	alter	alter	VERB
dpc-3378	90	13	the	the	DET
dpc-3378	90	14	therapeutic	therapeutic	ADJ
dpc-3378	90	15	management	management	NOUN
dpc-3378	90	16	.	.	PUNCT
dpc-3378	91	1	on	on	ADP
dpc-3378	91	2	the	the	DET
dpc-3378	91	3	other	other	ADJ
dpc-3378	91	4	side	side	NOUN
dpc-3378	91	5	of	of	ADP
dpc-3378	91	6	the	the	DET
dpc-3378	91	7	spectrum	spectrum	NOUN
dpc-3378	91	8	,	,	PUNCT
dpc-3378	91	9	pt1b	pt1b	ADJ
dpc-3378	91	10	and	and	CCONJ
dpc-3378	91	11	pt2a	pt2a	ADJ
dpc-3378	91	12	patients	patient	NOUN
dpc-3378	91	13	with	with	ADP
dpc-3378	91	14	negative	negative	ADJ
dpc-3378	91	15	slnb	slnb	NOUN
dpc-3378	91	16	(	(	PUNCT
dpc-3378	91	17	stages	stage	NOUN
dpc-3378	91	18	ia	ia	PROPN
dpc-3378	91	19	and	and	CCONJ
dpc-3378	91	20	ib	ib	VERB
dpc-3378	91	21	)	)	PUNCT
dpc-3378	91	22	and	and	CCONJ
dpc-3378	91	23	those	those	PRON
dpc-3378	91	24	with	with	ADP
dpc-3378	91	25	positive	positive	ADJ
dpc-3378	91	26	slnb	slnb	NOUN
dpc-3378	91	27	(	(	PUNCT
dpc-3378	91	28	stage	stage	NOUN
dpc-3378	91	29	iiia	iiia	NOUN
dpc-3378	91	30	)	)	PUNCT
dpc-3378	91	31	would	would	AUX
dpc-3378	91	32	all	all	PRON
dpc-3378	91	33	not	not	PART
dpc-3378	91	34	benefit	benefit	VERB
dpc-3378	91	35	from	from	ADP
dpc-3378	91	36	adjuvant	adjuvant	ADJ
dpc-3378	91	37	treatment	treatment	NOUN
dpc-3378	91	38	.	.	PUNCT
dpc-3378	92	1	therefore	therefore	ADV
dpc-3378	92	2	,	,	PUNCT
dpc-3378	92	3	slnb	slnb	NOUN
dpc-3378	92	4	might	might	AUX
dpc-3378	92	5	be	be	AUX
dpc-3378	92	6	avoided	avoid	VERB
dpc-3378	92	7	also	also	ADV
dpc-3378	92	8	in	in	ADP
dpc-3378	92	9	these	these	DET
dpc-3378	92	10	categories	category	NOUN
dpc-3378	92	11	of	of	ADP
dpc-3378	92	12	patients	patient	NOUN
dpc-3378	92	13	.	.	PUNCT
dpc-3378	93	1	patients	patient	NOUN
dpc-3378	93	2	with	with	ADP
dpc-3378	93	3	pt2b	pt2b	PROPN
dpc-3378	93	4	and	and	CCONJ
dpc-3378	93	5	pt3a	pt3a	VERB
dpc-3378	93	6	melanomas	melanomas	NOUN
dpc-3378	93	7	(	(	PUNCT
dpc-3378	93	8	clinical	clinical	ADJ
dpc-3378	93	9	stage	stage	NOUN
dpc-3378	93	10	iia	iia	PROPN
dpc-3378	93	11	)	)	PUNCT
dpc-3378	93	12	represent	represent	VERB
dpc-3378	93	13	the	the	DET
dpc-3378	93	14	only	only	ADJ
dpc-3378	93	15	two	two	NUM
dpc-3378	93	16	groups	group	NOUN
dpc-3378	93	17	whose	whose	DET
dpc-3378	93	18	management	management	NOUN
dpc-3378	93	19	would	would	AUX
dpc-3378	93	20	be	be	AUX
dpc-3378	93	21	significantly	significantly	ADV
dpc-3378	93	22	affected	affect	VERB
dpc-3378	93	23	by	by	ADP
dpc-3378	93	24	the	the	DET
dpc-3378	93	25	slnb	slnb	NOUN
dpc-3378	93	26	status	status	NOUN
dpc-3378	93	27	,	,	PUNCT
dpc-3378	93	28	being	be	AUX
dpc-3378	93	29	adjuvant	adjuvant	ADJ
dpc-3378	93	30	therapy	therapy	NOUN
dpc-3378	93	31	only	only	ADV
dpc-3378	93	32	indicated	indicate	VERB
dpc-3378	93	33	for	for	ADP
dpc-3378	93	34	sln	sln	PROPN
dpc-3378	93	35	positive	positive	ADJ
dpc-3378	93	36	patients	patient	NOUN
dpc-3378	93	37	.	.	PUNCT
dpc-3378	94	1	more	more	ADJ
dpc-3378	94	2	studies	study	NOUN
dpc-3378	94	3	are	be	AUX
dpc-3378	94	4	needed	need	VERB
dpc-3378	94	5	to	to	PART
dpc-3378	94	6	improve	improve	VERB
dpc-3378	94	7	evidence	evidence	NOUN
dpc-3378	94	8	around	around	ADP
dpc-3378	94	9	slnb	slnb	NOUN
dpc-3378	94	10	and	and	CCONJ
dpc-3378	94	11	its	its	PRON
dpc-3378	94	12	potential	potential	ADJ
dpc-3378	94	13	role	role	NOUN
dpc-3378	94	14	in	in	ADP
dpc-3378	94	15	only	only	ADV
dpc-3378	94	16	a	a	DET
dpc-3378	94	17	limited	limited	ADJ
dpc-3378	94	18	number	number	NOUN
dpc-3378	94	19	of	of	ADP
dpc-3378	94	20	patients	patient	NOUN
dpc-3378	94	21	.	.	PUNCT
dpc-3378	95	1	references	reference	NOUN
dpc-3378	95	2	1	1	NUM
dpc-3378	95	3	.	.	PUNCT
dpc-3378	95	4	morton	morton	PROPN
dpc-3378	95	5	d.	d.	PROPN
dpc-3378	95	6	overview	overview	NOUN
dpc-3378	95	7	and	and	CCONJ
dpc-3378	95	8	update	update	NOUN
dpc-3378	95	9	of	of	ADP
dpc-3378	95	10	the	the	DET
dpc-3378	95	11	phase	phase	NOUN
dpc-3378	95	12	iii	iii	NUM
dpc-3378	95	13	multicenter	multicenter	NOUN
dpc-3378	95	14	selective	selective	ADJ
dpc-3378	95	15	lymphadenectomy	lymphadenectomy	NOUN
dpc-3378	95	16	trials	trial	NOUN
dpc-3378	95	17	(	(	PUNCT
dpc-3378	95	18	mslt	mslt	NOUN
dpc-3378	95	19	-	-	PUNCT
dpc-3378	95	20	i	i	PROPN
dpc-3378	95	21	and	and	CCONJ
dpc-3378	95	22	mslt	mslt	PROPN
dpc-3378	95	23	-	-	PUNCT
dpc-3378	95	24	ii	ii	NOUN
dpc-3378	95	25	)	)	PUNCT
dpc-3378	95	26	in	in	ADP
dpc-3378	95	27	melanoma	melanoma	NOUN
dpc-3378	95	28	.	.	PUNCT
dpc-3378	96	1	impact	impact	NOUN
dpc-3378	96	2	(	(	PUNCT
dpc-3378	96	3	from	from	ADP
dpc-3378	96	4	83	83	NUM
dpc-3378	96	5	%	%	NOUN
dpc-3378	96	6	to	to	PART
dpc-3378	96	7	69	69	NUM
dpc-3378	96	8	%	%	NOUN
dpc-3378	96	9	and	and	CCONJ
dpc-3378	96	10	from	from	ADP
dpc-3378	96	11	77	77	NUM
dpc-3378	96	12	%	%	NOUN
dpc-3378	96	13	to	to	PART
dpc-3378	96	14	60	60	NUM
dpc-3378	96	15	%	%	NOUN
dpc-3378	96	16	5	5	NUM
dpc-3378	96	17	-	-	PUNCT
dpc-3378	96	18	year	year	NOUN
dpc-3378	96	19	and	and	CCONJ
dpc-3378	96	20	10	10	NUM
dpc-3378	96	21	-	-	PUNCT
dpc-3378	96	22	year	year	NOUN
dpc-3378	96	23	melanoma	melanoma	NOUN
dpc-3378	96	24	specific	specific	ADJ
dpc-3378	96	25	survival	survival	NOUN
dpc-3378	97	1	[	[	X
dpc-3378	97	2	mss	mss	X
dpc-3378	97	3	]	]	PUNCT
dpc-3378	97	4	respectively	respectively	ADV
dpc-3378	97	5	)	)	PUNCT
dpc-3378	97	6	,	,	PUNCT
dpc-3378	97	7	the	the	DET
dpc-3378	97	8	upgrade	upgrade	NOUN
dpc-3378	97	9	from	from	ADP
dpc-3378	97	10	stage	stage	NOUN
dpc-3378	97	11	iiib	iiib	NOUN
dpc-3378	97	12	to	to	PART
dpc-3378	97	13	stage	stage	NOUN
dpc-3378	97	14	iiic	iiic	PROPN
dpc-3378	97	15	does	do	AUX
dpc-3378	97	16	not	not	PART
dpc-3378	97	17	change	change	VERB
dpc-3378	97	18	the	the	DET
dpc-3378	97	19	therapeutic	therapeutic	ADJ
dpc-3378	97	20	management	management	NOUN
dpc-3378	97	21	of	of	ADP
dpc-3378	97	22	this	this	DET
dpc-3378	97	23	subgroup	subgroup	NOUN
dpc-3378	97	24	of	of	ADP
dpc-3378	97	25	patients	patient	NOUN
dpc-3378	97	26	,	,	PUNCT
dpc-3378	97	27	which	which	PRON
dpc-3378	97	28	would	would	AUX
dpc-3378	97	29	all	all	PRON
dpc-3378	97	30	be	be	AUX
dpc-3378	97	31	candidates	candidate	NOUN
dpc-3378	97	32	for	for	ADP
dpc-3378	97	33	adjuvant	adjuvant	ADJ
dpc-3378	97	34	therapy	therapy	NOUN
dpc-3378	97	35	[	[	X
dpc-3378	97	36	16,17	16,17	NUM
dpc-3378	97	37	]	]	PUNCT
dpc-3378	97	38	.	.	PUNCT
dpc-3378	98	1	pt1b	pt1b	ADJ
dpc-3378	98	2	and	and	CCONJ
dpc-3378	98	3	pt2a	pt2a	ADJ
dpc-3378	98	4	melanomas	melanomas	NOUN
dpc-3378	98	5	patients	patient	NOUN
dpc-3378	98	6	with	with	ADP
dpc-3378	98	7	pt1b	pt1b	ADJ
dpc-3378	98	8	melanoma	melanoma	NOUN
dpc-3378	98	9	and	and	CCONJ
dpc-3378	98	10	a	a	DET
dpc-3378	98	11	negative	negative	ADJ
dpc-3378	98	12	slnb	slnb	NOUN
dpc-3378	98	13	(	(	PUNCT
dpc-3378	98	14	n0	n0	NUM
dpc-3378	98	15	)	)	PUNCT
dpc-3378	98	16	are	be	AUX
dpc-3378	98	17	included	include	VERB
dpc-3378	98	18	in	in	ADP
dpc-3378	98	19	pathological	pathological	ADJ
dpc-3378	98	20	stage	stage	NOUN
dpc-3378	98	21	ia	ia	PROPN
dpc-3378	98	22	,	,	PUNCT
dpc-3378	98	23	which	which	PRON
dpc-3378	98	24	exhibit	exhibit	VERB
dpc-3378	98	25	an	an	DET
dpc-3378	98	26	excellent	excellent	ADJ
dpc-3378	98	27	5and	5and	NUM
dpc-3378	98	28	10	10	NUM
dpc-3378	98	29	-	-	PUNCT
dpc-3378	98	30	year	year	NOUN
dpc-3378	98	31	mss	mss	NOUN
dpc-3378	98	32	(	(	PUNCT
dpc-3378	98	33	99	99	NUM
dpc-3378	98	34	%	%	NOUN
dpc-3378	98	35	and	and	CCONJ
dpc-3378	98	36	96	96	NUM
dpc-3378	98	37	%	%	NOUN
dpc-3378	98	38	respectively	respectively	ADV
dpc-3378	98	39	)	)	PUNCT
dpc-3378	98	40	.	.	PUNCT
dpc-3378	99	1	similarly	similarly	ADV
dpc-3378	99	2	,	,	PUNCT
dpc-3378	99	3	patients	patient	NOUN
dpc-3378	99	4	with	with	ADP
dpc-3378	99	5	pt2a	pt2a	PROPN
dpc-3378	99	6	n0	n0	ADJ
dpc-3378	99	7	melanoma	melanoma	NOUN
dpc-3378	99	8	are	be	AUX
dpc-3378	99	9	characterized	characterize	VERB
dpc-3378	99	10	by	by	ADP
dpc-3378	99	11	an	an	DET
dpc-3378	99	12	excellent	excellent	ADJ
dpc-3378	99	13	survival	survival	NOUN
dpc-3378	99	14	(	(	PUNCT
dpc-3378	99	15	97	97	NUM
dpc-3378	99	16	%	%	NOUN
dpc-3378	99	17	and	and	CCONJ
dpc-3378	99	18	94	94	NUM
dpc-3378	99	19	%	%	NOUN
dpc-3378	99	20	5and	5and	NUM
dpc-3378	99	21	10	10	NUM
dpc-3378	99	22	-	-	PUNCT
dpc-3378	99	23	year	year	NOUN
dpc-3378	99	24	mss	mss	PROPN
dpc-3378	99	25	)	)	PUNCT
dpc-3378	100	1	[	[	X
dpc-3378	100	2	17	17	NUM
dpc-3378	100	3	]	]	PUNCT
dpc-3378	100	4	although	although	SCONJ
dpc-3378	100	5	are	be	AUX
dpc-3378	100	6	belonging	belong	VERB
dpc-3378	100	7	to	to	ADP
dpc-3378	100	8	stage	stage	NOUN
dpc-3378	100	9	ib	ib	NOUN
dpc-3378	100	10	.	.	PUNCT
dpc-3378	101	1	consequently	consequently	ADV
dpc-3378	101	2	,	,	PUNCT
dpc-3378	101	3	they	they	PRON
dpc-3378	101	4	do	do	AUX
dpc-3378	101	5	not	not	PART
dpc-3378	101	6	require	require	VERB
dpc-3378	101	7	adjuvant	adjuvant	ADJ
dpc-3378	101	8	therapy	therapy	NOUN
dpc-3378	101	9	.	.	PUNCT
dpc-3378	102	1	in	in	ADP
dpc-3378	102	2	the	the	DET
dpc-3378	102	3	literature	literature	NOUN
dpc-3378	102	4	the	the	DET
dpc-3378	102	5	probability	probability	NOUN
dpc-3378	102	6	of	of	ADP
dpc-3378	102	7	finding	find	VERB
dpc-3378	102	8	a	a	DET
dpc-3378	102	9	metastatic	metastatic	ADJ
dpc-3378	102	10	node	node	NOUN
dpc-3378	102	11	in	in	ADP
dpc-3378	102	12	pt1b	pt1b	ADJ
dpc-3378	102	13	and	and	CCONJ
dpc-3378	102	14	pt2a	pt2a	ADJ
dpc-3378	102	15	melanomas	melanoma	NOUN
dpc-3378	102	16	,	,	PUNCT
dpc-3378	102	17	meaning	mean	VERB
dpc-3378	102	18	n1a	n1a	NOUN
dpc-3378	102	19	subcategory	subcategory	ADJ
dpc-3378	102	20	,	,	PUNCT
dpc-3378	102	21	ranges	range	VERB
dpc-3378	102	22	from	from	ADP
dpc-3378	102	23	2.3	2.3	NUM
dpc-3378	102	24	%	%	NOUN
dpc-3378	102	25	and	and	CCONJ
dpc-3378	102	26	8.4	8.4	NUM
dpc-3378	102	27	%	%	NOUN
dpc-3378	102	28	to	to	PART
dpc-3378	102	29	7.5	7.5	NUM
dpc-3378	102	30	%	%	NOUN
dpc-3378	102	31	and	and	CCONJ
dpc-3378	102	32	14.6	14.6	NUM
dpc-3378	102	33	%	%	NOUN
dpc-3378	102	34	[	[	X
dpc-3378	102	35	18,19	18,19	NUM
dpc-3378	102	36	]	]	X
dpc-3378	102	37	,	,	PUNCT
dpc-3378	102	38	respectively	respectively	ADV
dpc-3378	102	39	.	.	PUNCT
dpc-3378	103	1	among	among	ADP
dpc-3378	103	2	those	those	PRON
dpc-3378	103	3	,	,	PUNCT
dpc-3378	103	4	the	the	DET
dpc-3378	103	5	overall	overall	ADJ
dpc-3378	103	6	incidence	incidence	NOUN
dpc-3378	103	7	of	of	ADP
dpc-3378	103	8	a	a	DET
dpc-3378	103	9	maximum	maximum	ADJ
dpc-3378	103	10	deposit	deposit	NOUN
dpc-3378	103	11	size	size	NOUN
dpc-3378	103	12	greater	great	ADJ
dpc-3378	103	13	than	than	ADP
dpc-3378	103	14	1.0	1.0	NUM
dpc-3378	103	15	mm	mm	NOUN
dpc-3378	103	16	is	be	AUX
dpc-3378	103	17	likewise	likewise	ADV
dpc-3378	103	18	slightly	slightly	ADV
dpc-3378	103	19	above	above	ADP
dpc-3378	103	20	3	3	NUM
dpc-3378	103	21	%	%	NOUN
dpc-3378	103	22	[	[	X
dpc-3378	103	23	18,19	18,19	NUM
dpc-3378	103	24	]	]	X
dpc-3378	103	25	.	.	PUNCT
dpc-3378	104	1	as	as	SCONJ
dpc-3378	104	2	shown	show	VERB
dpc-3378	104	3	in	in	ADP
dpc-3378	104	4	table	table	NOUN
dpc-3378	104	5	1	1	NUM
dpc-3378	104	6	,	,	PUNCT
dpc-3378	104	7	pt1b	pt1b	NOUN
dpc-3378	104	8	-	-	PUNCT
dpc-3378	104	9	n1a	n1a	NOUN
dpc-3378	104	10	,	,	PUNCT
dpc-3378	104	11	pt2a	pt2a	PROPN
dpc-3378	104	12	-	-	PUNCT
dpc-3378	104	13	n1a	n1a	NOUN
dpc-3378	104	14	,	,	PUNCT
dpc-3378	104	15	pt1b	pt1b	PROPN
dpc-3378	104	16	-	-	PUNCT
dpc-3378	104	17	n2a	n2a	ADJ
dpc-3378	104	18	and	and	CCONJ
dpc-3378	104	19	pt2b	pt2b	PROPN
dpc-3378	104	20	-	-	PUNCT
dpc-3378	104	21	n2a	n2a	ADJ
dpc-3378	104	22	melanomas	melanoma	NOUN
dpc-3378	104	23	are	be	AUX
dpc-3378	104	24	included	include	VERB
dpc-3378	104	25	in	in	ADP
dpc-3378	104	26	stage	stage	NOUN
dpc-3378	104	27	iiia	iiia	NOUN
dpc-3378	104	28	.	.	PUNCT
dpc-3378	105	1	the	the	DET
dpc-3378	105	2	probability	probability	NOUN
dpc-3378	105	3	to	to	PART
dpc-3378	105	4	find	find	VERB
dpc-3378	105	5	four	four	NUM
dpc-3378	105	6	or	or	CCONJ
dpc-3378	105	7	more	more	ADV
dpc-3378	105	8	metastatic	metastatic	ADJ
dpc-3378	105	9	nodes	node	NOUN
dpc-3378	105	10	(	(	PUNCT
dpc-3378	105	11	n3a	n3a	PROPN
dpc-3378	105	12	)	)	PUNCT
dpc-3378	105	13	through	through	ADP
dpc-3378	105	14	slnb	slnb	NOUN
dpc-3378	105	15	in	in	ADP
dpc-3378	105	16	pt1b	pt1b	ADJ
dpc-3378	105	17	and	and	CCONJ
dpc-3378	105	18	pt2a	pt2a	ADJ
dpc-3378	105	19	melanomas	melanoma	NOUN
dpc-3378	105	20	,	,	PUNCT
dpc-3378	105	21	which	which	PRON
dpc-3378	105	22	would	would	AUX
dpc-3378	105	23	be	be	AUX
dpc-3378	105	24	upgraded	upgrade	VERB
dpc-3378	105	25	to	to	ADP
dpc-3378	105	26	stage	stage	PROPN
dpc-3378	105	27	iiic	iiic	PROPN
dpc-3378	105	28	,	,	PUNCT
dpc-3378	105	29	can	can	AUX
dpc-3378	105	30	be	be	AUX
dpc-3378	105	31	considered	consider	VERB
dpc-3378	105	32	not	not	PART
dpc-3378	105	33	relevant	relevant	ADJ
dpc-3378	105	34	(	(	PUNCT
dpc-3378	105	35	0.1	0.1	NUM
dpc-3378	105	36	%	%	NOUN
dpc-3378	105	37	)	)	PUNCT
dpc-3378	106	1	[	[	X
dpc-3378	106	2	17,19	17,19	NUM
dpc-3378	106	3	]	]	PUNCT
dpc-3378	106	4	.	.	PUNCT
dpc-3378	107	1	stage	stage	NOUN
dpc-3378	107	2	iiia	iiia	NOUN
dpc-3378	107	3	carries	carry	VERB
dpc-3378	107	4	a	a	DET
dpc-3378	107	5	better	well	ADJ
dpc-3378	107	6	prognosis	prognosis	NOUN
dpc-3378	107	7	of	of	ADP
dpc-3378	107	8	stage	stage	NOUN
dpc-3378	107	9	iib	iib	PROPN
dpc-3378	107	10	and	and	CCONJ
dpc-3378	107	11	iic	iic	PROPN
dpc-3378	107	12	(	(	PUNCT
dpc-3378	107	13	5	5	NUM
dpc-3378	107	14	-	-	PUNCT
dpc-3378	107	15	year	year	NOUN
dpc-3378	107	16	mss	mss	NOUN
dpc-3378	107	17	:	:	PUNCT
dpc-3378	107	18	93	93	NUM
dpc-3378	107	19	%	%	NOUN
dpc-3378	107	20	versus	versus	ADP
dpc-3378	107	21	87	87	NUM
dpc-3378	107	22	%	%	NOUN
dpc-3378	107	23	and	and	CCONJ
dpc-3378	107	24	82	82	NUM
dpc-3378	107	25	%	%	NOUN
dpc-3378	107	26	;	;	PUNCT
dpc-3378	107	27	10	10	NUM
dpc-3378	107	28	-	-	PUNCT
dpc-3378	107	29	year	year	NOUN
dpc-3378	107	30	mss	mss	NOUN
dpc-3378	107	31	:	:	PUNCT
dpc-3378	107	32	88	88	NUM
dpc-3378	107	33	%	%	NOUN
dpc-3378	107	34	versus	versus	ADP
dpc-3378	107	35	82	82	NUM
dpc-3378	107	36	%	%	NOUN
dpc-3378	107	37	and	and	CCONJ
dpc-3378	107	38	75	75	NUM
dpc-3378	107	39	%	%	NOUN
dpc-3378	107	40	)	)	PUNCT
dpc-3378	107	41	,	,	PUNCT
dpc-3378	107	42	thus	thus	ADV
dpc-3378	107	43	it	it	PRON
dpc-3378	107	44	remains	remain	VERB
dpc-3378	107	45	highly	highly	ADV
dpc-3378	107	46	questionable	questionable	ADJ
dpc-3378	107	47	whether	whether	SCONJ
dpc-3378	107	48	adjuvant	adjuvant	ADJ
dpc-3378	107	49	treatment	treatment	NOUN
dpc-3378	107	50	is	be	AUX
dpc-3378	107	51	needed	need	VERB
dpc-3378	107	52	in	in	ADP
dpc-3378	107	53	this	this	DET
dpc-3378	107	54	stage	stage	NOUN
dpc-3378	107	55	[	[	X
dpc-3378	107	56	20,21	20,21	NUM
dpc-3378	107	57	]	]	PUNCT
dpc-3378	107	58	.	.	PUNCT
dpc-3378	108	1	recent	recent	ADJ
dpc-3378	108	2	updates	update	NOUN
dpc-3378	108	3	on	on	ADP
dpc-3378	108	4	adjuvant	adjuvant	ADJ
dpc-3378	108	5	therapy	therapy	NOUN
dpc-3378	108	6	survival	survival	NOUN
dpc-3378	108	7	rates	rate	NOUN
dpc-3378	108	8	highlighted	highlight	VERB
dpc-3378	108	9	that	that	SCONJ
dpc-3378	108	10	the	the	DET
dpc-3378	108	11	benefit	benefit	NOUN
dpc-3378	108	12	in	in	ADP
dpc-3378	108	13	stage	stage	NOUN
dpc-3378	108	14	iiia	iiia	ADP
dpc-3378	108	15	patients	patient	NOUN
dpc-3378	108	16	was	be	AUX
dpc-3378	108	17	lower	low	ADJ
dpc-3378	108	18	than	than	ADP
dpc-3378	108	19	other	other	ADJ
dpc-3378	108	20	stage	stage	NOUN
dpc-3378	108	21	iii	iii	NUM
dpc-3378	108	22	subgroups	subgroup	NOUN
dpc-3378	108	23	[	[	X
dpc-3378	108	24	22	22	NUM
dpc-3378	108	25	]	]	PUNCT
dpc-3378	108	26	.	.	PUNCT
dpc-3378	109	1	consequently	consequently	ADV
dpc-3378	109	2	,	,	PUNCT
dpc-3378	109	3	the	the	DET
dpc-3378	109	4	esmo	esmo	NOUN
dpc-3378	109	5	consensus	consensus	NOUN
dpc-3378	109	6	on	on	ADP
dpc-3378	109	7	melanoma	melanoma	NOUN
dpc-3378	109	8	management	management	NOUN
dpc-3378	109	9	underlined	underline	VERB
dpc-3378	109	10	that	that	SCONJ
dpc-3378	109	11	there	there	PRON
dpc-3378	109	12	is	be	VERB
dpc-3378	109	13	currently	currently	ADV
dpc-3378	109	14	insufficient	insufficient	ADJ
dpc-3378	109	15	evidence	evidence	NOUN
dpc-3378	109	16	to	to	PART
dpc-3378	109	17	support	support	VERB
dpc-3378	109	18	the	the	DET
dpc-3378	109	19	routine	routine	ADJ
dpc-3378	109	20	use	use	NOUN
dpc-3378	109	21	of	of	ADP
dpc-3378	109	22	adjuvant	adjuvant	ADJ
dpc-3378	109	23	therapy	therapy	NOUN
dpc-3378	109	24	in	in	ADP
dpc-3378	109	25	stage	stage	NOUN
dpc-3378	109	26	iiia	iiia	ADP
dpc-3378	109	27	melanoma	melanoma	NOUN
dpc-3378	109	28	 	 	SPACE
dpc-3378	110	1	[	[	X
dpc-3378	110	2	23	23	NUM
dpc-3378	110	3	]	]	PUNCT
dpc-3378	110	4	.	.	PUNCT
dpc-3378	111	1	nccn	nccn	PROPN
dpc-3378	111	2	guidelines	guideline	NOUN
dpc-3378	111	3	states	state	VERB
dpc-3378	111	4	that	that	SCONJ
dpc-3378	111	5	in	in	ADP
dpc-3378	111	6	patients	patient	NOUN
dpc-3378	111	7	with	with	ADP
dpc-3378	111	8	a	a	DET
dpc-3378	111	9	low	low	ADJ
dpc-3378	111	10	risk	risk	NOUN
dpc-3378	111	11	of	of	ADP
dpc-3378	111	12	recurrence	recurrence	NOUN
dpc-3378	111	13	(	(	PUNCT
dpc-3378	111	14	for	for	ADP
dpc-3378	111	15	example	example	NOUN
dpc-3378	111	16	,	,	PUNCT
dpc-3378	111	17	stage	stage	VERB
dpc-3378	111	18	iiia	iiia	NOUN
dpc-3378	111	19	with	with	ADP
dpc-3378	111	20	<	<	X
dpc-3378	111	21	1	1	NUM
dpc-3378	111	22	 	 	SPACE
dpc-3378	111	23	mm	mm	NOUN
dpc-3378	111	24	of	of	ADP
dpc-3378	111	25	nodal	nodal	ADJ
dpc-3378	111	26	tumor	tumor	NOUN
dpc-3378	111	27	burden	burden	NOUN
dpc-3378	111	28	)	)	PUNCT
dpc-3378	111	29	,	,	PUNCT
dpc-3378	111	30	the	the	DET
dpc-3378	111	31	toxicity	toxicity	NOUN
dpc-3378	111	32	of	of	ADP
dpc-3378	111	33	adjuvant	adjuvant	ADJ
dpc-3378	111	34	therapy	therapy	NOUN
dpc-3378	111	35	may	may	AUX
dpc-3378	111	36	outweigh	outweigh	VERB
dpc-3378	111	37	the	the	DET
dpc-3378	111	38	benefit	benefit	NOUN
dpc-3378	111	39	and	and	CCONJ
dpc-3378	111	40	observation	observation	NOUN
dpc-3378	111	41	is	be	AUX
dpc-3378	111	42	preferred	prefer	VERB
dpc-3378	111	43	.	.	PUNCT
dpc-3378	112	1	although	although	SCONJ
dpc-3378	112	2	adjuvant	adjuvant	ADJ
dpc-3378	112	3	systemic	systemic	ADJ
dpc-3378	112	4	therapy	therapy	NOUN
dpc-3378	112	5	is	be	AUX
dpc-3378	112	6	approved	approve	VERB
dpc-3378	112	7	for	for	ADP
dpc-3378	112	8	these	these	DET
dpc-3378	112	9	patients	patient	NOUN
dpc-3378	112	10	,	,	PUNCT
dpc-3378	112	11	they	they	PRON
dpc-3378	112	12	were	be	AUX
dpc-3378	112	13	excluded	exclude	VERB
dpc-3378	112	14	from	from	ADP
dpc-3378	112	15	the	the	DET
dpc-3378	112	16	prospective	prospective	ADJ
dpc-3378	112	17	adjuvant	adjuvant	NOUN
dpc-3378	112	18	therapy	therapy	NOUN
dpc-3378	112	19	trials	trial	NOUN
dpc-3378	112	20	[	[	X
dpc-3378	112	21	5	5	NUM
dpc-3378	112	22	]	]	PUNCT
dpc-3378	112	23	.	.	PUNCT
dpc-3378	113	1	in	in	ADP
dpc-3378	113	2	this	this	DET
dpc-3378	113	3	light	light	NOUN
dpc-3378	113	4	,	,	PUNCT
dpc-3378	113	5	weighing	weigh	VERB
dpc-3378	113	6	the	the	DET
dpc-3378	113	7	very	very	ADV
dpc-3378	113	8	low	low	ADJ
dpc-3378	113	9	frequency	frequency	NOUN
dpc-3378	113	10	of	of	ADP
dpc-3378	113	11	a	a	DET
dpc-3378	113	12	positive	positive	ADJ
dpc-3378	113	13	sln	sln	NOUN
dpc-3378	113	14	(	(	PUNCT
dpc-3378	113	15	especially	especially	ADV
dpc-3378	113	16	greater	great	ADJ
dpc-3378	113	17	than	than	ADP
dpc-3378	113	18	1	1	NUM
dpc-3378	113	19	mm	mm	NOUN
dpc-3378	113	20	)	)	PUNCT
dpc-3378	113	21	,	,	PUNCT
dpc-3378	113	22	the	the	DET
dpc-3378	113	23	morbidity	morbidity	NOUN
dpc-3378	113	24	and	and	CCONJ
dpc-3378	113	25	costs	cost	NOUN
dpc-3378	113	26	of	of	ADP
dpc-3378	113	27	the	the	DET
dpc-3378	113	28	surgical	surgical	ADJ
dpc-3378	113	29	procedure	procedure	NOUN
dpc-3378	113	30	and	and	CCONJ
dpc-3378	113	31	the	the	DET
dpc-3378	113	32	benefit	benefit	NOUN
dpc-3378	113	33	–	–	PUNCT
dpc-3378	113	34	risk	risk	NOUN
dpc-3378	113	35	ratio	ratio	NOUN
dpc-3378	113	36	of	of	ADP
dpc-3378	113	37	adjuvant	adjuvant	ADJ
dpc-3378	113	38	therapy	therapy	NOUN
dpc-3378	113	39	,	,	PUNCT
dpc-3378	113	40	the	the	DET
dpc-3378	113	41	indication	indication	NOUN
dpc-3378	113	42	to	to	ADP
dpc-3378	113	43	performing	perform	VERB
dpc-3378	113	44	slnb	slnb	NOUN
dpc-3378	113	45	in	in	ADP
dpc-3378	113	46	pt1b	pt1b	ADJ
dpc-3378	113	47	and	and	CCONJ
dpc-3378	113	48	pt2a	pt2a	ADJ
dpc-3378	113	49	melanomas	melanomas	NOUN
dpc-3378	113	50	can	can	AUX
dpc-3378	113	51	be	be	AUX
dpc-3378	113	52	questioned	question	VERB
dpc-3378	113	53	.	.	PUNCT
dpc-3378	114	1	pt2b	pt2b	ADJ
dpc-3378	114	2	and	and	CCONJ
dpc-3378	114	3	pt3a	pt3a	VERB
dpc-3378	114	4	melanomas	melanomas	NOUN
dpc-3378	114	5	patients	patient	NOUN
dpc-3378	114	6	with	with	ADP
dpc-3378	114	7	pt2b	pt2b	PROPN
dpc-3378	114	8	or	or	CCONJ
dpc-3378	114	9	pt3a	pt3a	PROPN
dpc-3378	114	10	n0	n0	NUM
dpc-3378	114	11	melanoma	melanoma	NOUN
dpc-3378	114	12	are	be	AUX
dpc-3378	114	13	included	include	VERB
dpc-3378	114	14	in	in	ADP
dpc-3378	114	15	stage	stage	NOUN
dpc-3378	114	16	iia	iia	NOUN
dpc-3378	114	17	,	,	PUNCT
dpc-3378	114	18	characterized	characterize	VERB
dpc-3378	114	19	by	by	ADP
dpc-3378	114	20	94	94	NUM
dpc-3378	114	21	%	%	NOUN
dpc-3378	114	22	and	and	CCONJ
dpc-3378	114	23	88	88	NUM
dpc-3378	114	24	%	%	NOUN
dpc-3378	114	25	5and	5and	NUM
dpc-3378	114	26	10year	10year	NUM
dpc-3378	114	27	review	review	NOUN
dpc-3378	114	28	|	|	ADV
dpc-3378	114	29	dermatol	dermatol	ADJ
dpc-3378	114	30	pract	pract	NOUN
dpc-3378	114	31	concept	concept	NOUN
dpc-3378	114	32	.	.	PUNCT
dpc-3378	115	1	2024;14(1):e2024038	2024;14(1):e2024038	NUM
dpc-3378	115	2	5	5	NUM
dpc-3378	115	3	13	13	NUM
dpc-3378	115	4	.	.	PUNCT
dpc-3378	116	1	long	long	ADV
dpc-3378	116	2	g	g	PROPN
dpc-3378	116	3	v	v	NOUN
dpc-3378	116	4	,	,	PUNCT
dpc-3378	116	5	luke	luke	PROPN
dpc-3378	116	6	jj	jj	PROPN
dpc-3378	116	7	,	,	PUNCT
dpc-3378	116	8	khattak	khattak	PROPN
dpc-3378	116	9	ma	ma	PROPN
dpc-3378	116	10	,	,	PUNCT
dpc-3378	116	11	et	et	PROPN
dpc-3378	116	12	al	al	PROPN
dpc-3378	116	13	.	.	PROPN
dpc-3378	116	14	pembrolizumab	pembrolizumab	NOUN
dpc-3378	116	15	versus	versus	ADP
dpc-3378	116	16	placebo	placebo	NOUN
dpc-3378	116	17	as	as	ADP
dpc-3378	116	18	adjuvant	adjuvant	ADJ
dpc-3378	116	19	therapy	therapy	NOUN
dpc-3378	116	20	in	in	ADP
dpc-3378	116	21	resected	resect	VERB
dpc-3378	116	22	stage	stage	NOUN
dpc-3378	116	23	iib	iib	NOUN
dpc-3378	116	24	or	or	CCONJ
dpc-3378	116	25	iic	iic	PROPN
dpc-3378	116	26	melanoma	melanoma	PROPN
dpc-3378	116	27	(	(	PUNCT
dpc-3378	116	28	keynote-716	keynote-716	NOUN
dpc-3378	116	29	):	):	PUNCT
dpc-3378	116	30	distant	distant	ADJ
dpc-3378	116	31	metastasis	metastasis	NOUN
dpc-3378	116	32	-	-	PUNCT
dpc-3378	116	33	free	free	ADJ
dpc-3378	116	34	survival	survival	NOUN
dpc-3378	116	35	results	result	NOUN
dpc-3378	116	36	of	of	ADP
dpc-3378	116	37	a	a	DET
dpc-3378	116	38	multicentre	multicentre	NOUN
dpc-3378	116	39	,	,	PUNCT
dpc-3378	116	40	double	double	ADJ
dpc-3378	116	41	-	-	PUNCT
dpc-3378	116	42	blind	blind	ADJ
dpc-3378	116	43	,	,	PUNCT
dpc-3378	116	44	randomised	randomise	VERB
dpc-3378	116	45	,	,	PUNCT
dpc-3378	116	46	phase	phase	NOUN
dpc-3378	116	47	3	3	NUM
dpc-3378	116	48	trial	trial	NOUN
dpc-3378	116	49	.	.	PUNCT
dpc-3378	117	1	lancet	lancet	PROPN
dpc-3378	117	2	oncol	oncol	PROPN
dpc-3378	117	3	.	.	PUNCT
dpc-3378	118	1	2022;23(11):1378–1388	2022;23(11):1378–1388	NUM
dpc-3378	118	2	.	.	PUNCT
dpc-3378	119	1	doi	doi	NOUN
dpc-3378	119	2	:	:	PUNCT
dpc-3378	119	3	10.1016	10.1016	NUM
dpc-3378	119	4	/	/	SYM
dpc-3378	119	5	s1470	s1470	PROPN
dpc-3378	119	6	-2045(22)00559	-2045(22)00559	PROPN
dpc-3378	119	7	-	-	PUNCT
dpc-3378	119	8	9	9	NUM
dpc-3378	119	9	.	.	PUNCT
dpc-3378	120	1	pmid	pmid	NOUN
dpc-3378	120	2	:	:	PUNCT
dpc-3378	120	3	36265502	36265502	NUM
dpc-3378	120	4	.	.	PUNCT
dpc-3378	121	1	14	14	NUM
dpc-3378	121	2	.	.	PUNCT
dpc-3378	121	3	wilson	wilson	PROPN
dpc-3378	121	4	m	m	PROPN
dpc-3378	121	5	,	,	PUNCT
dpc-3378	121	6	geskin	geskin	PROPN
dpc-3378	121	7	lj	lj	PROPN
dpc-3378	121	8	,	,	PUNCT
dpc-3378	121	9	carvajal	carvajal	PROPN
dpc-3378	121	10	rd	rd	PROPN
dpc-3378	121	11	,	,	PUNCT
dpc-3378	121	12	et	et	PROPN
dpc-3378	121	13	al	al	PROPN
dpc-3378	121	14	.	.	PROPN
dpc-3378	122	1	adjuvant	adjuvant	PROPN
dpc-3378	122	2	nivolumab	nivolumab	NOUN
dpc-3378	122	3	in	in	ADP
dpc-3378	122	4	high	high	ADJ
dpc-3378	122	5	-	-	PUNCT
dpc-3378	122	6	risk	risk	NOUN
dpc-3378	122	7	stage	stage	NOUN
dpc-3378	122	8	iib	iib	PROPN
dpc-3378	122	9	/	/	SYM
dpc-3378	122	10	iic	iic	PROPN
dpc-3378	122	11	melanoma	melanoma	PROPN
dpc-3378	122	12	patients	patient	NOUN
dpc-3378	122	13	:	:	PUNCT
dpc-3378	122	14	results	result	NOUN
dpc-3378	122	15	from	from	ADP
dpc-3378	122	16	investigator	investigator	NOUN
dpc-3378	122	17	initiated	initiate	VERB
dpc-3378	122	18	clinical	clinical	ADJ
dpc-3378	122	19	trial	trial	NOUN
dpc-3378	122	20	.	.	PUNCT
dpc-3378	123	1	j	j	PROPN
dpc-3378	123	2	clin	clin	PROPN
dpc-3378	123	3	oncol	oncol	PROPN
dpc-3378	123	4	.	.	PUNCT
dpc-3378	124	1	2021;suppl.9583	2021;suppl.9583	NOUN
dpc-3378	124	2	.	.	PUNCT
dpc-3378	125	1	doi	doi	NOUN
dpc-3378	125	2	:	:	PUNCT
dpc-3378	125	3	10.1200	10.1200	NUM
dpc-3378	125	4	/	/	SYM
dpc-3378	125	5	jco.2021.39.15	jco.2021.39.15	SYM
dpc-3378	125	6	_	_	NOUN
dpc-3378	125	7	15	15	NUM
dpc-3378	125	8	.	.	PUNCT
dpc-3378	126	1	hindié	hindié	PROPN
dpc-3378	126	2	e.	e.	PROPN
dpc-3378	126	3	adjuvant	adjuvant	PROPN
dpc-3378	126	4	therapy	therapy	PROPN
dpc-3378	126	5	in	in	ADP
dpc-3378	126	6	stage	stage	NOUN
dpc-3378	126	7	iib	iib	PROPN
dpc-3378	126	8	and	and	CCONJ
dpc-3378	126	9	iic	iic	PROPN
dpc-3378	126	10	melanoma	melanoma	PROPN
dpc-3378	126	11	:	:	PUNCT
dpc-3378	126	12	is	be	AUX
dpc-3378	126	13	sentinel	sentinel	ADJ
dpc-3378	126	14	biopsy	biopsy	NOUN
dpc-3378	126	15	needed	need	VERB
dpc-3378	126	16	?	?	PUNCT
dpc-3378	127	1	lancet	lancet	PROPN
dpc-3378	127	2	.	.	PUNCT
dpc-3378	128	1	2022;400(10352):559	2022;400(10352):559	NUM
dpc-3378	128	2	.	.	PUNCT
dpc-3378	129	1	doi	doi	NOUN
dpc-3378	129	2	:	:	PUNCT
dpc-3378	129	3	10.1016	10.1016	NUM
dpc-3378	129	4	/	/	SYM
dpc-3378	129	5	s0140	s0140	PROPN
dpc-3378	129	6	-	-	PUNCT
dpc-3378	129	7	6736(22)01388	6736(22)01388	NUM
dpc-3378	129	8	-	-	PUNCT
dpc-3378	129	9	5	5	NUM
dpc-3378	129	10	.	.	PUNCT
dpc-3378	130	1	pmid	pmid	NOUN
dpc-3378	130	2	:	:	PUNCT
dpc-3378	130	3	35988562	35988562	NUM
dpc-3378	130	4	.	.	PUNCT
dpc-3378	131	1	16	16	NUM
dpc-3378	131	2	.	.	PUNCT
dpc-3378	132	1	amin	amin	PROPN
dpc-3378	132	2	mb	mb	PROPN
dpc-3378	132	3	,	,	PUNCT
dpc-3378	132	4	edge	edge	PROPN
dpc-3378	132	5	sb	sb	PROPN
dpc-3378	132	6	,	,	PUNCT
dpc-3378	132	7	greene	greene	PROPN
dpc-3378	132	8	fl	fl	PROPN
dpc-3378	132	9	,	,	PUNCT
dpc-3378	132	10	et	et	PROPN
dpc-3378	132	11	al	al	PROPN
dpc-3378	132	12	.	.	PROPN
dpc-3378	133	1	american	american	PROPN
dpc-3378	133	2	joint	joint	PROPN
dpc-3378	133	3	committee	committee	PROPN
dpc-3378	133	4	on	on	ADP
dpc-3378	133	5	cancer	cancer	NOUN
dpc-3378	133	6	(	(	PUNCT
dpc-3378	133	7	ajcc	ajcc	PROPN
dpc-3378	133	8	)	)	PUNCT
dpc-3378	133	9	.	.	PUNCT
dpc-3378	134	1	ajcc	ajcc	PROPN
dpc-3378	134	2	cancer	cancer	NOUN
dpc-3378	134	3	staging	staging	NOUN
dpc-3378	134	4	manual	manual	NOUN
dpc-3378	134	5	.	.	PUNCT
dpc-3378	135	1	2017	2017	NUM
dpc-3378	135	2	.	.	PUNCT
dpc-3378	136	1	17	17	NUM
dpc-3378	136	2	.	.	PUNCT
dpc-3378	137	1	gershenwald	gershenwald	PROPN
dpc-3378	137	2	je	je	PROPN
dpc-3378	137	3	,	,	PUNCT
dpc-3378	137	4	scolyer	scolyer	PROPN
dpc-3378	137	5	ra	ra	PROPN
dpc-3378	137	6	,	,	PUNCT
dpc-3378	137	7	hess	hess	PROPN
dpc-3378	137	8	kr	kr	PROPN
dpc-3378	137	9	,	,	PUNCT
dpc-3378	137	10	et	et	PROPN
dpc-3378	137	11	al	al	PROPN
dpc-3378	137	12	.	.	PUNCT
dpc-3378	137	13	melanoma	melanoma	PROPN
dpc-3378	137	14	staging	staging	NOUN
dpc-3378	137	15	:	:	PUNCT
dpc-3378	137	16	evidence	evidence	NOUN
dpc-3378	137	17	-	-	PUNCT
dpc-3378	137	18	based	base	VERB
dpc-3378	137	19	changes	change	NOUN
dpc-3378	137	20	in	in	ADP
dpc-3378	137	21	the	the	DET
dpc-3378	137	22	american	american	PROPN
dpc-3378	137	23	joint	joint	PROPN
dpc-3378	137	24	committee	committee	PROPN
dpc-3378	137	25	on	on	ADP
dpc-3378	137	26	cancer	cancer	NOUN
dpc-3378	137	27	eighth	eighth	PROPN
dpc-3378	137	28	edition	edition	NOUN
dpc-3378	137	29	cancer	cancer	NOUN
dpc-3378	137	30	staging	staging	NOUN
dpc-3378	137	31	manual	manual	NOUN
dpc-3378	137	32	.	.	PUNCT
dpc-3378	138	1	ca	can	AUX
dpc-3378	138	2	cancer	cancer	PROPN
dpc-3378	138	3	j	j	PROPN
dpc-3378	138	4	 	 	SPACE
dpc-3378	138	5	clin	clin	PROPN
dpc-3378	138	6	.	.	PUNCT
dpc-3378	139	1	2017;67(6):472–492	2017;67(6):472–492	NUM
dpc-3378	139	2	.	.	PUNCT
dpc-3378	140	1	g	g	PROPN
dpc-3378	140	2	doi	doi	PROPN
dpc-3378	140	3	:	:	PUNCT
dpc-3378	140	4	10.3322	10.3322	NUM
dpc-3378	140	5	/	/	SYM
dpc-3378	140	6	caac.21409	caac.21409	PROPN
dpc-3378	140	7	.	.	PUNCT
dpc-3378	141	1	pmid	pmid	NOUN
dpc-3378	141	2	:	:	PUNCT
dpc-3378	141	3	29028110	29028110	NUM
dpc-3378	141	4	.	.	PUNCT
dpc-3378	142	1	pmcid	pmcid	ADJ
dpc-3378	142	2	:	:	PUNCT
dpc-3378	142	3	pmc5978683	pmc5978683	NOUN
dpc-3378	142	4	.	.	PUNCT
dpc-3378	143	1	18	18	NUM
dpc-3378	143	2	.	.	X
dpc-3378	143	3	brancaccio	brancaccio	PROPN
dpc-3378	143	4	g	g	NOUN
dpc-3378	143	5	,	,	PUNCT
dpc-3378	143	6	pellerone	pellerone	NOUN
dpc-3378	143	7	s	s	PART
dpc-3378	143	8	,	,	PUNCT
dpc-3378	143	9	scharf	scharf	PROPN
dpc-3378	143	10	c	c	NOUN
dpc-3378	143	11	,	,	PUNCT
dpc-3378	143	12	et	et	PROPN
dpc-3378	143	13	al	al	PROPN
dpc-3378	143	14	.	.	PROPN
dpc-3378	143	15	sentinel	sentinel	PROPN
dpc-3378	143	16	node	node	ADJ
dpc-3378	143	17	biopsy	biopsy	NOUN
dpc-3378	143	18	in	in	ADP
dpc-3378	143	19	thin	thin	ADJ
dpc-3378	143	20	melanoma	melanoma	NOUN
dpc-3378	143	21	:	:	PUNCT
dpc-3378	143	22	a	a	DET
dpc-3378	143	23	retrospective	retrospective	ADJ
dpc-3378	143	24	descriptive	descriptive	ADJ
dpc-3378	143	25	cohort	cohort	NOUN
dpc-3378	143	26	study	study	NOUN
dpc-3378	143	27	.	.	PUNCT
dpc-3378	144	1	j	j	PROPN
dpc-3378	144	2	  	  	SPACE
dpc-3378	144	3	eur	eur	PROPN
dpc-3378	144	4	acad	acad	NOUN
dpc-3378	144	5	dermatol	dermatol	NOUN
dpc-3378	144	6	venereol	venereol	NOUN
dpc-3378	144	7	.	.	PUNCT
dpc-3378	145	1	2022;36(10):e795	2022;36(10):e795	NUM
dpc-3378	145	2	-	-	PUNCT
dpc-3378	145	3	e796	e796	PROPN
dpc-3378	145	4	.	.	PUNCT
dpc-3378	145	5	doi	doi	NOUN
dpc-3378	145	6	:	:	PUNCT
dpc-3378	145	7	10.1111	10.1111	NUM
dpc-3378	145	8	/	/	SYM
dpc-3378	145	9	jdv.18274	jdv.18274	NOUN
dpc-3378	145	10	.	.	PUNCT
dpc-3378	146	1	pmid	pmid	NOUN
dpc-3378	146	2	:	:	PUNCT
dpc-3378	146	3	35622455	35622455	NUM
dpc-3378	146	4	.	.	PUNCT
dpc-3378	147	1	19	19	NUM
dpc-3378	147	2	.	.	X
dpc-3378	147	3	moncrieff	moncrieff	PROPN
dpc-3378	147	4	md	md	PROPN
dpc-3378	147	5	,	,	PUNCT
dpc-3378	147	6	lo	lo	PROPN
dpc-3378	147	7	sn	sn	PROPN
dpc-3378	147	8	,	,	PUNCT
dpc-3378	147	9	scolyer	scolyer	PROPN
dpc-3378	147	10	ra	ra	PROPN
dpc-3378	147	11	,	,	PUNCT
dpc-3378	147	12	et	et	PROPN
dpc-3378	147	13	al	al	PROPN
dpc-3378	147	14	.	.	PUNCT
dpc-3378	147	15	evaluation	evaluation	NOUN
dpc-3378	147	16	of	of	ADP
dpc-3378	147	17	the	the	DET
dpc-3378	147	18	indications	indication	NOUN
dpc-3378	147	19	for	for	ADP
dpc-3378	147	20	sentinel	sentinel	ADJ
dpc-3378	147	21	node	node	ADJ
dpc-3378	147	22	biopsy	biopsy	NOUN
dpc-3378	147	23	in	in	ADP
dpc-3378	147	24	early	early	ADJ
dpc-3378	147	25	-	-	PUNCT
dpc-3378	147	26	stage	stage	NOUN
dpc-3378	147	27	melanoma	melanoma	NOUN
dpc-3378	147	28	with	with	ADP
dpc-3378	147	29	the	the	DET
dpc-3378	147	30	advent	advent	NOUN
dpc-3378	147	31	of	of	ADP
dpc-3378	147	32	adjuvant	adjuvant	ADJ
dpc-3378	147	33	systemic	systemic	ADJ
dpc-3378	147	34	therapy	therapy	NOUN
dpc-3378	147	35	:	:	PUNCT
dpc-3378	147	36	an	an	DET
dpc-3378	147	37	international	international	ADJ
dpc-3378	147	38	,	,	PUNCT
dpc-3378	147	39	multicenter	multicenter	ADJ
dpc-3378	147	40	study	study	NOUN
dpc-3378	147	41	.	.	PUNCT
dpc-3378	148	1	ann	ann	PROPN
dpc-3378	148	2	surg	surg	PROPN
dpc-3378	148	3	oncol	oncol	PROPN
dpc-3378	148	4	.	.	PUNCT
dpc-3378	149	1	2022;29(9):5937–5945	2022;29(9):5937–5945	NUM
dpc-3378	149	2	.	.	PUNCT
dpc-3378	150	1	doi	doi	NOUN
dpc-3378	150	2	:	:	PUNCT
dpc-3378	150	3	10.1245	10.1245	NUM
dpc-3378	150	4	/	/	SYM
dpc-3378	150	5	s10434	s10434	PROPN
dpc-3378	150	6	-	-	PUNCT
dpc-3378	150	7	022	022	NUM
dpc-3378	150	8	-	-	PUNCT
dpc-3378	150	9	11761	11761	NUM
dpc-3378	150	10	-	-	SYM
dpc-3378	150	11	4	4	NUM
dpc-3378	150	12	.	.	PUNCT
dpc-3378	151	1	pmid	pmid	NOUN
dpc-3378	151	2	:	:	PUNCT
dpc-3378	151	3	35562521	35562521	NUM
dpc-3378	151	4	;	;	PUNCT
dpc-3378	151	5	pmcid	pmcid	PROPN
dpc-3378	151	6	:	:	PUNCT
dpc-3378	151	7	pmc9356930	pmc9356930	NOUN
dpc-3378	151	8	.	.	PUNCT
dpc-3378	152	1	20	20	NUM
dpc-3378	152	2	.	.	X
dpc-3378	153	1	moncrieff	moncrieff	PROPN
dpc-3378	153	2	md	md	PROPN
dpc-3378	153	3	,	,	PUNCT
dpc-3378	153	4	lo	lo	PROPN
dpc-3378	153	5	sn	sn	PROPN
dpc-3378	153	6	,	,	PUNCT
dpc-3378	153	7	scolyer	scolyer	PROPN
dpc-3378	153	8	ra	ra	PROPN
dpc-3378	153	9	,	,	PUNCT
dpc-3378	153	10	et	et	PROPN
dpc-3378	153	11	al	al	PROPN
dpc-3378	153	12	.	.	PUNCT
dpc-3378	154	1	clinical	clinical	ADJ
dpc-3378	154	2	outcomes	outcome	NOUN
dpc-3378	154	3	and	and	CCONJ
dpc-3378	154	4	risk	risk	NOUN
dpc-3378	154	5	stratification	stratification	NOUN
dpc-3378	154	6	of	of	ADP
dpc-3378	154	7	early	early	ADJ
dpc-3378	154	8	-	-	PUNCT
dpc-3378	154	9	stage	stage	NOUN
dpc-3378	154	10	melanoma	melanoma	NOUN
dpc-3378	154	11	micrometastases	micrometastase	NOUN
dpc-3378	154	12	from	from	ADP
dpc-3378	154	13	an	an	DET
dpc-3378	154	14	international	international	ADJ
dpc-3378	154	15	multicenter	multicenter	NOUN
dpc-3378	154	16	study	study	NOUN
dpc-3378	154	17	:	:	PUNCT
dpc-3378	154	18	implications	implication	NOUN
dpc-3378	154	19	for	for	ADP
dpc-3378	154	20	the	the	DET
dpc-3378	154	21	management	management	NOUN
dpc-3378	154	22	of	of	ADP
dpc-3378	154	23	american	american	PROPN
dpc-3378	154	24	joint	joint	PROPN
dpc-3378	154	25	committee	committee	PROPN
dpc-3378	154	26	on	on	ADP
dpc-3378	154	27	cancer	cancer	NOUN
dpc-3378	154	28	iiia	iiia	PROPN
dpc-3378	154	29	disease	disease	PROPN
dpc-3378	154	30	.	.	PUNCT
dpc-3378	155	1	j	j	PROPN
dpc-3378	155	2	clin	clin	PROPN
dpc-3378	155	3	oncol	oncol	PROPN
dpc-3378	155	4	.	.	PUNCT
dpc-3378	156	1	2022;40(34):3940	2022;40(34):3940	NOUN
dpc-3378	156	2	-	-	SYM
dpc-3378	156	3	3951	3951	NUM
dpc-3378	156	4	.	.	PUNCT
dpc-3378	157	1	doi	doi	NOUN
dpc-3378	157	2	:	:	PUNCT
dpc-3378	157	3	10.1200	10.1200	NUM
dpc-3378	157	4	/jco.21.02488	/jco.21.02488	NOUN
dpc-3378	157	5	.	.	PUNCT
dpc-3378	158	1	pmid	pmid	NOUN
dpc-3378	158	2	:	:	PUNCT
dpc-3378	158	3	35849790	35849790	NUM
dpc-3378	158	4	.	.	PUNCT
dpc-3378	159	1	21	21	NUM
dpc-3378	159	2	.	.	PUNCT
dpc-3378	159	3	hindié	hindié	PROPN
dpc-3378	159	4	e.	e.	PROPN
dpc-3378	159	5	adjuvant	adjuvant	PROPN
dpc-3378	159	6	therapy	therapy	PROPN
dpc-3378	159	7	in	in	ADP
dpc-3378	159	8	stage	stage	NOUN
dpc-3378	159	9	iiia	iiia	ADP
dpc-3378	159	10	melanoma	melanoma	NOUN
dpc-3378	159	11	.	.	PUNCT
dpc-3378	160	1	lancet	lancet	PROPN
dpc-3378	160	2	oncol	oncol	PROPN
dpc-3378	160	3	.	.	PUNCT
dpc-3378	161	1	2021;22(7):e299	2021;22(7):e299	NOUN
dpc-3378	161	2	.	.	PUNCT
dpc-3378	162	1	doi	doi	NOUN
dpc-3378	162	2	:	:	PUNCT
dpc-3378	162	3	10.1016	10.1016	NUM
dpc-3378	162	4	/	/	SYM
dpc-3378	162	5	s1470	s1470	PROPN
dpc-3378	162	6	-	-	PUNCT
dpc-3378	162	7	2045(21	2045(21	NUM
dpc-3378	162	8	)	)	PUNCT
dpc-3378	162	9	00346	00346	NUM
dpc-3378	162	10	-	-	SYM
dpc-3378	162	11	6	6	NUM
dpc-3378	162	12	.	.	PUNCT
dpc-3378	163	1	pmid	pmid	NOUN
dpc-3378	163	2	:	:	PUNCT
dpc-3378	163	3	34197759	34197759	NUM
dpc-3378	163	4	.	.	PUNCT
dpc-3378	164	1	22	22	NUM
dpc-3378	164	2	.	.	PUNCT
dpc-3378	165	1	eggermont	eggermont	PROPN
dpc-3378	165	2	amm	amm	PROPN
dpc-3378	165	3	,	,	PUNCT
dpc-3378	165	4	suciu	suciu	PROPN
dpc-3378	165	5	s	s	PROPN
dpc-3378	165	6	,	,	PUNCT
dpc-3378	165	7	robert	robert	PROPN
dpc-3378	165	8	c.	c.	PROPN
dpc-3378	165	9	adjuvant	adjuvant	PROPN
dpc-3378	165	10	therapy	therapy	NOUN
dpc-3378	165	11	in	in	ADP
dpc-3378	165	12	stage	stage	NOUN
dpc-3378	165	13	iiia	iiia	ADP
dpc-3378	165	14	melanoma	melanoma	PROPN
dpc-3378	165	15	authors	author	NOUN
dpc-3378	165	16	’	'	PUNCT
dpc-3378	165	17	reply	reply	NOUN
dpc-3378	165	18	.	.	PUNCT
dpc-3378	166	1	lancet	lancet	PROPN
dpc-3378	166	2	oncol	oncol	PROPN
dpc-3378	166	3	.	.	PUNCT
dpc-3378	167	1	2021;22(7):e300	2021;22(7):e300	INTJ
dpc-3378	167	2	.	.	PUNCT
dpc-3378	168	1	doi	doi	NOUN
dpc-3378	168	2	:	:	PUNCT
dpc-3378	168	3	10.1016	10.1016	NUM
dpc-3378	168	4	/	/	SYM
dpc-3378	168	5	s1470	s1470	PROPN
dpc-3378	168	6	-	-	PUNCT
dpc-3378	168	7	2045(21)00354	2045(21)00354	NUM
dpc-3378	168	8	-	-	SYM
dpc-3378	168	9	5	5	NUM
dpc-3378	168	10	.	.	PUNCT
dpc-3378	169	1	pmid	pmid	NOUN
dpc-3378	169	2	:	:	PUNCT
dpc-3378	169	3	34197760	34197760	NUM
dpc-3378	169	4	.	.	PUNCT
dpc-3378	170	1	23	23	NUM
dpc-3378	170	2	.	.	PUNCT
dpc-3378	171	1	michielin	michielin	PROPN
dpc-3378	171	2	o	o	PROPN
dpc-3378	171	3	,	,	PUNCT
dpc-3378	171	4	van	van	PROPN
dpc-3378	171	5	akkooi	akkooi	PROPN
dpc-3378	171	6	a	a	PRON
dpc-3378	171	7	,	,	PUNCT
dpc-3378	171	8	lorigan	lorigan	VERB
dpc-3378	171	9	p	p	X
dpc-3378	171	10	,	,	PUNCT
dpc-3378	171	11	et	et	PROPN
dpc-3378	171	12	al	al	PROPN
dpc-3378	171	13	.	.	PROPN
dpc-3378	172	1	esmo	esmo	PROPN
dpc-3378	172	2	consensus	consensus	NOUN
dpc-3378	172	3	conference	conference	NOUN
dpc-3378	172	4	recommendations	recommendation	NOUN
dpc-3378	172	5	on	on	ADP
dpc-3378	172	6	the	the	DET
dpc-3378	172	7	management	management	NOUN
dpc-3378	172	8	of	of	ADP
dpc-3378	172	9	locoregional	locoregional	ADJ
dpc-3378	172	10	melanoma	melanoma	NOUN
dpc-3378	172	11	:	:	PUNCT
dpc-3378	172	12	under	under	ADP
dpc-3378	172	13	the	the	DET
dpc-3378	172	14	auspices	auspex	NOUN
dpc-3378	172	15	of	of	ADP
dpc-3378	172	16	the	the	DET
dpc-3378	172	17	esmo	esmo	NOUN
dpc-3378	172	18	guidelines	guideline	NOUN
dpc-3378	172	19	committee	committee	NOUN
dpc-3378	172	20	.	.	PUNCT
dpc-3378	173	1	ann	ann	PROPN
dpc-3378	173	2	oncol	oncol	PROPN
dpc-3378	173	3	.	.	PUNCT
dpc-3378	174	1	2020;31(11):1449	2020;31(11):1449	X
dpc-3378	174	2	-	-	SYM
dpc-3378	174	3	1461	1461	NUM
dpc-3378	174	4	.	.	PUNCT
dpc-3378	175	1	doi	doi	NOUN
dpc-3378	175	2	:	:	PUNCT
dpc-3378	175	3	10.1016	10.1016	NUM
dpc-3378	175	4	/	/	SYM
dpc-3378	175	5	j	j	PROPN
dpc-3378	175	6	.annonc.2020.07.005	.annonc.2020.07.005	PUNCT
dpc-3378	175	7	.	.	PUNCT
dpc-3378	176	1	pmid	pmid	NOUN
dpc-3378	176	2	:	:	PUNCT
dpc-3378	176	3	32763452	32763452	NUM
dpc-3378	176	4	.	.	PUNCT
dpc-3378	177	1	clin	clin	PROPN
dpc-3378	177	2	exp	exp	NOUN
dpc-3378	177	3	metastasis	metastasis	NOUN
dpc-3378	177	4	.	.	PUNCT
dpc-3378	178	1	2012;29(7):699–706	2012;29(7):699–706	X
dpc-3378	178	2	.	.	PUNCT
dpc-3378	178	3	doi	doi	NOUN
dpc-3378	178	4	:	:	PUNCT
dpc-3378	178	5	10.1007	10.1007	NUM
dpc-3378	178	6	/s10585	/s10585	NOUN
dpc-3378	178	7	-	-	PUNCT
dpc-3378	178	8	012	012	NUM
dpc-3378	178	9	-	-	PUNCT
dpc-3378	178	10	9503	9503	NUM
dpc-3378	178	11	-	-	SYM
dpc-3378	178	12	3	3	NUM
dpc-3378	178	13	.	.	PUNCT
dpc-3378	179	1	pmid	pmid	NOUN
dpc-3378	179	2	:	:	PUNCT
dpc-3378	179	3	22729520	22729520	NUM
dpc-3378	179	4	.	.	PUNCT
dpc-3378	180	1	pmcid	pmcid	NOUN
dpc-3378	180	2	:	:	PUNCT
dpc-3378	180	3	pmc3463679	pmc3463679	NOUN
dpc-3378	180	4	.	.	PUNCT
dpc-3378	181	1	2	2	X
dpc-3378	181	2	.	.	X
dpc-3378	181	3	faries	farie	NOUN
dpc-3378	181	4	mb	mb	ADP
dpc-3378	181	5	,	,	PUNCT
dpc-3378	181	6	thompson	thompson	PROPN
dpc-3378	181	7	jf	jf	PROPN
dpc-3378	181	8	,	,	PUNCT
dpc-3378	181	9	cochran	cochran	PROPN
dpc-3378	181	10	aj	aj	PROPN
dpc-3378	181	11	,	,	PUNCT
dpc-3378	181	12	et	et	PROPN
dpc-3378	181	13	al	al	PROPN
dpc-3378	181	14	.	.	PUNCT
dpc-3378	181	15	completion	completion	NOUN
dpc-3378	181	16	dissection	dissection	NOUN
dpc-3378	181	17	or	or	CCONJ
dpc-3378	181	18	observation	observation	NOUN
dpc-3378	181	19	for	for	ADP
dpc-3378	181	20	sentinel	sentinel	ADJ
dpc-3378	181	21	-	-	PUNCT
dpc-3378	181	22	node	node	ADJ
dpc-3378	181	23	metastasis	metastasis	NOUN
dpc-3378	181	24	in	in	ADP
dpc-3378	181	25	melanoma	melanoma	NOUN
dpc-3378	181	26	.	.	PUNCT
dpc-3378	182	1	n	n	PRON
dpc-3378	182	2	engl	engl	PROPN
dpc-3378	182	3	j	j	PROPN
dpc-3378	182	4	med	med	PROPN
dpc-3378	182	5	.	.	PUNCT
dpc-3378	183	1	2017;376(23):2211–2222	2017;376(23):2211–2222	NUM
dpc-3378	183	2	.	.	PUNCT
dpc-3378	184	1	doi	doi	NOUN
dpc-3378	184	2	:	:	PUNCT
dpc-3378	184	3	10.1056	10.1056	NUM
dpc-3378	184	4	/nejmoa1613210	/nejmoa1613210	PUNCT
dpc-3378	184	5	.	.	PUNCT
dpc-3378	185	1	pmid	pmid	NOUN
dpc-3378	185	2	:	:	PUNCT
dpc-3378	185	3	28591523	28591523	NUM
dpc-3378	185	4	.	.	PUNCT
dpc-3378	186	1	pmcid	pmcid	NOUN
dpc-3378	186	2	:	:	PUNCT
dpc-3378	186	3	pmc5548388	pmc5548388	ADJ
dpc-3378	186	4	.	.	PUNCT
dpc-3378	187	1	3	3	X
dpc-3378	187	2	.	.	X
dpc-3378	187	3	wong	wong	PROPN
dpc-3378	187	4	sl	sl	PROPN
dpc-3378	187	5	,	,	PUNCT
dpc-3378	187	6	faries	farie	NOUN
dpc-3378	187	7	mb	mb	ADP
dpc-3378	187	8	,	,	PUNCT
dpc-3378	187	9	kennedy	kennedy	PROPN
dpc-3378	187	10	eb	eb	PROPN
dpc-3378	187	11	,	,	PUNCT
dpc-3378	187	12	et	et	PROPN
dpc-3378	187	13	al	al	PROPN
dpc-3378	187	14	.	.	PROPN
dpc-3378	187	15	sentinel	sentinel	PROPN
dpc-3378	187	16	lymph	lymph	PROPN
dpc-3378	187	17	node	node	PROPN
dpc-3378	187	18	biopsy	biopsy	NOUN
dpc-3378	187	19	and	and	CCONJ
dpc-3378	187	20	management	management	NOUN
dpc-3378	187	21	of	of	ADP
dpc-3378	187	22	regional	regional	ADJ
dpc-3378	187	23	lymph	lymph	NOUN
dpc-3378	187	24	nodes	node	NOUN
dpc-3378	187	25	in	in	ADP
dpc-3378	187	26	melanoma	melanoma	NOUN
dpc-3378	187	27	:	:	PUNCT
dpc-3378	187	28	american	american	ADJ
dpc-3378	187	29	society	society	NOUN
dpc-3378	187	30	of	of	ADP
dpc-3378	187	31	clinical	clinical	ADJ
dpc-3378	187	32	oncology	oncology	NOUN
dpc-3378	187	33	and	and	CCONJ
dpc-3378	187	34	society	society	NOUN
dpc-3378	187	35	of	of	ADP
dpc-3378	187	36	surgical	surgical	ADJ
dpc-3378	187	37	oncology	oncology	NOUN
dpc-3378	187	38	clinical	clinical	ADJ
dpc-3378	187	39	practice	practice	NOUN
dpc-3378	187	40	guideline	guideline	NOUN
dpc-3378	187	41	update	update	NOUN
dpc-3378	187	42	.	.	PUNCT
dpc-3378	188	1	j	j	PROPN
dpc-3378	188	2	clin	clin	PROPN
dpc-3378	188	3	oncol	oncol	PROPN
dpc-3378	188	4	.	.	PUNCT
dpc-3378	189	1	2018;36(4):399–413	2018;36(4):399–413	X
dpc-3378	189	2	.	.	PUNCT
dpc-3378	189	3	doi	doi	NOUN
dpc-3378	189	4	:	:	PUNCT
dpc-3378	189	5	10.1200	10.1200	NUM
dpc-3378	189	6	/	/	SYM
dpc-3378	189	7	jco.2017.75.7724	jco.2017.75.7724	PROPN
dpc-3378	189	8	.	.	PUNCT
dpc-3378	190	1	pmid	pmid	NOUN
dpc-3378	190	2	:	:	PUNCT
dpc-3378	190	3	29232171	29232171	NUM
dpc-3378	190	4	.	.	PUNCT
dpc-3378	191	1	4	4	X
dpc-3378	191	2	.	.	X
dpc-3378	191	3	morton	morton	PROPN
dpc-3378	191	4	dl	dl	PROPN
dpc-3378	191	5	,	,	PUNCT
dpc-3378	191	6	cochran	cochran	PROPN
dpc-3378	191	7	aj	aj	PROPN
dpc-3378	191	8	,	,	PUNCT
dpc-3378	191	9	thompson	thompson	PROPN
dpc-3378	191	10	jf	jf	PROPN
dpc-3378	191	11	,	,	PUNCT
dpc-3378	191	12	et	et	PROPN
dpc-3378	191	13	al	al	PROPN
dpc-3378	191	14	.	.	PROPN
dpc-3378	191	15	sentinel	sentinel	PROPN
dpc-3378	191	16	node	node	PROPN
dpc-3378	191	17	biopsy	biopsy	NOUN
dpc-3378	191	18	for	for	ADP
dpc-3378	191	19	early	early	ADJ
dpc-3378	191	20	-	-	PUNCT
dpc-3378	191	21	stage	stage	NOUN
dpc-3378	191	22	melanoma	melanoma	NOUN
dpc-3378	191	23	:	:	PUNCT
dpc-3378	191	24	accuracy	accuracy	NOUN
dpc-3378	191	25	and	and	CCONJ
dpc-3378	191	26	morbidity	morbidity	NOUN
dpc-3378	191	27	in	in	ADP
dpc-3378	191	28	mslt	mslt	PROPN
dpc-3378	191	29	-	-	PUNCT
dpc-3378	191	30	i	i	PROPN
dpc-3378	191	31	,	,	PUNCT
dpc-3378	191	32	an	an	DET
dpc-3378	191	33	international	international	ADJ
dpc-3378	191	34	multicenter	multicenter	NOUN
dpc-3378	191	35	trial	trial	NOUN
dpc-3378	191	36	.	.	PUNCT
dpc-3378	192	1	ann	ann	PROPN
dpc-3378	192	2	surg	surg	PROPN
dpc-3378	192	3	.	.	PUNCT
dpc-3378	193	1	2005;242(3):302	2005;242(3):302	NUM
dpc-3378	193	2	-	-	SYM
dpc-3378	193	3	311	311	NUM
dpc-3378	193	4	;	;	PUNCT
dpc-3378	193	5	doi	doi	NOUN
dpc-3378	193	6	:	:	PUNCT
dpc-3378	193	7	10.1097/01.sla.0000181092.50141.fa	10.1097/01.sla.0000181092.50141.fa	NUM
dpc-3378	193	8	.	.	PUNCT
dpc-3378	194	1	pmid	pmid	NOUN
dpc-3378	194	2	:	:	PUNCT
dpc-3378	194	3	16135917	16135917	NUM
dpc-3378	194	4	.	.	PUNCT
dpc-3378	195	1	pmcid	pmcid	NOUN
dpc-3378	195	2	:	:	PUNCT
dpc-3378	195	3	pmc1357739	pmc1357739	ADJ
dpc-3378	195	4	.	.	PUNCT
dpc-3378	196	1	5	5	X
dpc-3378	196	2	.	.	X
dpc-3378	196	3	national	national	ADJ
dpc-3378	196	4	comprehensive	comprehensive	ADJ
dpc-3378	196	5	cancer	cancer	NOUN
dpc-3378	196	6	network	network	NOUN
dpc-3378	196	7	.	.	PUNCT
dpc-3378	197	1	melanoma	melanoma	NOUN
dpc-3378	197	2	:	:	PUNCT
dpc-3378	197	3	cutaneous	cutaneous	ADJ
dpc-3378	197	4	(	(	PUNCT
dpc-3378	197	5	version	version	NOUN
dpc-3378	197	6	1.2023	1.2023	NUM
dpc-3378	197	7	)	)	PUNCT
dpc-3378	198	1	[	[	X
dpc-3378	198	2	internet	internet	NOUN
dpc-3378	198	3	]	]	X
dpc-3378	198	4	.	.	PUNCT
dpc-3378	199	1	2023	2023	NUM
dpc-3378	199	2	.	.	PUNCT
dpc-3378	200	1	available	available	ADJ
dpc-3378	200	2	from	from	ADP
dpc-3378	200	3	:	:	PUNCT
dpc-3378	200	4	https://www	https://www	PROPN
dpc-3378	200	5	.nccn.org	.nccn.org	PROPN
dpc-3378	200	6	/	/	SYM
dpc-3378	200	7	professionals	professional	NOUN
dpc-3378	200	8	/	/	SYM
dpc-3378	200	9	physician_gls	physician_gls	NOUN
dpc-3378	200	10	/	/	SYM
dpc-3378	200	11	pdf	pdf	NOUN
dpc-3378	200	12	/	/	SYM
dpc-3378	200	13	cutaneous_melanoma	cutaneous_melanoma	ADJ
dpc-3378	200	14	.pdf	.pdf	NOUN
dpc-3378	200	15	please	please	INTJ
dpc-3378	200	16	provide	provide	VERB
dpc-3378	200	17	date	date	NOUN
dpc-3378	200	18	of	of	ADP
dpc-3378	200	19	access	access	NOUN
dpc-3378	200	20	6	6	NUM
dpc-3378	200	21	.	.	PUNCT
dpc-3378	201	1	garbe	garbe	PROPN
dpc-3378	201	2	c	c	PROPN
dpc-3378	201	3	,	,	PUNCT
dpc-3378	201	4	amaral	amaral	PROPN
dpc-3378	201	5	t	t	PROPN
dpc-3378	201	6	,	,	PUNCT
dpc-3378	201	7	peris	peris	PROPN
dpc-3378	201	8	k	k	PROPN
dpc-3378	201	9	,	,	PUNCT
dpc-3378	201	10	et	et	PROPN
dpc-3378	201	11	al	al	PROPN
dpc-3378	201	12	.	.	PUNCT
dpc-3378	202	1	european	european	PROPN
dpc-3378	202	2	consensus	consensus	NOUN
dpc-3378	202	3	-	-	PUNCT
dpc-3378	202	4	based	base	VERB
dpc-3378	202	5	interdisciplinary	interdisciplinary	ADJ
dpc-3378	202	6	guideline	guideline	NOUN
dpc-3378	202	7	for	for	ADP
dpc-3378	202	8	melanoma	melanoma	NOUN
dpc-3378	202	9	.	.	PUNCT
dpc-3378	203	1	part	part	NOUN
dpc-3378	203	2	2	2	NUM
dpc-3378	203	3	:	:	PUNCT
dpc-3378	203	4	treatment	treatment	NOUN
dpc-3378	203	5	update	update	NOUN
dpc-3378	203	6	2022	2022	NUM
dpc-3378	203	7	.	.	PUNCT
dpc-3378	204	1	eur	eur	PROPN
dpc-3378	204	2	j	j	PROPN
dpc-3378	204	3	cancer	cancer	NOUN
dpc-3378	204	4	.	.	PUNCT
dpc-3378	205	1	2022;170:256–284	2022;170:256–284	NOUN
dpc-3378	205	2	.	.	PUNCT
dpc-3378	206	1	doi	doi	NOUN
dpc-3378	206	2	:	:	PUNCT
dpc-3378	206	3	10.1016	10.1016	NUM
dpc-3378	206	4	/	/	SYM
dpc-3378	206	5	j	j	PROPN
dpc-3378	206	6	.ejca.2022.04.018	.ejca.2022.04.018	PUNCT
dpc-3378	206	7	.	.	PUNCT
dpc-3378	207	1	epub	epub	NOUN
dpc-3378	207	2	2022	2022	NUM
dpc-3378	207	3	may	may	AUX
dpc-3378	207	4	24	24	NUM
dpc-3378	207	5	.	.	PUNCT
dpc-3378	208	1	pmid	pmid	NOUN
dpc-3378	208	2	:	:	PUNCT
dpc-3378	208	3	35623961	35623961	NUM
dpc-3378	208	4	.	.	PUNCT
dpc-3378	209	1	7	7	X
dpc-3378	209	2	.	.	X
dpc-3378	209	3	nieweg	nieweg	PROPN
dpc-3378	209	4	oe	oe	PROPN
dpc-3378	209	5	.	.	PROPN
dpc-3378	209	6	false	false	ADJ
dpc-3378	209	7	-	-	PUNCT
dpc-3378	209	8	negative	negative	ADJ
dpc-3378	209	9	sentinel	sentinel	ADJ
dpc-3378	209	10	node	node	ADJ
dpc-3378	209	11	biopsy	biopsy	NOUN
dpc-3378	209	12	:	:	PUNCT
dpc-3378	209	13	editorial	editorial	NOUN
dpc-3378	209	14	.	.	PUNCT
dpc-3378	210	1	ann	ann	PROPN
dpc-3378	210	2	surg	surg	PROPN
dpc-3378	210	3	oncol	oncol	PROPN
dpc-3378	210	4	.	.	PUNCT
dpc-3378	211	1	2009;16(8):2089–2091	2009;16(8):2089–2091	NUM
dpc-3378	211	2	.	.	PUNCT
dpc-3378	212	1	doi	doi	NOUN
dpc-3378	212	2	:	:	PUNCT
dpc-3378	212	3	10.1245	10.1245	NUM
dpc-3378	212	4	/	/	SYM
dpc-3378	212	5	s10434	s10434	NOUN
dpc-3378	212	6	-009	-009	PROPN
dpc-3378	212	7	-	-	PUNCT
dpc-3378	212	8	0540	0540	NUM
dpc-3378	212	9	-	-	PUNCT
dpc-3378	212	10	3	3	NUM
dpc-3378	212	11	.	.	PUNCT
dpc-3378	212	12	epub	epub	PROPN
dpc-3378	212	13	2009	2009	NUM
dpc-3378	212	14	jun	jun	PROPN
dpc-3378	212	15	12	12	NUM
dpc-3378	212	16	.	.	PUNCT
dpc-3378	213	1	pmid	pmid	NOUN
dpc-3378	213	2	:	:	PUNCT
dpc-3378	213	3	19521734	19521734	NUM
dpc-3378	213	4	;	;	PUNCT
dpc-3378	213	5	pmcid	pmcid	ADJ
dpc-3378	213	6	:	:	PUNCT
dpc-3378	213	7	pmc2711910	pmc2711910	NOUN
dpc-3378	213	8	.	.	PUNCT
dpc-3378	214	1	8	8	X
dpc-3378	214	2	.	.	PUNCT
dpc-3378	215	1	weber	weber	PROPN
dpc-3378	215	2	j	j	PROPN
dpc-3378	215	3	,	,	PUNCT
dpc-3378	215	4	mandala	mandala	PROPN
dpc-3378	215	5	m	m	PROPN
dpc-3378	215	6	,	,	PUNCT
dpc-3378	215	7	del	del	PROPN
dpc-3378	215	8	vecchio	vecchio	PROPN
dpc-3378	215	9	m	m	PROPN
dpc-3378	215	10	,	,	PUNCT
dpc-3378	215	11	et	et	PROPN
dpc-3378	215	12	al	al	PROPN
dpc-3378	215	13	.	.	PROPN
dpc-3378	216	1	adjuvant	adjuvant	PROPN
dpc-3378	216	2	nivolumab	nivolumab	ADV
dpc-3378	216	3	versus	versus	ADP
dpc-3378	216	4	ipilimumab	ipilimumab	VERB
dpc-3378	216	5	in	in	ADP
dpc-3378	216	6	resected	resect	VERB
dpc-3378	216	7	stage	stage	NOUN
dpc-3378	216	8	iii	iii	NOUN
dpc-3378	216	9	or	or	CCONJ
dpc-3378	216	10	iv	iv	NUM
dpc-3378	216	11	melanoma	melanoma	NOUN
dpc-3378	216	12	.	.	PUNCT
dpc-3378	217	1	n	n	CCONJ
dpc-3378	217	2	  	  	SPACE
dpc-3378	217	3	engl	engl	PROPN
dpc-3378	217	4	j	j	PROPN
dpc-3378	217	5	med	med	PROPN
dpc-3378	217	6	.	.	PUNCT
dpc-3378	218	1	2017;377(19):1824–1835	2017;377(19):1824–1835	NUM
dpc-3378	218	2	.	.	PUNCT
dpc-3378	219	1	doi	doi	NOUN
dpc-3378	219	2	:	:	PUNCT
dpc-3378	219	3	10.1056	10.1056	NUM
dpc-3378	219	4	/	/	SYM
dpc-3378	219	5	nejmoa1709030	nejmoa1709030	PROPN
dpc-3378	219	6	.	.	PUNCT
dpc-3378	220	1	pmid	pmid	NOUN
dpc-3378	220	2	:	:	PUNCT
dpc-3378	220	3	28891423	28891423	NUM
dpc-3378	220	4	.	.	PUNCT
dpc-3378	221	1	9	9	X
dpc-3378	221	2	.	.	X
dpc-3378	221	3	eggermont	eggermont	PROPN
dpc-3378	221	4	amm	amm	PROPN
dpc-3378	221	5	,	,	PUNCT
dpc-3378	221	6	blank	blank	PROPN
dpc-3378	221	7	cu	cu	PROPN
dpc-3378	221	8	,	,	PUNCT
dpc-3378	221	9	mandala	mandala	PROPN
dpc-3378	221	10	m	m	PROPN
dpc-3378	221	11	,	,	PUNCT
dpc-3378	221	12	et	et	PROPN
dpc-3378	221	13	al	al	PROPN
dpc-3378	221	14	.	.	PROPN
dpc-3378	221	15	adjuvant	adjuvant	PROPN
dpc-3378	221	16	pembrolizumab	pembrolizumab	NOUN
dpc-3378	221	17	versus	versus	ADP
dpc-3378	221	18	placebo	placebo	NOUN
dpc-3378	221	19	in	in	ADP
dpc-3378	221	20	resected	resect	VERB
dpc-3378	221	21	stage	stage	NOUN
dpc-3378	221	22	iii	iii	NUM
dpc-3378	221	23	melanoma	melanoma	NOUN
dpc-3378	221	24	.	.	PUNCT
dpc-3378	222	1	n	n	PRON
dpc-3378	222	2	engl	engl	PROPN
dpc-3378	222	3	j	j	PROPN
dpc-3378	222	4	med	med	PROPN
dpc-3378	222	5	.	.	PUNCT
dpc-3378	223	1	2018;378(19):1789–1801	2018;378(19):1789–1801	NUM
dpc-3378	223	2	.	.	PUNCT
dpc-3378	224	1	doi	doi	NOUN
dpc-3378	224	2	:	:	PUNCT
dpc-3378	224	3	10.1056	10.1056	NUM
dpc-3378	224	4	/nejmoa1802357	/nejmoa1802357	PUNCT
dpc-3378	224	5	.	.	PUNCT
dpc-3378	225	1	epub	epub	PROPN
dpc-3378	225	2	2018	2018	NUM
dpc-3378	225	3	apr	apr	NOUN
dpc-3378	225	4	15	15	NUM
dpc-3378	225	5	.	.	PUNCT
dpc-3378	226	1	pmid	pmid	NOUN
dpc-3378	226	2	:	:	PUNCT
dpc-3378	226	3	29658430	29658430	NUM
dpc-3378	226	4	.	.	PUNCT
dpc-3378	227	1	10	10	NUM
dpc-3378	227	2	.	.	X
dpc-3378	228	1	long	long	ADV
dpc-3378	228	2	g	g	PROPN
dpc-3378	228	3	v	v	NOUN
dpc-3378	228	4	,	,	PUNCT
dpc-3378	228	5	hauschild	hauschild	NOUN
dpc-3378	228	6	a	a	PRON
dpc-3378	228	7	,	,	PUNCT
dpc-3378	228	8	santinami	santinami	NOUN
dpc-3378	228	9	m	m	PROPN
dpc-3378	228	10	,	,	PUNCT
dpc-3378	228	11	et	et	PROPN
dpc-3378	228	12	al	al	PROPN
dpc-3378	228	13	.	.	PROPN
dpc-3378	229	1	adjuvant	adjuvant	PROPN
dpc-3378	229	2	dabrafenib	dabrafenib	NOUN
dpc-3378	229	3	plus	plus	CCONJ
dpc-3378	229	4	trametinib	trametinib	NOUN
dpc-3378	229	5	in	in	ADP
dpc-3378	229	6	stage	stage	NOUN
dpc-3378	229	7	iii	iii	NUM
dpc-3378	229	8	braf	braf	NOUN
dpc-3378	229	9	-mutated	-mutate	VERB
dpc-3378	229	10	melanoma	melanoma	NOUN
dpc-3378	229	11	.	.	PUNCT
dpc-3378	230	1	n	n	PRON
dpc-3378	230	2	engl	engl	PROPN
dpc-3378	230	3	j	j	PROPN
dpc-3378	230	4	med	med	PROPN
dpc-3378	230	5	.	.	PUNCT
dpc-3378	231	1	2017;377(19):1813–1823	2017;377(19):1813–1823	NUM
dpc-3378	231	2	.	.	PUNCT
dpc-3378	231	3	doi	doi	NOUN
dpc-3378	231	4	:	:	PUNCT
dpc-3378	231	5	10.1056	10.1056	NUM
dpc-3378	231	6	/nejmoa1708539	/nejmoa1708539	PUNCT
dpc-3378	231	7	.	.	PUNCT
dpc-3378	232	1	pmid	pmid	NOUN
dpc-3378	232	2	:	:	PUNCT
dpc-3378	232	3	28891408	28891408	NUM
dpc-3378	232	4	.	.	PUNCT
dpc-3378	233	1	11	11	NUM
dpc-3378	233	2	.	.	X
dpc-3378	234	1	napolitano	napolitano	PROPN
dpc-3378	234	2	s	s	PROPN
dpc-3378	234	3	,	,	PUNCT
dpc-3378	234	4	brancaccio	brancaccio	NOUN
dpc-3378	234	5	g	g	NOUN
dpc-3378	234	6	,	,	PUNCT
dpc-3378	234	7	argenziano	argenziano	ADJ
dpc-3378	234	8	g	g	NOUN
dpc-3378	234	9	,	,	PUNCT
dpc-3378	234	10	et	et	PROPN
dpc-3378	234	11	al	al	PROPN
dpc-3378	234	12	.	.	PUNCT
dpc-3378	235	1	it	it	PRON
dpc-3378	235	2	is	be	AUX
dpc-3378	235	3	finally	finally	ADV
dpc-3378	235	4	time	time	NOUN
dpc-3378	235	5	for	for	ADP
dpc-3378	235	6	adjuvant	adjuvant	ADJ
dpc-3378	235	7	therapy	therapy	NOUN
dpc-3378	235	8	in	in	ADP
dpc-3378	235	9	melanoma	melanoma	NOUN
dpc-3378	235	10	.	.	PUNCT
dpc-3378	236	1	cancer	cancer	NOUN
dpc-3378	236	2	treat	treat	PROPN
dpc-3378	236	3	rev	rev	VERB
dpc-3378	236	4	.	.	PUNCT
dpc-3378	237	1	2018;69:101111	2018;69:101111	NUM
dpc-3378	237	2	.	.	PUNCT
dpc-3378	237	3	doi	doi	NOUN
dpc-3378	237	4	:	:	PUNCT
dpc-3378	237	5	10.1016	10.1016	NUM
dpc-3378	237	6	/	/	SYM
dpc-3378	237	7	j.ctrv.2018.06.003	j.ctrv.2018.06.003	PROPN
dpc-3378	237	8	.	.	PUNCT
dpc-3378	238	1	pmid	pmid	NOUN
dpc-3378	238	2	:	:	PUNCT
dpc-3378	238	3	29957365	29957365	NUM
dpc-3378	238	4	.	.	PUNCT
dpc-3378	239	1	12	12	NUM
dpc-3378	239	2	.	.	PUNCT
dpc-3378	240	1	brancaccio	brancaccio	PROPN
dpc-3378	240	2	g	g	PROPN
dpc-3378	240	3	,	,	PUNCT
dpc-3378	240	4	napolitano	napolitano	PROPN
dpc-3378	240	5	s	s	PROPN
dpc-3378	240	6	,	,	PUNCT
dpc-3378	240	7	troiani	troiani	PROPN
dpc-3378	240	8	t	t	PROPN
dpc-3378	240	9	,	,	PUNCT
dpc-3378	240	10	et	et	PROPN
dpc-3378	240	11	al	al	PROPN
dpc-3378	240	12	.	.	PROPN
dpc-3378	240	13	eighth	eighth	PROPN
dpc-3378	240	14	american	american	PROPN
dpc-3378	240	15	joint	joint	PROPN
dpc-3378	240	16	committee	committee	PROPN
dpc-3378	240	17	on	on	ADP
dpc-3378	240	18	cancer	cancer	NOUN
dpc-3378	240	19	(	(	PUNCT
dpc-3378	240	20	ajcc	ajcc	PROPN
dpc-3378	240	21	)	)	PUNCT
dpc-3378	240	22	melanoma	melanoma	NOUN
dpc-3378	240	23	classification	classification	NOUN
dpc-3378	240	24	:	:	PUNCT
dpc-3378	240	25	what	what	PRON
dpc-3378	240	26	about	about	ADP
dpc-3378	240	27	stage	stage	NOUN
dpc-3378	240	28	iic	iic	PROPN
dpc-3378	240	29	?	?	PUNCT
dpc-3378	241	1	br	br	PROPN
dpc-3378	241	2	j	j	PROPN
dpc-3378	241	3	dermatol	dermatol	NOUN
dpc-3378	241	4	.	.	PUNCT
dpc-3378	242	1	2018;179(6):1422	2018;179(6):1422	NUM
dpc-3378	242	2	-	-	SYM
dpc-3378	242	3	1423	1423	NUM
dpc-3378	242	4	.	.	PUNCT
dpc-3378	243	1	doi	doi	NOUN
dpc-3378	243	2	:	:	PUNCT
dpc-3378	243	3	10.1111	10.1111	NUM
dpc-3378	243	4	/	/	SYM
dpc-3378	243	5	bjd.17145	bjd.17145	NOUN
dpc-3378	243	6	.	.	PUNCT
dpc-3378	244	1	pmid	pmid	NOUN
dpc-3378	244	2	:	:	PUNCT
dpc-3378	244	3	30187449	30187449	NUM
dpc-3378	244	4	.	.	PUNCT